0000021665-26-000006 | 10-K | XBRL Viewer

Print Document

Income Taxes - Schedule of Components of Income Before Income Taxes (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Income Tax Disclosure [Abstract]
United States	$ 1,419	$ 1,084	$ 692
International	1,640	2,872	2,700
Income before income taxes	$ 3,059	$ 3,956	$ 3,392

- Definition

Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-4

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 21
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-21

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-14

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 235
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 235
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 48
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-48

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 270
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482964/270-10-50-1

Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (ee)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 12: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(11))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1

Reference 14: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-31

Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(10))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 942
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(15))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1

+ Details

Supplemental Balance Sheet Information - Schedule of Property, Plant and Equipment (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Property, plant and equipment, net
Land	$ 234	$ 226
Buildings	2,171	2,056
Manufacturing machinery and equipment	6,935	6,265
Other equipment	1,516	1,580
Property, plant and equipment, gross	10,856	10,127
Accumulated depreciation	(6,196)	(5,705)
Property, plant and equipment, net	$ 4,660	$ 4,422

Retirement Plans and Other Retiree Benefits - Schedule of Benefit Obligation Exceeds Fair Value of Plan Assets (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Projected benefit obligation	$ 2,117	$ 2,251
Fair value of plan assets	1,443	1,486
Accumulated benefit obligation	2,002	2,075
Fair value of plan assets	1,363	1,345
Other Retiree Benefit Plans
Defined Benefit Plan Disclosure [Line Items]
Accumulated benefit obligation	0	0
Fair value of plan assets	$ 0	$ 0

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (k)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (l)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (j)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (j)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (j)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (j)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (c)(iv)(02)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (c)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-7

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (q)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (m)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

+ Details

Nature of Operations - Schedule of Percentage of Worldwide Sales (Details) - Sales Revenue, Net - Product	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Entity-Wide Information, Revenue from External Customer [Line Items]
Percent of net sales	100.00%	100.00%	100.00%
Oral Care
Entity-Wide Information, Revenue from External Customer [Line Items]
Percent of net sales	44.00%	43.00%	42.00%
Personal Care
Entity-Wide Information, Revenue from External Customer [Line Items]
Percent of net sales	17.00%	18.00%	19.00%
Home Care
Entity-Wide Information, Revenue from External Customer [Line Items]
Percent of net sales	16.00%	17.00%	17.00%
Pet Nutrition
Entity-Wide Information, Revenue from External Customer [Line Items]
Percent of net sales	23.00%	22.00%	22.00%

- Definition

For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.

+ References + Details

Income Taxes - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
Income Taxes - Narrative (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Income Tax Disclosure [Abstract]
Net operating loss and capital loss carryforwards	$ 38
Net operating loss and capital loss carryforwards, set to begin expiring	4
Net operating loss carryforwards, not subject to expiration	6
Net operating loss carryforward, valuation allowance	28
Tax credit carryforward	455
Tax credit carryforward, subject to expiration	36
Tax credit carryforward, not subject to expiration	17
tax credit carryforward, valuation allowance	402
Income tax expense (benefit) allocated directly to equity	76	$ 55	$ 19
Unrecognized tax benefits that would impact effective tax rate	308
Interest (income) expense recognized related to unrecognized tax benefits	26	22	10
Accrued interest related to unrecognized tax benefits	95	$ 68	$ 45
Tax plus interest for years 2010 through 2018	$ 165

Consolidated Statements of Changes in Shareholders' Equity (Parenthetical)	12 Months Ended
	Dec. 31, 2025 dividend $ / shares	Dec. 31, 2024 dividend $ / shares	Dec. 31, 2023 dividend $ / shares
Statement of Stockholders' Equity [Abstract]
Dividends declared per common share (in dollars per share) \| $ / shares	$ 2.08	$ 2.48	$ 1.91
Number of dividends declared per quarter \| dividend	4	5	4

Fair Value Measurements and Financial Instruments - Schedule of Notional Values (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Fair Value Hedges
Derivative Instruments, Gain (Loss) [Line Items]
Notional value of derivative	$ 2,093	$ 1,669
Fair Value Hedges \| Foreign currency contracts
Derivative Instruments, Gain (Loss) [Line Items]
Notional value of derivative	2,093	1,669
Fair Value Hedges \| Foreign Currency Debt
Derivative Instruments, Gain (Loss) [Line Items]
Notional value of derivative	0	0
Fair Value Hedges \| Commodity contracts
Derivative Instruments, Gain (Loss) [Line Items]
Notional value of derivative	0	0
Cash Flow Hedges
Derivative Instruments, Gain (Loss) [Line Items]
Notional value of derivative	1,122	1,041
Cash Flow Hedges \| Foreign currency contracts
Derivative Instruments, Gain (Loss) [Line Items]
Notional value of derivative	1,106	1,023
Cash Flow Hedges \| Foreign Currency Debt
Derivative Instruments, Gain (Loss) [Line Items]
Notional value of derivative	0	0
Cash Flow Hedges \| Commodity contracts
Derivative Instruments, Gain (Loss) [Line Items]
Notional value of derivative	16	18
Net Investment Hedges
Derivative Instruments, Gain (Loss) [Line Items]
Notional value of derivative	4,278	4,039
Net Investment Hedges \| Foreign currency contracts
Derivative Instruments, Gain (Loss) [Line Items]
Notional value of derivative	336	289
Net Investment Hedges \| Foreign Currency Debt
Derivative Instruments, Gain (Loss) [Line Items]
Notional value of derivative	3,942	3,750
Net Investment Hedges \| Commodity contracts
Derivative Instruments, Gain (Loss) [Line Items]
Notional value of derivative	$ 0	$ 0

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4C
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 182
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480401/815-10-55-182

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4D
-Subparagraph (a)(5)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4D

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4D
-Subparagraph (a)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4D

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4D
-Subparagraph (a)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4D

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4D
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4D

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4A
-Subparagraph (b)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4D
-Subparagraph (a)(6)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4D

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4D
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4D

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4A
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4C
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4CCC
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4CCC

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4CCC
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4CCC

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4CCC
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4CCC

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4CC
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4CC

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4C
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4C
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4C
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4C
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4C
-Subparagraph (bb)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4D
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4D

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4E
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-4E

+ Details

Capital Stock and Stock-Based Compensation Plans - Schedule of Common Stock and Treasury Stock Activity (Details) - shares	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Common Stock Outstanding
Common stock balance, January 1 (in shares)	812,574,698	821,412,769	830,212,606
Common stock acquired (in shares)	13,652,320	18,321,422	14,735,909
Shares issued for stock options (in shares)	1,339,704	8,606,699	5,318,430
Shares issued for restricted stock and other (in shares)	977,442	876,652	617,642
Common stock balance, December 31 (in shares)	801,239,524	812,574,698	821,412,769
Treasury Stock
Treasury stock balance, January 1 (in shares)	653,131,662	644,293,591	635,493,754
Common stock acquired (in shares)	13,652,320	18,321,422	14,735,909
Shares issued for stock options (in shares)	1,339,704	8,606,699	5,318,430
Shares issued for restricted stock and other (in shares)	977,442	876,652	617,642
Treasury stock balance, December 31 (in shares)	664,466,836	653,131,662	644,293,591

Restructuring and Related Implementation Charges

12 Months Ended

Dec. 31, 2025

Restructuring and Related Activities [Abstract]

Restructuring and Related Implementation Charges

Strategic Growth and Productivity Program

On July 31, 2025, the Company’s Board of Directors (the “Board”) approved a new three-year productivity program to drive future growth and support the Company’s 2030 strategy (the “Strategic Growth and Productivity Program”). The program includes initiatives to better align the Company’s organizational structure to support its strategic initiatives, optimize the Company’s global supply chain to drive agility and efficiencies and simplify and streamline its organizational structure to reduce overhead costs.

The Strategic Growth and Productivity Program is estimated to result in cumulative pre-tax charges, once all initiatives are approved and implemented, totaling between $200 and $300, which is currently estimated to be comprised of the following: employee-related costs, including severance and other termination benefits (65% to 75%) and asset-related costs and other charges (25% to 35%), which include accelerated depreciation, asset write-downs, contract termination and other exit costs. It is estimated that approximately 75% to 85% of the charges will result in cash expenditures and substantially all charges resulting from the program will be incurred by December 31, 2028.

It is estimated that the cumulative pretax charges, once all projects are approved and implemented, will relate to initiatives undertaken in North America (15% to 20%), Latin America (15% to 20%), Europe (10% to 15%), Asia Pacific (10% to 15%), Africa/Eurasia (5% to 10%), Hill’s Pet Nutrition (10% to 15%) and Corporate (10% to 15%).

For the twelve months ended December 31, 2025, charges resulting from the Strategic Growth and Productivity Program are reflected in the income statement as follows:


	Twelve months ended December 31, 2025


Selling, general and administrative expenses	$	6
Other (income) expense, net	7

Total Strategic Growth and Productivity Program charges, pretax	$	13

Total Strategic Growth and Productivity Program charges, aftertax	$	11

Restructuring and related implementation charges are recorded in the Corporate segment as these initiatives are predominantly centrally directed and controlled and are not included in internal measures of segment operating performance.

Total charges incurred for the Strategic Growth and Productivity Program relate to initiatives undertaken by the following reportable operating segments:


	Twelve months ended December 31, 2025

North America	30	%
Latin America	—	%
Europe	4	%
Asia Pacific	—	%
Africa/Eurasia	—	%
Pet Nutrition	1	%
Corporate	65	%
Total	100	%

The Company has incurred pretax charges of $13 ($11 aftertax) in connection with the implementation of various projects as follows:


	Twelve months ended December 31, 2025

Employee-Related Costs	$	6
Asset-Related Costs and Other	7

Total	$	13

The following table summarizes the activity for the restructuring accrual:


	Twelve months ended December 31, 2025
	Employee-Related Costs		Asset-Related Costs and Other		Total
Balance at December 31, 2024	$	—	$	—	$	—

Charges	6		7		13
Cash Payments	—		(3)		(3)


Balance at December 31, 2025	$	6	$	4	$	10

2022 Global Productivity Initiative

The Company’s prior targeted productivity program (the “2022 Global Productivity Initiative”) concluded on December 31, 2024. The 2022 Global Productivity Initiative resulted in the reallocation of resources towards the Company’s strategic priorities and faster growth businesses, efficiencies in the Company’s operations and the streamlining of its supply chain to reduce structural costs. Over the course of the 2022 Global Productivity Initiative, the Company incurred total pretax charges of $228 ($186 aftertax).

For the twelve months ended December 31, 2024, charges resulting from the 2022 Global Productivity Initiative are reflected in the income statement as follows:


	Twelve Months Ended December 31, 2024

Gross Profit	$	20
Selling, general and administrative expenses	6
Other (income) expense, net	59

Total 2022 Global Productivity Initiative charges, pretax	$	85

Total 2022 Global Productivity Initiative charges, aftertax	$	73

Restructuring and related implementation charges were recorded in the Corporate segment as these initiatives were predominantly centrally directed and controlled and were not included in internal measures of segment operating performance.

The following table summarizes the activity for the restructuring accrual:


	Twelve months ended December 31, 2025
	Employee-Related Costs		Other		Total
Balance at December 31, 2024	$	34	$	10	$	44

Cash Payments	(13)		(4)		(17)

Foreign exchange	3		—		3
Balance at December 31, 2025	$	24	$	6	$	30

Long-Term Debt and Credit Facilities - Schedule of Components of Long-term Debt (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Debt Instrument [Line Items]
Total debt	$ 7,986	$ 7,941
Less: Current portion of long-term debt	(1,115)	(652)
Total	$ 6,871	7,289
Notes
Debt Instrument [Line Items]
Weighted Average Interest Rate	2.90%
Total debt	$ 7,767	6,946
Commercial paper
Debt Instrument [Line Items]
Weighted Average Interest Rate	2.00%
Total debt	$ 147	936
Finance Lease Obligations
Debt Instrument [Line Items]
Total debt	$ 72	$ 59

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 235
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(f))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 55
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482949/835-30-55-8

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C

Reference 11: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69E
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E

Reference 12: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69F
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 15: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1D
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1D
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1D
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1F
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1F
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1F
-Subparagraph (b)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1F
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I

Reference 30: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482925/835-30-45-2

Reference 31: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482900/835-30-50-1

+ Details

Commitments and Contingencies	12 Months Ended
Commitments and Contingencies	Dec. 31, 2025
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies As of December 31, 2025, the Company has various contractual commitments for future multi-year purchases of raw, packaging and other materials and services totaling approximately $637. As a global company serving consumers in more than 200 countries and territories, the Company is routinely subject to a wide variety of legal proceedings. These include disputes relating to intellectual property, contracts, product liability, marketing, advertising, foreign exchange controls, antitrust and trade regulation, labor and employment, pension and benefits, data privacy and security, environmental and tax matters and consumer class actions. In addition, management proactively reviews and monitors the Company’s exposure to, and the impact of, environmental matters. The Company is party to various environmental matters and, as such, may be responsible for all or a portion of the cleanup, restoration and post-closure monitoring of several sites. The Company establishes accruals for loss contingencies when it has determined that a loss is probable and that the amount of loss, or range of loss, can be reasonably estimated. Any such accruals are adjusted thereafter as appropriate to reflect changes in circumstances. The Company does not accrue for legal defense costs, which are recognized as incurred when the legal services are provided. The Company also determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that a loss is reasonably possible and it is able to determine such estimates. For those matters disclosed below for which the amount of any reasonably possible losses can be reasonably estimated, the Company currently estimates that the aggregate range of reasonably possible losses in excess of any accrued liabilities is $0 to approximately $225 (based on current exchange rates). The estimates included in this amount are based on the Company’s analysis of currently available information and, as new information is obtained, these estimates may change. Due to the inherent subjectivity of the assessments and the unpredictability of outcomes of legal proceedings, any amounts accrued or included in this aggregate range may not represent the ultimate loss to the Company. Thus, the Company’s exposure and ultimate losses may be higher or lower, and possibly significantly so, than the amounts accrued or the range disclosed above. Based on current knowledge, management does not believe that the ultimate resolution of loss contingencies arising from the matters discussed herein will have a material effect on the Company’s consolidated financial position or its ongoing results of operations or cash flows. However, in light of the inherent uncertainties noted above, an adverse outcome in one or more matters could be material to the Company’s results of operations or cash flows for any particular quarter or year. Brazilian Matters There are certain tax and civil proceedings outstanding, as described below, related to the Company’s 1995 acquisition of the Kolynos oral care business from Wyeth (the “Seller”). The Brazilian internal revenue authority has disallowed interest deductions and foreign exchange losses taken by the Company’s Brazilian subsidiary for certain years in connection with the financing of the Kolynos acquisition. The tax assessments with interest, penalties and any court-mandated fees, at the current exchange rate, are approximately $97. This amount includes additional assessments received from the Brazilian internal revenue authority in April 2016 relating to net operating loss carryforwards used by the Company’s Brazilian subsidiary to offset taxable income that had also been deducted from the authority’s original assessments. The Company has been disputing the disallowances by appealing the assessments since October 2001. Following adverse administrative decisions, the Company filed five cases in the Lower Federal Courts in the City of São Paulo (the “Lower Federal Court”) in October 2015, March 2017, October 2018, June 2019 and September 2020. Of those five cases, currently one case is pending in the Lower Federal Court and four cases have been appealed to the Federal Court of Appeals. Of the four cases pending in the Federal Court of Appeals, one case was appealed by the Brazilian federal government following a ruling in favor of the Company in the Lower Federal Court and three were appealed by the Company following rulings against the Company in the Lower Federal Court. In December 2025, in one of these three cases, the Federal Court of Appeals ruled against the Company with respect to the deductibility of the corporate income tax for the years 1999 through 2001. The amount at issue in this case, with interest and any court-mandated fees, at the current exchange rate, is approximately $18. The Company has filed a motion for clarification with the Federal Court of Appeals and, if necessary following resolution of that motion, will seek a further appeal to the Superior Court of Justice. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that it has strong legal grounds to contest these matters, and it is more likely than not that the Company will ultimately prevail. The Company is challenging these matters vigorously. In July 2002, the Brazilian Federal Public Attorney filed a case against the federal government of Brazil, Laboratorios Wyeth-Whitehall Ltda. (the Brazilian subsidiary of the Seller) and the Company’s Brazilian subsidiary in the Lower Federal Court, seeking to annul an April 2000 decision by the Brazilian Board of Tax Appeals that found in favor of the Seller’s Brazilian subsidiary on the issue of whether it had incurred taxable capital gains as a result of the divestiture of Kolynos. The case seeks to make the Company’s Brazilian subsidiary jointly and severally liable for any tax due from the Seller’s Brazilian subsidiary. The case has been pending since 2002, and the Lower Federal Court has not issued a decision. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that it has strong legal grounds to contest this matter and it is more likely than not that the Company will ultimately prevail. The Company is challenging this matter vigorously. In December 2005, the Brazilian internal revenue authority issued to the Company’s Brazilian subsidiary a tax assessment with interest and any court-mandated fees of approximately $26, at the current exchange rate, based on a claim that certain purchases of U.S. Treasury bills by the subsidiary and their subsequent disposition during the period 2000 to 2001 were subject to a tax on foreign exchange transactions. Following adverse administrative decisions, in January 2016, the Company filed a case in the Lower Federal Court. In the event the Company is unsuccessful in this case, further appeals are available. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that it has strong legal grounds to contest this matter and it is more likely than not that the Company will ultimately prevail. The Company is challenging this matter vigorously. In addition, in April 2024, based upon changes in Brazilian tax law, the Company filed a petition in this matter requesting that the penalty portion of the claim be removed. The Brazilian tax authority agreed with the Company’s position and, in March 2025, reduced its claim in this matter. Talcum Powder Matters The Company has been named as a defendant in civil actions alleging that certain of its talcum powder products were contaminated with asbestos and/or caused mesothelioma and other cancers. Many of these actions involve a number of co-defendants from a variety of different industries, including suppliers of asbestos and manufacturers of products that, unlike the Company’s products, were designed to contain asbestos. As of December 31, 2025, there were 454 individual cases pending against the Company in state and federal courts throughout the United States, as compared to 308 cases as of December 31, 2024. During the year ended December 31, 2025, 253 new cases were filed and 107 cases were resolved by voluntary dismissal, settlement or dismissal by the court. The value of the settlements in the periods presented was not material, either individually or in the aggregate, to such period's results of operations. The Company and its legal counsel believe that the Company has strong legal grounds to contest these cases and is challenging them vigorously. Given the inherent uncertainties of litigation, the Company cannot predict the outcome of all individual cases pending against it, and is only able to make an estimate for those cases that have advanced to the later stages of legal proceedings. For the remaining cases, the Company includes in the range of reasonably possible losses in excess of accrued liabilities stated above an aggregated amount that takes into account historical outcomes of the Company’s cases. As of December 31, 2025, a portion of the Company’s costs incurred in defending and resolving these claims has been, and the Company believes will continue to be, covered by insurance policies issued by several primary, excess and umbrella insurance carriers, subject to exhaustion, deductibles, exclusions, retentions, policy limits and insurance carrier insolvencies. ERISA Matter In June 2016, a lawsuit was filed in the District Court against the Retirement Plan, the Company and certain individuals claiming that residual annuity payments associated with a 2005 residual annuity amendment to the Retirement Plan were improperly calculated for certain Retirement Plan participants in violation of the Employee Retirement Income Security Act. The relief sought included recalculation of benefits, pre- and post-judgment interest and attorneys’ fees. Following adverse decisions by the District Court and the United States Court of Appeals for the Second Circuit, the Company recorded charges to earnings of $267 in the quarter ended March 31, 2023 and $65 in the quarter ended March 31, 2025 to reflect the then current estimated increase in pension plan liability and other related costs. In the three months ended September 30, 2025, the parties entered into a settlement agreement to fully resolve the litigation for $332, inclusive of attorneys’ fees and costs. In January 2026, the District Court granted final approval of the settlement. In February 2026, the District Court granted plaintiffs’ request to allocate $99 of the settlement amount for plaintiffs’ attorneys’ fees and costs. These attorneys’ fees and costs will be paid by the Company, while the remainder of the settlement amount will be funded by the Plan. The litigation resulted in an increase in the obligations of the Retirement Plan and, based on the current funded status of the Retirement Plan, required immaterial cash contributions by the Company in 2025 and will require additional immaterial cash contributions by the Company in 2026.

Supplemental Other Comprehensive Income (Loss) Information - Narrative (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Equity [Abstract]
Unrecognized pension and other retiree benefit costs, aftertax	$ 583	$ 605
Foreign currency translation losses	$ 3,351	$ 3,687

Income Taxes - Schedule of Components of Deferred Tax Assets (Liabilities) (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Deferred tax liabilities:
Goodwill and intangible assets	$ (283)	$ (389)
Property, plant and equipment	(384)	(397)
Right-of-use assets	(124)	(126)
Deferred withholding tax	(114)	(110)
Other	(71)	(130)
Total deferred tax liabilities	(976)	(1,152)
Deferred tax assets:
Pension and other retiree benefits	245	272
Tax credits and tax loss carryforwards	493	430
Lease liabilities	134	137
Accrued liabilities	266	223
Stock-based compensation	61	61
Research and experimentation capitalization	132	108
Other	99	101
Total deferred tax assets	1,430	1,332
Valuation allowance	(430)	(328)	$ (287)	$ (129)
Net deferred tax assets	1,000	1,004
Net deferred income taxes	$ 24
Net deferred income taxes		$ (148)

Fair Value Measurements and Financial Instruments - Narrative (Details) $ in Millions	12 Months Ended
	Dec. 31, 2025 USD ($) countryAndTerritory	Dec. 31, 2024 USD ($)
Debt Instrument [Line Items]
Minimum number of countries and territories serving consumers (more than) (in countries and territories) \| countryAndTerritory	200
Total	$ 7,839
Carrying Value
Debt Instrument [Line Items]
Total	7,988	$ 7,949
Fair Value, Inputs, Level 2
Debt Instrument [Line Items]
Estimated fair value of long-term debt	$ 7,518	$ 7,441

- Definition

Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (bbb)(2)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (bbb)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (bbb)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 28
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-28

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-11

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 11
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-11

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 825
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-10

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2E
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B

Reference 11: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1D
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D

+ Details

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

+ Details

- Definition

Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22))
-SubTopic 10
-Topic 210
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 235
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 55
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482949/835-30-55-8

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(16))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1D
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D

Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 944
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(16)(a)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (b)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-4

+ Details

Retirement Plans and Other Retiree Benefits (Tables)

12 Months Ended

Dec. 31, 2025

Retirement Benefits [Abstract]

Schedule of Allocation of Plan Assets

The target asset allocation for the Company’s defined benefit plans is as follows:


	United States		International
Asset Category
Equity securities	26	%	19	%
Fixed income securities	60	%	61	%
Other investments	14	%	20	%
Total	100	%	100	%

At December 31, 2025, the allocation of the Company’s plan assets and the level of valuation input, as applicable, for each major asset category were as follows:


	Level of Valuation Input	Pension Plans
		United States		International

Cash and cash equivalents	Level 1	$	230	$	21
U.S. common stocks	Level 1	1		2
International common stocks	Level 1	—		16
Pooled funds(1)	Level 1	33		120
Fixed income securities(2)	Level 2	600		82
Multi-asset funds(7)	Level 2	23		—
Guaranteed investment contracts(3)	Level 2	—		30
		887		271
Investments valued using NAV per share(4)
Domestic, developed and emerging markets equity funds		253		25
Fixed income funds(5)		60		237
Hedge funds(6)		—		9
Multi-asset funds(7)		131		2
Real estate funds(8)		—		33
		444		306

Other assets and liabilities, net(9)		(18)		5
Total Investments		$	1,313	$	582

At December 31, 2024, the allocation of the Company’s plan assets and the level of valuation input, as applicable, for each major asset category were as follows:


	Level of Valuation Input	Pension Plans
		United States		International

Cash and cash equivalents	Level 1	$	226	$	21
U.S. common stocks	Level 1	1		2
International common stocks	Level 1	—		15
Pooled funds(1)	Level 1	35		103
Fixed income securities(2)	Level 2	624		75
Guaranteed investment contracts(3)	Level 2	—		30
		886		246
Investments valued using NAV per share(4)
Domestic, developed and emerging markets equity funds		223		28
Fixed income funds(5)		68		222
Hedge funds(6)		—		7
Multi-asset funds(7)		157		2
Real estate funds(8)		—		27
		448		286

Other assets and liabilities, net(9)		(39)		5
Total Investments		$	1,295	$	537

(1)Pooled funds primarily invest in U.S. and foreign equity securities, debt and money market securities.

(2)The fixed income securities are traded over-the-counter and certain of these securities lack daily pricing or liquidity and as such are classified as Level 2. As of December 31, 2025 and December 31, 2024, approximately 30% of the U.S. pension plan fixed income portfolio was invested in U.S. treasury or agency securities, with the remainder invested in other government bonds and corporate bonds.

(3)The guaranteed investment contracts (“GICs”) represent contracts with insurance companies measured at the cash surrender value of each contract. The Level 2 valuation reflects that the cash surrender value is based principally on a referenced pool of investment funds with active redemption.

(4)Investments that are measured at fair value using net asset value (“NAV”) per share as a practical expedient have not been classified in the fair value hierarchy. The NAV is based on the value of the underlying investments owned, minus its liabilities, divided by the number of shares outstanding. There are no unfunded commitments related to these investments. Redemption notice period primarily ranges from 0 to 3 months and redemption frequency windows range from daily to quarterly.

(5)Fixed income funds primarily invest in U.S. government and investment grade corporate bonds.

(6)Consists of investments in underlying hedge fund strategies that are primarily implemented through the use of long and short equity and fixed income securities and derivative instruments such as futures and options.

(7)Multi-asset funds primarily invest across a variety of asset classes, including global stocks and bonds, as well as alternative strategies.

(8)Real estate is valued using the NAV per unit of funds that are invested in real estate property. The investment value of the real estate property is determined quarterly using independent market appraisals as determined by the investment manager.

(9)This category primarily includes unsettled trades for investments purchased and sold and interest receivables.

Schedule of Defined Benefit Plans Disclosures

The Company uses a December 31 measurement date for its defined benefit and other retiree benefit plans. Summarized information for the Company’s defined benefit and other retiree benefit plans is as follows:


	Pension Plans								Other Retiree Benefit Plans
	2025		2024		2025		2024		2025		2024
	United States				International
Change in Benefit Obligations
Benefit obligations at beginning of year	$	1,831	$	1,922	$	720	$	776	$	632	$	665
Service cost	1		1		18		16		7		7
Interest cost	102		99		34		33		38		36
Participants’ contributions	—		—		5		5		—		—
Plan amendments	—		—		1		—		—		—
Actuarial loss (gain)	—		(54)		(20)		(11)		37		(14)
Foreign exchange impact	(1)		—		59		(40)		4		(8)
Termination benefits	—		5		—		—		—		—
Curtailments and settlements	—		(1)		(12)		(18)		—		—
Benefit payments	(145)		(141)		(44)		(41)		(55)		(54)
ERISA litigation matter	(34)		—		—		—		—		—
Benefit obligations at end of year	$	1,754	$	1,831	$	761	$	720	$	663	$	632
Change in Plan Assets
Fair value of plan assets at beginning of year	$	1,295	$	1,360	$	537	$	566	$	—	$	—
Actual return on plan assets	111		49		16		18		—		—
Company contributions	51		29		37		37		55		54
Participants’ contributions	—		—		5		5		—		—
Foreign exchange impact	1		—		41		(31)		—		—
Settlements and acquisitions	—		(2)		(10)		(17)		—		—
Benefit payments	(145)		(141)		(44)		(41)		(55)		(54)

Fair value of plan assets at end of year	$	1,313	$	1,295	$	582	$	537	$	—	$	—
Funded Status
Benefit obligations at end of year	$	1,754	$	1,831	$	761	$	720	$	663	$	632
Fair value of plan assets at end of year	1,313		1,295		582		537		—		—
Net amount recognized	$	(441)	$	(536)	$	(179)	$	(183)	$	(663)	$	(632)
Amounts Recognized in Balance Sheet
Noncurrent assets	$	1	$	1	$	53	$	47	$	—	$	—
Current liabilities	(28)		(27)		(16)		(15)		(52)		(51)
Noncurrent liabilities	(414)		(510)		(216)		(215)		(611)		(581)
Net amount recognized	$	(441)	$	(536)	$	(179)	$	(183)	$	(663)	$	(632)
Amounts Recognized in Accumulated Other Comprehensive Income (Loss)
Actuarial loss	$	644	$	710	$	158	$	174	$	141	$	109
Transition/prior service cost (credit)	—		—		8		8		(138)		(159)
	$	644	$	710	$	166	$	182	$	3	$	(50)
Accumulated benefit obligation	$	1,742	$	1,818	$	702	$	668	$	—	$	—


	Pension Plans								Other Retiree Benefit Plans
	2025		2024		2025		2024		2025		2024
	United States				International
Weighted-Average Assumptions Used to Determine Benefit Obligations
Discount rate	5.51	%	5.73	%	4.86	%	4.69	%	5.56	%	5.74	%

Long-term rate of compensation increase	3.50	%	3.50	%	3.27	%	3.36	%	—	%	—	%
ESOP growth rate	—	%	—	%	—	%	—	%	6.00	%	6.00	%
Medical cost trend rate of increase	—	%	—	%	—	%	—	%	7.00	%	7.00	%
Interest Crediting Rate	5.49	%	5.58	%	3.19	%	3.23	%	—	%	—	%

Schedule of Accumulated Benefit Obligations in Excess of Fair Value of Plan Assets

Pension plans with projected benefit obligations in excess of plan assets and plans with accumulated benefit obligations in excess of plan assets as of December 31 consisted of the following:



	2025		2024
Benefit Obligation Exceeds Fair Value of Plan Assets
Projected benefit obligation	$	2,117	$	2,251
Fair value of plan assets	1,443		1,486

Accumulated benefit obligation	2,002		2,075
Fair value of plan assets	1,363		1,345

Other Retiree Benefit plans with accumulated postretirement benefit obligation in excess of plan assets as of December 31 consisted of the following:



	2025		2024
Benefit Obligation Exceeds Fair Value of Plan Assets
Accumulated postretirement benefit obligation	$	663	$	632
Fair value of plan assets	—		—

Schedule of Net Benefit Costs

Summarized information regarding the net periodic benefit costs for the Company’s defined benefit and other retiree benefit plans is as follows:


	Pension Plans																		Other Retiree Benefit Plans
	2025			2024			2023			2025			2024			2023			2025			2024			2023
	United States									International
Components of Net Periodic Benefit Cost
Service cost	$	1		$	1		$	—		$	18		$	16		$	15		$	7		$	7		$	7
Interest cost	102			99			91			34			33			33			38			36			38

Expected return on plan assets	(83)			(85)			(79)			(26)			(29)			(25)			—			—			—
Amortization of transition and prior service costs (credits)	—			—			—			—			1			1			(21)			(21)			(20)
Amortization of actuarial loss	35			39			43			5			5			5			5			4			1
Net periodic benefit cost	$	55		$	54		$	55		$	31		$	26		$	29		$	29		$	26		$	26
Other postretirement charges	—			5			3			—			—			2			—			—			—

ERISA litigation matter	(34)			—			267			—			—			—			—			—			—
Total pension cost	$	21		$	59		$	325		$	31		$	26		$	31		$	29		$	26		$	26
Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost
Discount rate	5.73		%	5.40		%	5.66		%	4.69		%	4.61		%	4.75		%	5.74		%	5.37		%	5.67		%
Expected long-term rate of return on plan assets	6.50		%	6.50		%	6.25		%	5.36		%	5.69		%	4.66		%	N/A			N/A			N/A
Long-term rate of compensation increase	3.50		%	3.50		%	3.50		%	3.36		%	3.24		%	3.22		%	—		%	—		%	—		%
ESOP growth rate	—		%	—		%	—		%	—		%	—		%	—		%	6.00		%	6.00		%	6.00		%
Medical cost trend rate of increase	—		%	—		%	—		%	—		%	—		%	—		%	7.00		%	6.00		%	6.25		%
Interest Crediting Rate	5.58		%	4.99		%	5.21		%	3.23		%	0.64		%	2.28		%	—		%	—		%	—		%

Schedule of Expected Benefit Payments

Total benefit payments expected to be paid to participants in both funded and unfunded plans are estimated as follows:


	Pension Plans
Years Ended December 31,	United States		International		Other Retiree Benefit Plans		Total
2026	$	335	$	47	$	53	$	435
2027	142		46		57		245
2028	143		49		58		250
2029	140		52		58		250
2030	140		52		58		250
2031-2035	633		273		288		1,194

Leases - Schedule of Operating Lease Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Leases [Abstract]
2026	$ 140
2027	125
2028	100
2029	72
2030	60
Thereafter	163
Total lease commitments	660
Less: Interest	(94)
Present value of lease liabilities	$ 566	$ 563

Leases - Schedule of Right-of-use Assets and Liabilities for Operating Leases (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Leases [Abstract]
Other assets	$ 531	$ 529
Other accruals	118	107
Other liabilities	448	456
Total operating lease liabilities	$ 566	$ 563
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]	Other non-current assets	Other non-current assets
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]	Other accruals	Other accruals
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]	Other non-current liabilities	Other non-current liabilities

Supplemental Balance Sheet Information (Tables)

12 Months Ended

Dec. 31, 2025

Balance Sheet Related Disclosures [Abstract]

Schedule of Inventories by Major Class

Inventories by major class are as follows at December 31:


Inventories	2025		2024
Raw materials and supplies	$	632	$	631
Work-in-process	46		46
Finished goods	1,479		1,431
Total Inventories, net	$	2,157	$	2,108
Non-current inventory, net	(125)		(121)
Current Inventories, net	$	2,032	$	1,987

Schedule of Property, Plant and Equipment


Property, plant and equipment, net	2025		2024
Land	$	234	$	226
Buildings	2,171		2,056
Manufacturing machinery and equipment	6,935		6,265
Other equipment	1,516		1,580
	10,856		10,127
Accumulated depreciation	(6,196)		(5,705)
Total Property, plant and equipment, net	$	4,660	$	4,422

Schedule of Other Current Assets


Other current assets	2025		2024
Marketable securities	$	107	$	160
Prepaids	589		520
Derivatives	18		33
Total Other current assets	$	714	$	713

Schedule of Other Accruals


Other accruals	2025		2024
Accrued advertising and consumer and trade promotions	$	997	$	912
Accrued payroll and employee benefits	420		437
Accrued taxes other than income taxes	254		162
Restructuring accrual	31		15
Pension and other retiree benefits	96		93
Lease liabilities due in one year	118		107
Accrued interest	72		72
Derivatives	22		23
Dividend payable	418		408
Other	836		662
Total Other accruals	$	3,264	$	2,891

Schedule of Other Liabilities


Other liabilities	2025		2024
Pension and other retiree benefits	$	1,241	$	1,306
Long-term lease liabilities	448		456
Restructuring accrual	9		29
Other	362		320
Total Other liabilities	$	2,060	$	2,111

Acquisitions - Schedule of Business Combination, Recognized Asset Acquired and Liability Assumed (Details) $ in Millions, $ in Millions	Dec. 31, 2025 USD ($)	Apr. 30, 2025 USD ($)	Apr. 30, 2025 AUD ($)	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)
Business Combination [Line Items]
Goodwill	$ 3,122			$ 3,272	$ 3,410
Care TopCo Pty Ltd
Business Combination [Line Items]
Cash		$ 8
Other current assets		12
Property, plant and equipment		13
Other assets		5
Other intangible assets		64
Goodwill		207
Total liabilities		(8)
Fair value of net assets acquired		$ 301	$ 471

Income Taxes - Schedule of Change in Valuation Allowance for Deferred Tax Assets (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Deferred Tax Asset, Valuation Allowance [Roll Forward]
Balance, January 1	$ 328	$ 287	$ 129
Additions
Balance, December 31	430	328	287
Charged to costs and expenses
Additions
Valuation allowance, deferred tax asset, additions (deductions)	102	56	158
Deductions
Additions
Valuation allowance, deferred tax asset, additions (deductions)	$ 0	$ (15)	$ 0

Summary of Significant Accounting Policies	12 Months Ended
Summary of Significant Accounting Policies	Dec. 31, 2025
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Principles of Consolidation The Consolidated Financial Statements include the accounts of Colgate-Palmolive Company and its majority-owned or controlled subsidiaries. Intercompany transactions and balances have been eliminated. The Company’s investments in consumer products companies with interests ranging between 20% and 50%, where the Company has significant influence over the investee, are accounted for using the equity method. Net income (loss) from such investments is recorded in Other (income) expense, net in the Consolidated Statements of Income. As of December 31, 2025 and 2024, equity method investments included in Other assets in the Consolidated Balance Sheets were $82 and $81, respectively. Unrelated third parties hold the remaining ownership interests in these investments. Investments with less than a 20% interest are recorded at cost and periodically adjusted based on observable price changes or quoted market prices in active markets, if applicable. Use of Estimates The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to use judgment and make estimates that affect the reported amounts of assets and liabilities and disclosure of contingent gains and losses at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The level of uncertainty in estimates and assumptions increases with the length of time until the underlying transactions are completed. As such, the most significant uncertainty in the Company’s assumptions and estimates involved in preparing the financial statements includes pension and other retiree benefit cost assumptions, stock-based compensation, asset impairments, uncertain tax positions, tax valuation allowances and legal and other contingency reserves. Additionally, the Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments and retirement plan assets. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. Actual results could ultimately differ from those estimates. Revenue Recognition The Company’s revenue contracts represent a single performance obligation to sell its products to trade customers. Sales are recorded at the time control of the products is transferred to trade customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for the products. Control is the ability of trade customers to “direct the use of” and “obtain the benefit from” our products. In evaluating the timing of the transfer of control of products to trade customers, the Company considers several control indicators, including significant risks and rewards of products, the Company’s right to payment and the legal title of the products. Based on the assessment of control indicators, sales are generally recognized when products are delivered to trade customers. Net sales reflect the transaction prices for contracts, which include units shipped at selling list prices reduced by variable consideration. Variable consideration includes expected sales returns and the cost of current and continuing promotional programs. Current promotional programs primarily include product listing allowances and co-operative advertising arrangements. Continuing promotional programs are predominantly consumer coupons and volume-based sales incentive arrangements. The cost of promotional programs is estimated using the expected value method considering all reasonably available information, including the Company’s historical experience and its current expectations, and is reflected in the transaction price when sales are recorded. Adjustments to the cost of promotional programs in subsequent periods are generally not material, as the Company’s promotional programs are typically of short duration, thereby reducing the uncertainty inherent in such estimates. Sales returns are generally accepted at the Company’s discretion and are not material to the Company’s Consolidated Financial Statements. The Company’s contracts with trade customers do not have significant financing components or non-cash consideration and the Company does not have unbilled revenue or significant amounts of prepayments from customers. The Company records Net sales excluding taxes collected on its sales to its trade customers. Shipping and handling activities are accounted for as contract fulfillment costs and classified as Selling, general and administrative expenses. Shipping and Handling Costs Shipping and handling costs (also referred to as logistics costs) are classified as Selling, general and administrative expenses and were $1,789, $1,777 and $1,771 for the years ended December 31, 2025, 2024 and 2023, respectively. Marketing Costs The Company markets its products through advertising and other promotional activities. Advertising costs are included in Selling, general and administrative expenses and are expensed as incurred. Certain consumer and trade promotional programs, such as consumer coupons, are recorded as a reduction of sales. Cash and Cash Equivalents The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. Inventories The cost of approximately 75% of inventories is determined using the FIFO method, which is stated at the lower of cost or net realizable value. The cost of the remaining inventories is determined using the LIFO method, which is stated at the lower of cost or market. Inventories in excess of one year of forecasted sales are classified in the Consolidated Balance Sheets as non-current “Other assets.” Property, Plant and Equipment Land, buildings and machinery and equipment are stated at cost. Depreciation is provided, primarily using the straight-line method, over the estimated useful lives ranging from 3 to 15 years for machinery and equipment and up to 40 years for buildings. Depreciation attributable to manufacturing operations is included in Cost of sales. The remaining component of depreciation is included in Selling, general and administrative expenses. Goodwill and Other Intangibles Goodwill and indefinite-life intangible assets, such as the Company’s global brands, are subject to impairment tests at least annually or when events or changes in circumstances indicate that an asset may be impaired. In assessing impairment, the Company performs either a quantitative or a qualitative analysis. Determining the fair value of the Company’s reporting units for goodwill and the fair value of its intangible assets requires significant judgments and estimates by management. When a quantitative analysis is performed, the Company generally uses the income approach, which requires several estimates, including future cash flows consistent with management’s strategic plans, sales growth rates, operating margins, customer attrition rate and the selection of royalty rates and discount rates. In determining the fair value of the Company’s reporting units, fair value is also generally determined using the market approach, which is generally derived from metrics of comparable publicly traded companies. As multiple valuation methodologies are used, the Company also performs a qualitative analysis comparing the fair value of a reporting unit under each method to assess its reasonableness and ensure consistency of results. The Company generally engages a third-party valuation firm to assist in determining the fair value of intangible assets acquired in business combinations. Other intangible assets with finite lives, such as local brands and trademarks, customer relationships and non-compete agreements, are amortized over their estimated useful lives, generally ranging from 5 to 40 years. Amortization expense related to intangible assets is included in Other (income) expense, net, which is included in Operating profit. Income Taxes The provision for income taxes is determined using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized based upon the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates that will be in effect at the time such differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The Company uses a comprehensive model to recognize, measure, present and disclose in its financial statements uncertain tax positions that the Company has taken or expects to take on an income tax return. The Company recognizes interest expense and penalties related to unrecognized tax benefits within Provision for income taxes. Financial Instruments Derivative instruments are recorded as assets and liabilities at estimated fair value based on available market information. The Company’s derivative instruments that qualify for hedge accounting are designated as either fair value hedges, cash flow hedges or net investment hedges. For fair value hedges, changes in the fair value of the derivative, as well as the offsetting changes in the fair value of the hedged item, are recognized in earnings each period. For cash flow hedges, changes in the fair value of the derivative are recorded in Other comprehensive income (loss) and are recognized in earnings when the offsetting effect of the hedged item is also recognized in earnings. For hedges of the net investment in foreign subsidiaries, changes in the fair value of the derivative are recorded in Other comprehensive income (loss) to offset the change in the value of the net investment being hedged. Cash flows related to hedges are classified in the same category as the cash flows from the hedged item in the Consolidated Statements of Cash Flows. The Company may also enter into certain foreign currency and interest rate instruments that economically hedge certain of its risks but do not qualify for hedge accounting. Changes in fair value of these derivative instruments, based on quoted market prices, are recognized in earnings each period. The Company’s derivative instruments and other financial instruments are more fully described in Note 7, Fair Value Measurements and Financial Instruments along with the related fair value measurement considerations. Stock-Based Compensation The Company recognizes the cost of employee services received in exchange for awards of equity instruments, such as stock options and restricted stock units (both performance-based and time-vested), based on the fair value of those awards at the date of grant over the requisite service period. The Company uses the Black-Scholes-Merton (“Black-Scholes”) option pricing model to estimate the fair value of stock option awards. In addition to performance conditions, performance-based restricted stock units also include a total shareholder return modifier. Because the total shareholder return modifier is considered a market condition, the Company uses a Monte-Carlo simulation model to determine the fair value of performance-based restricted stock units. The fair value of time-vested restricted stock units is determined based on the closing market price of the Company’s stock at the date of grant. Stock-based compensation plans, related expenses and assumptions used in the Black-Scholes option pricing model are more fully described in Note 8, Capital Stock and Stock-Based Compensation Plans. Currency Translation The assets and liabilities of foreign subsidiaries, other than those operating in highly inflationary environments, are translated into U.S. dollars at year-end exchange rates with resulting translation gains and losses accumulated in a separate component of shareholders’ equity. Income and expense items are translated into U.S. dollars at average rates of exchange prevailing during the year. For subsidiaries operating in highly inflationary environments, local currency-denominated non-monetary assets, including inventories, goodwill and property, plant and equipment, are remeasured at their historical exchange rates, while local currency-denominated monetary assets and liabilities are remeasured at year-end exchange rates. Remeasurement adjustments for these operations are included in Net income attributable to Colgate-Palmolive Company. Recent Accounting Pronouncements In September 2025, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2025-06, “Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software.” This ASU modernizes the capitalization criteria for internal-use software by eliminating references to project stages and clarifying the threshold applied to begin capitalizing costs. This guidance is effective for the Company for fiscal years beginning after December 15, 2027. The Company is currently assessing the impact of this new guidance. In November 2024, the FASB issued ASU No. 2024-03, “Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses.” This ASU requires additional disclosures related to the disaggregation of the income statement expense categories. This guidance is effective for the Company for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. Other than the new disclosure requirements, this guidance will not have an impact on the Company’s Consolidated Financial Statements. In December 2023, the FASB issued ASU No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures.” This ASU improves the transparency of income tax disclosure by requiring consistent categories and greater disaggregation of information in the rate reconciliation, and income taxes paid disaggregated by jurisdiction. The Company adopted this guidance in 2025. See Note 11, Income Taxes for additional information. There have been no other accounting pronouncements issued or effective during the fiscal year that have had, or are expected to have, a material impact on the Company’s Consolidated Financial Statements. Reclassifications Certain prior year amounts have been reclassified to conform to the current year presentation.

Restructuring and Related Implementation Charges (Tables)

12 Months Ended

Dec. 31, 2025

Restructuring and Related Activities [Abstract]

Schedule of Restructuring and Related Costs

For the twelve months ended December 31, 2025, charges resulting from the Strategic Growth and Productivity Program are reflected in the income statement as follows:


	Twelve months ended December 31, 2025


Selling, general and administrative expenses	$	6
Other (income) expense, net	7

Total Strategic Growth and Productivity Program charges, pretax	$	13

Total Strategic Growth and Productivity Program charges, aftertax	$	11

The following table summarizes the activity for the restructuring accrual:


	Twelve months ended December 31, 2025
	Employee-Related Costs		Asset-Related Costs and Other		Total
Balance at December 31, 2024	$	—	$	—	$	—

Charges	6		7		13
Cash Payments	—		(3)		(3)


Balance at December 31, 2025	$	6	$	4	$	10

For the twelve months ended December 31, 2024, charges resulting from the 2022 Global Productivity Initiative are reflected in the income statement as follows:


	Twelve Months Ended December 31, 2024

Gross Profit	$	20
Selling, general and administrative expenses	6
Other (income) expense, net	59

Total 2022 Global Productivity Initiative charges, pretax	$	85

Total 2022 Global Productivity Initiative charges, aftertax	$	73

The following table summarizes the activity for the restructuring accrual:


	Twelve months ended December 31, 2025
	Employee-Related Costs		Other		Total
Balance at December 31, 2024	$	34	$	10	$	44

Cash Payments	(13)		(4)		(17)

Foreign exchange	3		—		3
Balance at December 31, 2025	$	24	$	6	$	30

Schedule of Percent of Total Restructuring Charges Related To Segment for the period

Total charges incurred for the Strategic Growth and Productivity Program relate to initiatives undertaken by the following reportable operating segments:


	Twelve months ended December 31, 2025

North America	30	%
Latin America	—	%
Europe	4	%
Asia Pacific	—	%
Africa/Eurasia	—	%
Pet Nutrition	1	%
Corporate	65	%
Total	100	%

Schedule of Cumulative Pretax Restructuring Charges

The Company has incurred pretax charges of $13 ($11 aftertax) in connection with the implementation of various projects as follows:


	Twelve months ended December 31, 2025

Employee-Related Costs	$	6
Asset-Related Costs and Other	7

Total	$	13

Earnings Per Share (Tables)

12 Months Ended

Dec. 31, 2025

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted

For the years ended December 31, 2025, 2024 and 2023, earnings per share were as follows:


	2025					2024					2023
	Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share		Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share		Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share
Basic EPS	$	2,132	808.7	$	2.64	$	2,889	819.1	$	3.53	$	2,300	827.4	$	2.78
Stock options and restricted stock units			2.4					4.1					1.8
Diluted EPS	$	2,132	811.1	$	2.63	$	2,889	823.2	$	3.51	$	2,300	829.2	$	2.77

Earnings Per Share - Narrative (Details) - shares	12 Months Ended
Earnings Per Share - Narrative (Details) - shares	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Employee Stock Option
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	1,076,140	295,968	13,719,286
Restricted Stock Units (RSUs)
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	1,459	100,191	1,183

Income Taxes - Schedule of Effective Tax Rate Reconciliation (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Amount
U.S. federal statutory tax rate	$ 642
State and local income taxes, net of federal income tax effect	42
Other	(7)
Nondeductible goodwill impairment	37
Other	19
Foreign-derived intangible income benefit	(88)
Foreign tax credits	(83)
Branch U.S. tax, net of foreign tax credit	(49)
Other	(15)
Tax credits	(10)
Branch U.S. tax	65
Changes in unrecognized tax benefits	23
Total Provision for income taxes	$ 798	$ 907	$ 937
Percent
U.S. federal statutory rate	21.00%	21.00%	21.00%
State and local income taxes, net of federal benefit	1.40%	0.50%	(0.10%)
Earnings taxed at other than U.S. federal statutory rate		4.10%	5.40%
Other, net	(0.10%)	(0.10%)	0.00%
Nondeductible goodwill impairment	1.20%	0.00%	0.00%
Other	0.60%
Foreign-derived intangible income benefit	(2.90%)	(2.60%)	(2.40%)
Foreign tax matter		0.00%	3.70%
Foreign tax credits	(2.70%)
Branch U.S. tax, net of foreign tax credit	(1.60%)
Other	(0.50%)
Tax credits	(0.30%)
Branch U.S. tax	2.10%
Changes in unrecognized tax benefits	0.70%
Global effective tax rate	26.10%	22.90%	27.60%
Brazil
Amount
Statutory income tax rate differential and other foreign jurisdictions	$ 38
Percent
Earnings taxed at other than U.S. federal statutory rate	1.20%
Switzerland
Amount
State and local income taxes, net of federal income tax effect	$ 35
Statutory income tax rate differential and other foreign jurisdictions	(82)
Other	$ 12
Percent
State and local income taxes, net of federal benefit	1.10%
Earnings taxed at other than U.S. federal statutory rate	(2.70%)
Other, net	0.40%
France
Amount
Nondeductible goodwill impairment	$ 59
Other	$ (13)
Percent
Nondeductible goodwill impairment	1.90%
Other	(0.40%)
Other foreign jurisdictions
Amount
Statutory income tax rate differential and other foreign jurisdictions	$ 168
Percent
Earnings taxed at other than U.S. federal statutory rate	5.50%
United States
Amount
Other	$ 5
Percent
Other, net	0.20%

Segment Information - Schedule of Net Sales and Operating Profit by Segment (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Segment Reporting Information [Line Items]
Net sales	$ 20,382	$ 20,101	$ 19,457
Cost of sales	8,131	7,940	8,131
Selling, general and administrative expenses	7,903	7,729	7,151
Operating profit	3,306	4,268	3,984
Capital expenditures	564	561	705
Depreciation and amortization	630	605	567
Total long lived assets	5,191	4,951
United States
Segment Reporting Information [Line Items]
Total long lived assets	2,663	2,728
International
Segment Reporting Information [Line Items]
Total long lived assets	2,528	2,223
Total Oral, Personal and Home Care \| United States
Segment Reporting Information [Line Items]
Net sales	3,596	3,640	3,625
Pet Nutrition \| United States
Segment Reporting Information [Line Items]
Net sales	3,062	3,059	2,918
Operating Segments \| Total Oral, Personal and Home Care
Segment Reporting Information [Line Items]
Net sales	15,769	15,618	15,167
Operating profit	3,959	4,088	3,882
Capital expenditures	361	317	311
Depreciation and amortization	385	378	372
Operating Segments \| Total Oral, Personal and Home Care \| North America
Segment Reporting Information [Line Items]
Net sales	4,045	4,113	4,091
Cost of sales	1,589	1,571	1,588
Selling, general and administrative expenses	1,626	1,668	1,594
Other	47	36	37
Operating profit	784	839	871
Capital expenditures	65	52	46
Depreciation and amortization	123	124	116
Operating Segments \| Total Oral, Personal and Home Care \| Latin America
Segment Reporting Information [Line Items]
Net sales	4,776	4,782	4,640
Cost of sales	2,107	1,933	1,977
Selling, general and administrative expenses	1,268	1,328	1,241
Other	(11)	(5)	5
Operating profit	1,411	1,526	1,417
Capital expenditures	141	126	146
Depreciation and amortization	106	100	98
Operating Segments \| Total Oral, Personal and Home Care \| Europe
Segment Reporting Information [Line Items]
Net sales	2,962	2,770	2,571
Cost of sales	1,099	1,050	1,069
Selling, general and administrative expenses	1,087	1,031	899
Other	28	31	31
Operating profit	748	658	573
Capital expenditures	63	63	44
Depreciation and amortization	66	65	65
Operating Segments \| Total Oral, Personal and Home Care \| Asia Pacific
Segment Reporting Information [Line Items]
Net sales	2,814	2,858	2,782
Cost of sales	1,067	1,078	1,108
Selling, general and administrative expenses	1,013	997	925
Other	(27)	(30)	(18)
Operating profit	760	812	767
Capital expenditures	80	64	65
Depreciation and amortization	80	81	84
Operating Segments \| Total Oral, Personal and Home Care \| Africa/Eurasia
Segment Reporting Information [Line Items]
Net sales	1,172	1,095	1,083
Cost of sales	465	432	442
Selling, general and administrative expenses	436	395	377
Other	16	16	9
Operating profit	255	253	254
Capital expenditures	12	12	10
Depreciation and amortization	10	8	9
Operating Segments \| Pet Nutrition
Segment Reporting Information [Line Items]
Net sales	4,613	4,483	4,290
Cost of sales	1,818	1,869	1,964
Selling, general and administrative expenses	1,717	1,641	1,493
Other	14	8	26
Operating profit	1,064	965	806
Capital expenditures	88	143	301
Depreciation and amortization	144	132	101
Corporate
Segment Reporting Information [Line Items]
Operating profit	(1,717)	(784)	(704)
Capital expenditures	115	101	93
Depreciation and amortization	$ 101	$ 95	$ 94

Acquisitions (Tables)

12 Months Ended

Dec. 31, 2025

Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]

Schedule of Business Combination, Recognized Asset Acquired and Liability Assumed

The total purchase price of $301 has been allocated to the net assets acquired based on their respective estimated fair values as follows:


Cash	$	8
Other current assets	12
Property, plant and equipment	13
Other assets	5
Other intangible assets	64
Goodwill	207
Total liabilities	(8)
Fair value of net assets acquired	$	301

Capital Stock and Stock-Based Compensation Plans - Schedule of Restricted Stock Activity (Details) - Time-Vested Stock shares in Thousands	12 Months Ended
	Dec. 31, 2025 $ / shares shares
Shares (in thousands)
Restricted stock awards - beginning balance (in shares) \| shares	1,987
Granted (in shares) \| shares	1,197
Vested (in shares) \| shares	(1,049)
Forfeited (in shares) \| shares	(77)
Restricted stock awards - ending balance (in shares) \| shares	2,058
Weighted Average Grant Date Fair Value Per Award
Restricted stock awards - beginning of period (in dollars per share) \| $ / shares	$ 88
Restricted stock awards - shares granted (in dollars per share) \| $ / shares	85
Restricted stock awards - shares vested (in dollars per share) \| $ / shares	83
Restricted stock awards - shares forfeited (in dollars per share) \| $ / shares	89
Restricted stock awards - end of period (in dollars per share) \| $ / shares	$ 88

Restructuring and Related Implementation Charges - Schedule of Restructuring Charges Incurred, by Segment (Details) - Strategic Growth and Productivity Program	Dec. 31, 2025
Restructuring Cost and Reserve [Line Items]
Program-to-date accumulated charges (percent)	100.00%
Pet Nutrition
Restructuring Cost and Reserve [Line Items]
Program-to-date accumulated charges (percent)	1.00%
Corporate
Restructuring Cost and Reserve [Line Items]
Program-to-date accumulated charges (percent)	65.00%
North America
Restructuring Cost and Reserve [Line Items]
Program-to-date accumulated charges (percent)	30.00%
Latin America
Restructuring Cost and Reserve [Line Items]
Program-to-date accumulated charges (percent)	0.00%
Europe
Restructuring Cost and Reserve [Line Items]
Program-to-date accumulated charges (percent)	4.00%
Asia Pacific
Restructuring Cost and Reserve [Line Items]
Program-to-date accumulated charges (percent)	0.00%
Africa/Eurasia
Restructuring Cost and Reserve [Line Items]
Program-to-date accumulated charges (percent)	0.00%

Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Millions

Total

Common Stock

Additional Paid-In Capital

Unearned Compensation

Treasury Stock

Retained Earnings

Accumulated Other Comprehensive Income (Loss)

Noncontrolling Interests

Beginning balance at Dec. 31, 2022

$ 1,466

$ 3,546

$ (1)

$ (25,128)

$ 24,573

$ (4,055)

$ 405

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Net income

$ 2,455

2,300

155

Other comprehensive income (loss), net of tax

117

(42)

Dividends

^[1]

(1,584)

(170)

Stock-based compensation expense

122

Shares issued for stock options

170

212

Shares issued for restricted stock awards

(34)

Treasury stock acquired

(1,128)

Other

(7)

Ending balance at Dec. 31, 2023

1,466

3,808

(26,017)

25,289

(3,937)

348

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Net income

3,049

2,889

160

Other comprehensive income (loss), net of tax

(292)

(284)

(8)

Dividends

^[1]

(2,034)

(168)

Stock-based compensation expense

135

Shares issued for stock options

284

354

Shares issued for restricted stock awards

(52)

Treasury stock acquired

(1,739)

Other

(8)

(1)

Ending balance at Dec. 31, 2024

544

1,466

4,181

(27,358)

26,145

(4,222)

332

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Net income

2,261

Other comprehensive income (loss), net of tax

344

342

Dividends

^[1]

(1,681)

(157)

Stock-based compensation expense

155

Shares issued for stock options

Shares issued for restricted stock awards

(65)

Treasury stock acquired

(1,214)

Other

(1)

Ending balance at Dec. 31, 2025

$ 365

$ 1,466

$ 4,322

$ 0

$ (28,450)

$ 26,595

$ (3,879)

$ 311

[1]	* Four dividends were declared in 2025. Five dividends were declared in 2024. Four dividends were declared in 2023.

Cybersecurity Risk Management and Strategy Disclosure	12 Months Ended
Cybersecurity Risk Management and Strategy Disclosure	Dec. 31, 2025
Cybersecurity Risk Management, Strategy, and Governance [Line Items]
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]	Cybersecurity Risk Management and Strategy We have a systematic and thorough risk management process, which is designed to identify, assess, prioritize and mitigate the risks that could negatively impact achievement of our strategic and operating objectives. A key component of this process is our Enterprise Risk Management (“ERM”) Committee, which is led by our Chairman, President and Chief Executive Officer, and includes our Chief Financial Officer, Chief Legal Officer, Chief Information Officer and other members of senior management. The ERM Committee monitors both current and emerging risks facing the Company and meets at least quarterly to review the prioritization of identified risks. We assess cybersecurity risk through our standardized ERM methodology, which considers both likelihood and severity, and assigns a result accordingly. This methodology applies to all of the Company’s identified risks, including cybersecurity. The risk scores allow the company to determine the significance of each risk in relation to other risks. The ERM Committee has identified cybersecurity as a critical risk facing the Company. Each of the most critical risks identified is assigned to a member of senior management who oversees the management, mitigation and presentation of the risk to the senior leadership team and throughout the year to our Board. The risks relating to information technology, including cybersecurity, are overseen by our Chief Information Officer. Our Chief Information Officer then assigns the risks within the Information Technology risk category to others on his team. The cybersecurity risk is managed and overseen by our Chief Information Security Officer (“CISO”), who reports to our Chief Information Officer. Cybersecurity as a risk is presented to the full ERM Committee annually or more frequently as needed. We have a dedicated information security organization, led by our CISO and overseen by our Chief Information Officer, which is responsible for assessing and managing material risks from cybersecurity threats. Our Chief Information Officer reports to our Chief Financial Officer. Our CISO has over 25 years of information technology experience, including leading data analytics, customer relationship management, architecture, network operations and application development teams. He has been leading our global information security program for eight years. He is a Certified Information Systems Professional, a member of Google Cloud CISO Customer Advisory Board and New Jersey InfraGard and completed the FBI CISO Academy. He joined the Company over 25 years ago and has extensive knowledge regarding our business processes and the associated information technology platforms utilized worldwide, enabling him to guide his organization to protect the Company’s systems and information. Our Chief Information Officer joined the Company over 25 years ago and has expertise across a wide array of information technology and systems, with experience leading a large array of different functions within the global information technology organization. He has led our information technology Operational Performance and Reliability Committee for the last ten years, which reviews and provides continuous improvement processes and technology across infrastructure, information security, architecture, application and end user performance. He has application development leadership experience across all functions, including the policies and controls that govern both application development and implementation of packaged software. He has a certification from Stanford University for Cybersecurity and Executive Strategy. The Company’s information security organization seeks to employ cybersecurity best practices, including implementing new technologies to proactively identify and monitor new vulnerabilities and reduce risk, conducting due diligence of third-party vendors’ information security programs, maintaining security policies and standards and regularly updating and testing our response planning and protocols. The information security organization also works in partnership with our Internal Audit function to identify cybersecurity risks and review cybersecurity-related internal controls with third parties as part of the overall internal controls process. In addition, the information security organization gains valuable information to improve our threat and risk awareness capabilities as a member of an industry information sharing and analysis organization, which provides strategic and tactical information sharing channels. Employees are provided mandatory cybersecurity awareness training on an annual basis, which includes information about how to identify and report cybersecurity concerns and incidents. The information security organization also conducts phishing simulations and testing scenarios through tabletop exercises and assessment activities, to help ensure compliance with our cyber policies and procedures. We maintain a cybersecurity insurance policy and have retained relevant incident response services. Additionally, we maintain an offensive security team that works both independently and with third-party cybersecurity professionals to conduct security assessments of our enterprise-wide cybersecurity practices, including penetration testing, and identify areas for continuous improvement within the information security program. The Company is a member of the Retail and Hospitality Information Sharing and Analysis Center, which provides additional intelligence associated with threats pertaining to our industry. We maintain a Data Security Incident Response Plan (the “Plan”), which outlines the processes and procedures that we should follow to respond to, remediate and resolve a security incident involving a potential or actual compromise of our proprietary information and/or personal information. It also describes the structure, roles and responsibilities of personnel involved in responding to such incidents and provides a process for alerting senior management of such incidents. The Plan is reviewed on an annual basis and revised as necessary. Our dedicated information security organization leverages various frameworks for managing cybersecurity risks, including the National Institute of Standards and Technology (“NIST”) framework. The key pillars of the NIST framework are to develop and, as applicable, implement (i) an organizational understanding to manage cybersecurity risk to systems, people, assets, data and capabilities; (ii) appropriate safeguards to ensure delivery of critical services; (iii) appropriate activities to identify the occurrence of a cybersecurity event; (iv) appropriate activities to maintain plans for resilience and to restore any capabilities or services that were impaired due to a cybersecurity incident; and (v) appropriate activities to action an incident. We have a comprehensive third-party cybersecurity risk review process, which prioritizes, monitors and assesses the risks associated with our third-party service provider interactions. The third-party service provider assessment framework follows industry standard practices and allows us to properly understand the risk associated with the services provided which are key to our company’s daily operations. For additional information regarding risks faced by the Company from cybersecurity threats, see Item 1A, “Risk Factors - A cybersecurity incident, data breach or a failure of key technology systems could adversely impact our business.”
Cybersecurity Risk Management Processes Integrated [Flag]	true
Cybersecurity Risk Management Processes Integrated [Text Block]	We have a systematic and thorough risk management process, which is designed to identify, assess, prioritize and mitigate the risks that could negatively impact achievement of our strategic and operating objectives. A key component of this process is our Enterprise Risk Management (“ERM”) Committee, which is led by our Chairman, President and Chief Executive Officer, and includes our Chief Financial Officer, Chief Legal Officer, Chief Information Officer and other members of senior management.
Cybersecurity Risk Management Third Party Engaged [Flag]	true
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]	true
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]	false
Cybersecurity Risk Board of Directors Oversight [Text Block]	Our Board is focused on cybersecurity. Specific responsibility for cybersecurity oversight is delegated to the Audit Committee. The Board oversees our risk management process to ensure it is properly designed, well-functioning and consistent with our overall corporate strategy. Our Audit Committee oversees the ERM process and the implementation of appropriate risk monitoring and management systems, though all Board members attend Audit Committee meetings and participate in risk management discussions. Our Board has adopted a written statement, known as the Independent Board Candidate Qualifications and made available on our website, outlining the qualities sought in our directors. This statement, which is refreshed periodically, is used by the Nominating, Governance and Corporate Responsibility Committee (“NGCR Committee”) to evaluate individual director candidates. The NGCR Committee has identified experience with overseeing and managing risk management processes, including with respect to cybersecurity, as being important to creating an effective, well-rounded and diverse Board. Directors with experience overseeing and managing risk management processes play a critical role in the Board’s oversight of our enterprise risk management process. Our CISO reports to the Audit Committee on cybersecurity quarterly, or more frequently if circumstances warrant, including relevant cybersecurity incidents impacting the Company and on topics related to information security, data privacy and cyber risks and mitigation strategies. In addition, outside experts periodically present to the Board on cybersecurity.
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]	Specific responsibility for cybersecurity oversight is delegated to the Audit Committee.
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]	Our CISO reports to the Audit Committee on cybersecurity quarterly, or more frequently if circumstances warrant, including relevant cybersecurity incidents impacting the Company and on topics related to information security, data privacy and cyber risks and mitigation strategies. In addition, outside experts periodically present to the Board on cybersecurity.
Cybersecurity Risk Role of Management [Text Block]	Our Chief Information Officer joined the Company over 25 years ago and has expertise across a wide array of information technology and systems, with experience leading a large array of different functions within the global information technology organization. He has led our information technology Operational Performance and Reliability Committee for the last ten years, which reviews and provides continuous improvement processes and technology across infrastructure, information security, architecture, application and end user performance. He has application development leadership experience across all functions, including the policies and controls that govern both application development and implementation of packaged software. He has a certification from Stanford University for Cybersecurity and Executive Strategy.
Cybersecurity Risk Management Positions or Committees Responsible [Text Block]	Our CISO reports to the Audit Committee on cybersecurity quarterly, or more frequently if circumstances warrant, including relevant cybersecurity incidents impacting the Company and on topics related to information security, data privacy and cyber risks and mitigation strategies. In addition, outside experts periodically present to the Board on cybersecurity.
Cybersecurity Risk Management Expertise of Management Responsible [Text Block]	Our Chief Information Officer joined the Company over 25 years ago and has expertise across a wide array of information technology and systems, with experience leading a large array of different functions within the global information technology organization. He has led our information technology Operational Performance and Reliability Committee for the last ten years, which reviews and provides continuous improvement processes and technology across infrastructure, information security, architecture, application and end user performance. He has application development leadership experience across all functions, including the policies and controls that govern both application development and implementation of packaged software. He has a certification from Stanford University for Cybersecurity and Executive Strategy.
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]	We have a dedicated information security organization, led by our CISO and overseen by our Chief Information Officer, which is responsible for assessing and managing material risks from cybersecurity threats.
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]	true

Goodwill and Other Intangible Assets (Tables)

12 Months Ended

Dec. 31, 2025

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Goodwill by Segment

The changes in net carrying value of Goodwill by segment for the years ended December 31, 2024 and 2025 were as follows:


	2024
	Beginning Balance		Reallocation (1)		Foreign currency translation		Ending Balance
Oral, Personal and Home Care
North America (3)	$	908	$	223	$	(23)	$	1,108
Latin America	179		—		(34)		145
Europe	1,571		(223)		(67)		1,281
Asia Pacific	179		—		(1)		178
Africa/Eurasia	88		—		(10)		78
Total Oral, Personal and Home Care	2,925		—		(135)		2,790
Pet Nutrition	485		—		(3)		482
Total Goodwill	$	3,410	$	—	$	(138)	$	3,272


	2025
	Beginning Balance		Acquisitions (2)		Impairments		Foreign currency translation		Ending Balance
Oral, Personal and Home Care
North America (3)	$	1,108	$	—	$	(582)	$	32	$	558
Latin America	145		—		—		16		161
Europe	1,281		—		—		149		1,430
Asia Pacific	178		—		—		7		185
Africa/Eurasia	78		—		—		4		82
Total Oral, Personal and Home Care	2,790		—		(582)		208		2,416
Pet Nutrition	482		207		—		17		706
Total Goodwill	$	3,272	$	207	$	(582)	$	225	$	3,122

(1) As a result of a reporting structure realignment effective as of July 1, 2024, the Company reallocated the goodwill of a certain reporting unit from the Europe segment to the North America segment. Before and after the reallocation of the goodwill, the Company completed an assessment indicating no goodwill impairment was required as a result of this segment reporting structure realignment.
(2) For information related to the Company’s acquisitions, refer to Note 3, Acquisitions.
(3) The carrying value of goodwill is reflected net of accumulated impairment charges of $1,281 and $699 as of December 31, 2025 and December 31, 2024, respectively.

Schedule of Finite and Indefinite Lived Intangible Assets By Major Class

Other intangible assets as of December 31, 2025 and 2024 were comprised of the following:


	2025						2024
	Gross Carrying Amount		Accumulated Amortization		Net		Gross Carrying Amount		Accumulated Amortization		Net
Trademarks - finite life	$	974	$	(594)	$	380	$	1,135	$	(545)	$	590
Other finite life intangible assets	574		(445)		129		603		(385)		218
Indefinite life intangible assets	1,027		—		1,027		948		—		948
Total Other intangible assets	$	2,575	$	(1,039)	$	1,536	$	2,686	$	(930)	$	1,756

- Definition

Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 24
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482548/350-20-55-24

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1A

Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-2

+ Details

Income Taxes - Schedule of Unrecognized Tax Benefits (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Unrecognized tax benefits:
Balance, January 1	$ 296	$ 314	$ 298
Increases as a result of tax positions taken during the current year	25	37	73
Decreases of tax positions taken during prior years	(22)	(53)	(61)
Increases of tax positions taken during prior years	10	10	6
Decreases as a result of settlements with taxing authorities and the expiration of statutes of limitations	(1)	(3)	(2)
Effect of foreign currency rate movements	11	(9)	0
Balance, December 31	$ 319	$ 296	$ 314

Retirement Plans and Other Retiree Benefits - Schedule of Target Asset Allocation (Details)	Dec. 31, 2025
United States
Defined Benefit Plan, Plan Assets, Allocations [Abstract]
Target asset allocation	100.00%
International
Defined Benefit Plan, Plan Assets, Allocations [Abstract]
Target asset allocation	100.00%
Equity securities \| United States
Defined Benefit Plan, Plan Assets, Allocations [Abstract]
Target asset allocation	26.00%
Equity securities \| International
Defined Benefit Plan, Plan Assets, Allocations [Abstract]
Target asset allocation	19.00%
Fixed income securities \| United States
Defined Benefit Plan, Plan Assets, Allocations [Abstract]
Target asset allocation	60.00%
Fixed income securities \| International
Defined Benefit Plan, Plan Assets, Allocations [Abstract]
Target asset allocation	61.00%
Other investments \| United States
Defined Benefit Plan, Plan Assets, Allocations [Abstract]
Target asset allocation	14.00%
Other investments \| International
Defined Benefit Plan, Plan Assets, Allocations [Abstract]
Target asset allocation	20.00%

Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Current Assets
Cash and cash equivalents	$ 1,288	$ 1,096
Receivables (net of allowances of $90 and $85, respectively)	1,675	1,521
Inventories	2,032	1,987
Other current assets	714	713
Total current assets	5,709	5,317
Property, plant and equipment, net	4,660	4,422
Goodwill	3,122	3,272
Other intangible assets, net	1,536	1,756
Deferred income taxes	205	195
Other non-current assets	1,098	1,084
Total assets	16,330	16,046
Current Liabilities
Debt payable within one-year	1,117	660
Accounts payable	2,089	1,805
Accrued income taxes	383	403
Other accruals	3,264	2,891
Total current liabilities	6,853	5,759
Long-term debt	6,871	7,289
Deferred income taxes	181	343
Other non-current liabilities	2,060	2,111
Total liabilities	15,965	15,502
Commitments and contingent liabilities	0	0
Shareholders’ Equity
Common stock, $1 par value (2,000,000,000 shares authorized, 1,465,706,360 shares issued)	1,466	1,466
Additional paid-in capital	4,322	4,181
Retained earnings	26,595	26,145
Accumulated other comprehensive income (loss)	(3,879)	(4,222)
Treasury stock, at cost	(28,450)	(27,358)
Total Colgate-Palmolive Company shareholders’ equity	54	212
Noncontrolling interests	311	332
Total equity	365	544
Total liabilities and equity	$ 16,330	$ 16,046

Insider Trading Policies and Procedures	12 Months Ended
Insider Trading Policies and Procedures	Dec. 31, 2025
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted	true

Retirement Plans and Other Retiree Benefits - Schedule of Defined Benefit and Other Retiree Benefit Plans (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Amounts Recognized in Balance Sheet
Current liabilities	$ (96)	$ (93)
Pension Plans
Amounts Recognized in Accumulated Other Comprehensive Income (Loss)
Accumulated benefit obligation	2,002	2,075
Other Retiree Benefit Plans
Change in Benefit Obligations
Benefit obligations at beginning of year	632	665
Service cost	7	7	$ 7
Interest cost	38	36	38
Participants’ contributions	0	0
Plan amendments	0	0
Actuarial loss (gain)	37	(14)
Foreign exchange impact	4	(8)
Termination benefits	0	0
Curtailments and settlements	0	0
Benefit payments	(55)	(54)
ERISA litigation matter	0	0
Benefit obligations at end of year	663	632	665
Change in Plan Assets
Fair value of plan assets at beginning of year	0	0
Actual return on plan assets	0	0
Company contributions	55	54
Participants’ contributions	0	0
Foreign exchange impact	0	0
Settlements and acquisitions	0	0
Benefit payments	(55)	(54)
Fair value of plan assets at end of year	0	0	0
Funded Status
Benefit obligations at end of year	663	632	665
Fair value of plan assets at end of year	0	0	0
Net amount recognized	(663)	(632)
Amounts Recognized in Balance Sheet
Noncurrent assets	0	0
Current liabilities	(52)	(51)
Noncurrent liabilities	(611)	(581)
Net amount recognized	(663)	(632)
Amounts Recognized in Accumulated Other Comprehensive Income (Loss)
Actuarial loss	141	109
Transition/prior service cost (credit)	(138)	(159)
Amounts recognized in accumulated other comprehensive income	3	(50)
Accumulated benefit obligation	663	632
Accumulated benefit obligation	$ 0	$ 0
Weighted-Average Assumptions Used to Determine Benefit Obligations
Discount rate	5.56%	5.74%
Long-term rate of compensation increase	0.00%	0.00%
ESOP growth rate	6.00%	6.00%
Medical cost trend rate of increase	7.00%	7.00%
Interest Crediting Rate	0.00%	0.00%
United States \| Pension Plans
Change in Benefit Obligations
Benefit obligations at beginning of year	$ 1,831	$ 1,922
Service cost	1	1	0
Interest cost	102	99	91
Participants’ contributions	0	0
Plan amendments	0	0
Actuarial loss (gain)	0	(54)
Foreign exchange impact	(1)	0
Termination benefits	0	5
Curtailments and settlements	0	(1)
Benefit payments	(145)	(141)
ERISA litigation matter	(34)	0
Benefit obligations at end of year	1,754	1,831	1,922
Change in Plan Assets
Fair value of plan assets at beginning of year	1,295	1,360
Actual return on plan assets	111	49
Company contributions	51	29
Participants’ contributions	0	0
Foreign exchange impact	1	0
Settlements and acquisitions	0	(2)
Benefit payments	(145)	(141)
Fair value of plan assets at end of year	1,313	1,295	1,360
Funded Status
Benefit obligations at end of year	1,754	1,831	1,922
Fair value of plan assets at end of year	1,313	1,295	1,360
Net amount recognized	(441)	(536)
Amounts Recognized in Balance Sheet
Noncurrent assets	1	1
Current liabilities	(28)	(27)
Noncurrent liabilities	(414)	(510)
Net amount recognized	(441)	(536)
Amounts Recognized in Accumulated Other Comprehensive Income (Loss)
Actuarial loss	644	710
Transition/prior service cost (credit)	0	0
Amounts recognized in accumulated other comprehensive income	644	710
Accumulated benefit obligation	$ 1,742	$ 1,818
Weighted-Average Assumptions Used to Determine Benefit Obligations
Discount rate	5.51%	5.73%
Long-term rate of compensation increase	3.50%	3.50%
ESOP growth rate	0.00%	0.00%
Medical cost trend rate of increase	0.00%	0.00%
Interest Crediting Rate	5.49%	5.58%
International \| Pension Plans
Change in Benefit Obligations
Benefit obligations at beginning of year	$ 720	$ 776
Service cost	18	16	15
Interest cost	34	33	33
Participants’ contributions	5	5
Plan amendments	1	0
Actuarial loss (gain)	(20)	(11)
Foreign exchange impact	59	(40)
Termination benefits	0	0
Curtailments and settlements	(12)	(18)
Benefit payments	(44)	(41)
ERISA litigation matter	0	0
Benefit obligations at end of year	761	720	776
Change in Plan Assets
Fair value of plan assets at beginning of year	537	566
Actual return on plan assets	16	18
Company contributions	37	37
Participants’ contributions	5	5
Foreign exchange impact	41	(31)
Settlements and acquisitions	(10)	(17)
Benefit payments	(44)	(41)
Fair value of plan assets at end of year	582	537	566
Funded Status
Benefit obligations at end of year	761	720	776
Fair value of plan assets at end of year	582	537	$ 566
Net amount recognized	(179)	(183)
Amounts Recognized in Balance Sheet
Noncurrent assets	53	47
Current liabilities	(16)	(15)
Noncurrent liabilities	(216)	(215)
Net amount recognized	(179)	(183)
Amounts Recognized in Accumulated Other Comprehensive Income (Loss)
Actuarial loss	158	174
Transition/prior service cost (credit)	8	8
Amounts recognized in accumulated other comprehensive income	166	182
Accumulated benefit obligation	$ 702	$ 668
Weighted-Average Assumptions Used to Determine Benefit Obligations
Discount rate	4.86%	4.69%
Long-term rate of compensation increase	3.27%	3.36%
ESOP growth rate	0.00%	0.00%
Medical cost trend rate of increase	0.00%	0.00%
Interest Crediting Rate	3.19%	3.23%

Capital Stock and Stock-Based Compensation Plans

12 Months Ended

Dec. 31, 2025

Share-Based Payment Arrangement [Abstract]

Capital Stock and Stock-Based Compensation Plans

Preference Stock

The Company has the authority to issue 50,262,150 shares of preference stock.

Stock Repurchases

On March 20, 2025, the Board authorized the repurchase of shares of the Company’s common stock having an aggregate purchase price of up to $5 billion under a new share repurchase program, which replaced a previously authorized share repurchase program. The Board also has authorized share repurchases on an ongoing basis to fulfill certain requirements of the Company’s compensation and benefit programs. The shares are repurchased from time to time in open market or privately negotiated transactions at the Company’s discretion, subject to market conditions, customary blackout periods and other factors. The Company repurchased its common stock at a cost of $1,214 during 2025.

The Company may use either authorized and unissued shares or treasury shares to meet share requirements resulting from the exercise of stock options and the vesting of restricted stock unit awards.

A summary of common stock and treasury stock activity for the three years ended December 31 is as follows:


	Common Stock Outstanding	Treasury Stock
Balance, January 1, 2023	830,212,606	635,493,754

Common stock acquired	(14,735,909)	14,735,909
Shares issued for stock options	5,318,430	(5,318,430)
Shares issued for restricted stock units and other	617,642	(617,642)
Balance, December 31, 2023	821,412,769	644,293,591

Common stock acquired	(18,321,422)	18,321,422
Shares issued for stock options	8,606,699	(8,606,699)
Shares issued for restricted stock units and other	876,652	(876,652)
Balance, December 31, 2024	812,574,698	653,131,662

Common stock acquired	(13,652,320)	13,652,320
Shares issued for stock options	1,339,704	(1,339,704)
Shares issued for restricted stock units and other	977,442	(977,442)
Balance, December 31, 2025	801,239,524	664,466,836

Stock-Based Compensation

The Company recognizes the cost of employee services received in exchange for awards of equity instruments, such as stock options and restricted stock units, based on the fair value of those awards at the date of grant. The fair value of restricted stock units, generally based on market price, is amortized ratably over the requisite service period. The estimated fair value of stock options on the date of grant, based on the Black-Scholes value described below, is amortized on a straight-line basis over the requisite service period for each separately vesting portion of the award. The Company accounts for forfeitures as they occur. Awards to employees eligible for retirement prior to the award becoming fully vested are recognized as compensation cost from the grant date through the date that the employee first becomes eligible to retire and is no longer required to provide service to earn the award.

The Company has one incentive compensation plan pursuant to which it issues restricted stock units (both performance-based and time-vested) and stock options to employees and shares of common stock and stock options to non-employee directors. The Personnel and Organization Committee of the Board, which is comprised entirely of independent directors, administers the incentive compensation plan. The total stock-based compensation expense charged against pretax income for this plan was $155, $135 and $122 for the years ended December 31, 2025, 2024 and 2023, respectively. The total income tax benefit recognized on stock-based compensation, excluding excess tax benefits, was approximately $28, $26 and $22 for the years ended December 31, 2025, 2024 and 2023, respectively.

Stock-based compensation expense is recorded within Selling, general and administrative expenses in the Corporate segment as these amounts are not included in internal measures of segment operating performance.

The Company uses the Black-Scholes option pricing model to estimate the fair value of stock option awards. The weighted-average fair value assumptions are summarized in the following table:


	2025			2024			2023
Expected term of options	6 years			6 years			6 years
Expected volatility rate	20.6		%	20.5		%	19.8		%
Risk-free interest rate	4.0		%	3.8		%	4.3		%
Expected dividend yield	2.1		%	2.1		%	2.5		%
Weighted-average estimated fair value	$	18.21		$	22.65		$	14.89

The weighted-average expected term of stock options granted each year was determined with reference to historical exercise and post-vesting cancellation experience, the vesting period of the awards and the contractual term of the awards, among other factors. Expected volatility incorporates implied share-price volatility derived from exchange traded options on the Company’s common stock. The risk-free interest rate for the expected term of the option is based on the yield of a zero-coupon U.S. Treasury bond with a maturity period equal to the option’s expected term.

Stock Options

The Company issues non-qualified stock options to non-employee directors, officers and other key employees. Stock options have a contractual term of eight years and generally vest ratably over three years. As of December 31, 2025, approximately 18,063,072 shares of common stock were available for future stock option grants.

A summary of stock option activity during 2025 is presented below:


	Shares (in thousands)	Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (in years)	Intrinsic Value of Unexercised In-the-Money Options
Options outstanding, January 1, 2025	12,774	$	78
Granted	1,284	84
Exercised	(1,340)	76
Forfeited	(87)	82
Expired	(12)	79
Options outstanding, December 31, 2025	12,619	79		4	$	32
Options exercisable, December 31, 2025	10,174	$	77	4	$	28

As of December 31, 2025, there was $8 of total unrecognized compensation expense related to unvested stock options, which will be recognized over a weighted-average period of 1.4 years. The total intrinsic value of stock options exercised during the years ended December 31, 2025, 2024 and 2023 was $18, $150 and $28, respectively.

The benefits of tax deductions in excess of grant date fair value resulting from the exercise of stock options and vesting of restricted stock unit awards for the years ended December 31, 2025, 2024 and 2023 were $3, $18 and $4, respectively, and are recognized in the provision for income taxes as a discrete item in the quarterly period in which they occur and classified as an operating cash flow. Cash proceeds received from stock options exercised for the years ended December 31, 2025, 2024 and 2023 were $101, $638 and $380, respectively.

Performance-based Restricted Stock Units

Under the Company’s long-term incentive compensation program, the Company grants officers and other key employees a target number of unearned performance-based restricted stock units at the beginning of each three-year performance cycle. Awards are earned and vest following the conclusion of the performance period on the basis of achievement of performance goals established at the commencement of each three-year performance period.

A summary of performance-based restricted stock unit activity for the year ended December 31, 2025 is presented below:


	Shares (in thousands)	Weighted Average Grant Date Fair Value Per Award
Performance-based restricted stock units as of January 1, 2025	1,037	$	74
Activity:
Granted	317	85
Vested	(458)	68
Forfeited	(217)	70
Change due to performance and/or market condition achievement	251	67
Performance-based restricted stock units as of December 31, 2025	930	$	80

As of December 31, 2025, there was $32 of total unrecognized compensation expense related to unvested performance-based restricted stock unit awards, which will be recognized ratably over the remaining performance period.

The Company uses a Monte-Carlo simulation model to estimate the fair value of performance-based restricted stock units at the date of grant.

Time-Vested Restricted Stock Units

The Company also grants time-vested restricted stock unit awards. Awards either vest annually on a ratable basis over the restriction period or at the end of the restriction period, which is generally three years from the date of grant. As of December 31, 2025, approximately 6,091,685 shares of common stock were available for future restricted stock unit awards.

A summary of restricted stock unit activity during 2025 is presented below:


	Shares (in thousands)	Weighted Average Grant Date Fair Value Per Award
Restricted stock units as of January 1, 2025	1,987	$	88
Activity:
Granted	1,197	85
Vested	(1,049)	83
Forfeited	(77)	89
Restricted stock units as of December 31, 2025	2,058	$	88

As of December 31, 2025, there was $74 of total unrecognized compensation expense related to unvested time-vested restricted stock unit awards, which will be recognized over a weighted-average period of 1.6 years. The total fair value of time-vested restricted stock units vested during the years ended December 31, 2025, 2024 and 2023 was $87, $72 and $45, respectively.

Supplemental Balance Sheet Information - Schedule of Inventories by Major Class (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Inventories
Raw materials and supplies	$ 632	$ 631
Work-in-process	46	46
Finished goods	1,479	1,431
Total Inventories, net	2,157	2,108
Non-current inventory, net	(125)	(121)
Current Inventories, net	$ 2,032	$ 1,987

Fair Value Measurements and Financial Instruments - Schedule of Fair Value of Derivative Instruments and Other Financial Instruments (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Designated derivative instruments
Derivative asset	$ 18	$ 33
Derivative liability	22	23
Other financial instruments
Investments fair value	$ 107	$ 160
Derivative Asset, Statement of Financial Position [Extensible Enumeration]	Other current assets	Other current assets
Derivative Liability, Statement of Financial Position [Extensible Enumeration]	Other accruals	Other accruals
Foreign currency contracts
Designated derivative instruments
Derivative asset	$ 18	$ 33
Derivative liability	22	22
Commodity contracts
Designated derivative instruments
Derivative asset	0	0
Derivative liability	0	1
Other current assets
Other financial instruments
Marketable securities	$ 107	$ 160

Nature of Operations - Narrative (Details)	12 Months Ended
Nature of Operations - Narrative (Details)	Dec. 31, 2025 countryAndTerritory segment
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of countries in which entity operates (more than) \| countryAndTerritory	200
Number of operating segments (in segments) \| segment	2

Supplemental Other Comprehensive Income (Loss) Information (Tables)

12 Months Ended

Dec. 31, 2025

Equity [Abstract]

Schedule of Comprehensive Income (Loss)

Other comprehensive income (loss) components attributable to Colgate-Palmolive Company before tax and net of tax during the years ended December 31 were as follows:


	2025		2024		2023
Cumulative translation adjustments:
Cumulative translation adjustments, pre-tax	$	258	$	(298)	$	127
Tax amounts	78		(37)		13
Cumulative translation adjustments, net of tax	336		(335)		140
Pension and other benefits:
Net actuarial gain (loss), prior service costs and settlements during the period	5		31		(49)
Amortization of net actuarial loss, transition and prior service costs(1)	24		28		30

Retirement Plan and other retiree benefit adjustments, pre-tax	29		59		(19)





Tax amounts	(7)		(16)		3
Retirement Plan and other retiree benefit adjustments, net of tax	22		43		(16)
Cash flow hedges:


Gains (losses) on cash flow hedges, pre-tax	(21)		10		(10)
Tax amounts	5		(2)		3
Gains (losses) on cash flow hedges, net of tax	(16)		8		(7)
Total Other comprehensive income (loss), net of tax	$	342	$	(284)	$	117

(1)These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 10, Retirement Plans and Other Retiree Benefits for additional details.

Leases - Schedule of Components of Operating Lease Expense (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Leases [Abstract]
Operating lease cost	$ 152	$ 144
Short-term lease cost	1	3
Variable lease cost	17	19
Sublease Income	(1)	(2)
Total lease cost	$ 169	$ 164

Consolidated Statements of Income - USD ($) $ in Millions	12 Months Ended
Consolidated Statements of Income - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Income Statement [Abstract]
Net sales	$ 20,382	$ 20,101	$ 19,457
Cost of sales	8,131	7,940	8,131
Gross profit	12,251	12,161	11,326
Selling, general and administrative expenses	7,903	7,729	7,151
Other (income) expense, net	123	164	191
Goodwill and intangible assets impairment charges	919	0	0
Operating profit	3,306	4,268	3,984
Non-service related postretirement costs	55	87	360
Interest expense	267	292	287
Interest income	75	67	55
Income before income taxes	3,059	3,956	3,392
Global effective tax rate	798	907	937
Net income including noncontrolling interests	2,261	3,049	2,455
Less: Net income attributable to noncontrolling interests	129	160	155
Net income attributable to Colgate-Palmolive Company	$ 2,132	$ 2,889	$ 2,300
Earnings per common share, basic (in dollars per share)	$ 2.64	$ 3.53	$ 2.78
Earnings per common share, diluted (in dollars per share)	$ 2.63	$ 3.51	$ 2.77

Employee Stock Ownership Plan	12 Months Ended
Employee Stock Ownership Plan	Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]
Employee Stock Ownership Plan	Employee Stock Ownership Plan In 1989, the Company expanded its Employee Stock Ownership Plan (“ESOP”) through the introduction of a leveraged ESOP that funds certain benefits for employees who have met eligibility requirements. As of December 31, 2025 and 2024, there were 6,646,688 and 7,428,343 shares of common stock, respectively, outstanding and issued to the Company’s ESOP, which have all been released and allocated to participant accounts as of December 31, 2025. During 2000, the ESOP entered into a loan agreement with the Company under which the benefits of the ESOP may be extended through 2035. As of December 31, 2025, the ESOP had no outstanding borrowings from the Company. Dividends on the stock used to repay principal and interest or credited to participant accounts are deductible for income tax purposes and, accordingly, are reflected net of their tax benefit in the Consolidated Statements of Changes in Shareholders’ Equity. Annual expense related to the ESOP was $0 in 2025, 2024 and 2023. The Company paid dividends on the shares held by the ESOP of $15 in 2025, $16 in 2024 and $17 in 2023. The Company did not make any contributions to the ESOP in 2025, 2024 or 2023.

Supplemental Balance Sheet Information

12 Months Ended

Dec. 31, 2025

Balance Sheet Related Disclosures [Abstract]

Supplemental Balance Sheet Information

Inventories by major class are as follows at December 31:


Inventories	2025		2024
Raw materials and supplies	$	632	$	631
Work-in-process	46		46
Finished goods	1,479		1,431
Total Inventories, net	$	2,157	$	2,108
Non-current inventory, net	(125)		(121)
Current Inventories, net	$	2,032	$	1,987

Inventories valued under LIFO amounted to $476 and $453 at December 31, 2025 and 2024, respectively. The excess of current cost over LIFO cost at the end of each year was $129 and $105, respectively. The liquidations of LIFO inventory quantities had no material effect on income in 2025, 2024 and 2023. Inventory classified as non-current at December 31, 2025 was recorded on the Consolidated Balance Sheets as “Other assets”.


Property, plant and equipment, net	2025		2024
Land	$	234	$	226
Buildings	2,171		2,056
Manufacturing machinery and equipment	6,935		6,265
Other equipment	1,516		1,580
	10,856		10,127
Accumulated depreciation	(6,196)		(5,705)
Total Property, plant and equipment, net	$	4,660	$	4,422


Other current assets	2025		2024
Marketable securities	$	107	$	160
Prepaids	589		520
Derivatives	18		33
Total Other current assets	$	714	$	713


Other accruals	2025		2024
Accrued advertising and consumer and trade promotions	$	997	$	912
Accrued payroll and employee benefits	420		437
Accrued taxes other than income taxes	254		162
Restructuring accrual	31		15
Pension and other retiree benefits	96		93
Lease liabilities due in one year	118		107
Accrued interest	72		72
Derivatives	22		23
Dividend payable	418		408
Other	836		662
Total Other accruals	$	3,264	$	2,891


Other liabilities	2025		2024
Pension and other retiree benefits	$	1,241	$	1,306
Long-term lease liabilities	448		456
Restructuring accrual	9		29
Other	362		320
Total Other liabilities	$	2,060	$	2,111

Acquisitions

12 Months Ended

Dec. 31, 2025

Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]

Acquisitions

On April 30, 2025, the Company acquired Care TopCo Pty Ltd, the owner of the Prime100 pet food business, for cash consideration of AU $471 (approximately $301). This acquisition provides the Company’s Hill’s Pet Nutrition segment with an entry into the fast-growing fresh pet food category in Australia. The acquisition was financed with a combination of debt and cash and was accounted for as a business combination in accordance with ASC 805.

The total purchase price of $301 has been allocated to the net assets acquired based on their respective estimated fair values as follows:


Cash	$	8
Other current assets	12
Property, plant and equipment	13
Other assets	5
Other intangible assets	64
Goodwill	207
Total liabilities	(8)
Fair value of net assets acquired	$	301

Goodwill of $207 was allocated to the Hill’s Pet Nutrition segment. The Company expects that goodwill will be deductible for tax purposes. Other intangible assets acquired include trademarks, customer relationships and product formulations, which now have useful lives ranging from five to 20 years.

The preliminary estimates of the fair value of identifiable assets acquired and liabilities assumed are subject to revisions, which may result in adjustments to the preliminary values discussed above. The Company expects to finalize the purchase price allocation no later than the second quarter of 2026.

Pro forma results of operations have not been presented as the impact on the Company’s Consolidated Financial Statements is not material.

- Definition

The entire disclosure for business combination.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-8

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 38
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479303/805-10-55-38

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 46
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479303/805-10-55-46

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 43
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479303/805-10-55-43

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 45
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479303/805-10-55-45

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 29
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479303/805-10-55-29

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 29
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479303/805-10-55-29

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479907/805-20-50-5

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)(1)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479907/805-20-50-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479907/805-20-50-3

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479581/805-30-50-3

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-2

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479907/805-20-50-2

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479581/805-30-50-2

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479581/805-30-50-1

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (f)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479581/805-30-50-1

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-3

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479581/805-30-50-1

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-2

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-4

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479581/805-30-50-4

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479907/805-20-50-1

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479907/805-20-50-1

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (h)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-2

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-2

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 40
-Name Accounting Standards Codification
-Section 45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479326/805-40-45-1

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/805-30/tableOfContent

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/805-20/tableOfContent

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-7

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-5

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/805-10/tableOfContent

+ Details

Retirement Plans and Other Retiree Benefits - Schedule of Net Periodic Benefit Costs (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Components of Net Periodic Benefit Cost
ERISA litigation matter	$ 65	$ 0	$ 267
Other Retiree Benefit Plans
Components of Net Periodic Benefit Cost
Service cost	7	7	7
Interest cost	38	36	38
Expected return on plan assets	0	0	0
Amortization of transition and prior service costs (credits)	(21)	(21)	(20)
Amortization of actuarial loss	5	4	1
Net periodic benefit cost	29	26	26
Other postretirement charges	0	0	0
ERISA litigation matter	0	0	0
Total pension cost	$ 29	$ 26	$ 26
Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost
Discount rate	5.74%	5.37%	5.67%
Long-term rate of compensation increase	0.00%	0.00%	0.00%
ESOP growth rate	6.00%	6.00%	6.00%
Medical cost trend rate of increase	7.00%	6.00%	6.25%
Interest Crediting Rate	0.00%	0.00%	0.00%
United States \| Pension Plans
Components of Net Periodic Benefit Cost
Service cost	$ 1	$ 1	$ 0
Interest cost	102	99	91
Expected return on plan assets	(83)	(85)	(79)
Amortization of transition and prior service costs (credits)	0	0	0
Amortization of actuarial loss	35	39	43
Net periodic benefit cost	55	54	55
Other postretirement charges	0	5	3
ERISA litigation matter	(34)	0	267
Total pension cost	$ 21	$ 59	$ 325
Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost
Discount rate	5.73%	5.40%	5.66%
Expected long-term rate of return on plan assets	6.50%	6.50%	6.25%
Long-term rate of compensation increase	3.50%	3.50%	3.50%
ESOP growth rate	0.00%	0.00%	0.00%
Medical cost trend rate of increase	0.00%	0.00%	0.00%
Interest Crediting Rate	5.58%	4.99%	5.21%
International \| Pension Plans
Components of Net Periodic Benefit Cost
Service cost	$ 18	$ 16	$ 15
Interest cost	34	33	33
Expected return on plan assets	(26)	(29)	(25)
Amortization of transition and prior service costs (credits)	0	1	1
Amortization of actuarial loss	5	5	5
Net periodic benefit cost	31	26	29
Other postretirement charges	0	0	2
ERISA litigation matter	0	0	0
Total pension cost	$ 31	$ 26	$ 31
Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost
Discount rate	4.69%	4.61%	4.75%
Expected long-term rate of return on plan assets	5.36%	5.69%	4.66%
Long-term rate of compensation increase	3.36%	3.24%	3.22%
ESOP growth rate	0.00%	0.00%	0.00%
Medical cost trend rate of increase	0.00%	0.00%	0.00%
Interest Crediting Rate	3.23%	0.64%	2.28%

Earnings Per Share

12 Months Ended

Dec. 31, 2025

Earnings Per Share [Abstract]

Earnings Per Share

For the years ended December 31, 2025, 2024 and 2023, earnings per share were as follows:


	2025					2024					2023
	Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share		Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share		Net income attributable to Colgate-Palmolive Company		Shares (millions)	Per Share
Basic EPS	$	2,132	808.7	$	2.64	$	2,889	819.1	$	3.53	$	2,300	827.4	$	2.78
Stock options and restricted stock units			2.4					4.1					1.8
Diluted EPS	$	2,132	811.1	$	2.63	$	2,889	823.2	$	3.51	$	2,300	829.2	$	2.77

Basic earnings per common share is computed by dividing net income available for common stockholders by the weighted-average number of shares of common stock outstanding for the period.

Diluted earnings per common share is computed using the treasury stock method on the basis of the weighted-average number of shares of common stock plus the dilutive effect of potential common shares outstanding during the period. Dilutive potential common shares include outstanding stock options and restricted stock units.

For the years ended December 31, 2025, 2024 and 2023, the average number of stock options that were anti-dilutive and not included in diluted earnings per share calculations were 1,076,140, 295,968 and 13,719,286, respectively. For the years ended December 31, 2025, 2024 and 2023, the average number of restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 1,459, 100,191 and 1,183, respectively.

Restructuring and Related Implementation Charges - Schedule of Restructuring and Related Costs (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Strategic Growth and Productivity Program
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost	$ 13
Restructuring and related cost, incurred cost, after tax	11
Strategic Growth and Productivity Program \| Selling, general and administrative expenses
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost	6
Strategic Growth and Productivity Program \| Other (income) expense, net
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost	$ 7
Global Productivity Initiative
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost		$ 85
Restructuring and related cost, incurred cost, after tax		73
Global Productivity Initiative \| Gross Profit
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost		20
Global Productivity Initiative \| Selling, general and administrative expenses
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost		6
Global Productivity Initiative \| Other (income) expense, net
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost		$ 59

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References + Details

Long-Term Debt and Credit Facilities

12 Months Ended

Dec. 31, 2025

Debt Disclosure [Abstract]

Long-Term Debt and Credit Facilities

Long-term debt consisted of the following at December 31:


	Weighted Average Interest Rate	Maturities			2025		2024
Notes	2.9%	2026	-	2078	$	7,767	$	6,946
Commercial paper	2.0%	2026			147		936
Finance Lease Obligations		Various			72		59
					7,986		7,941
Less: Current portion of long-term debt					(1,115)		(652)
Total					$	6,871	$	7,289

Debt payable within one year consisted of the following at December 31:


	2025		2024
Notes and loans payable	$	2	$	8
Current portion of long-term debt	1,115		652
Debt payable within one year	$	1,117	$	660

The Company classifies commercial paper and certain long-term debt that is subject to a put option as long-term debt when it has the intent and ability to refinance such obligations on a long-term basis, including, if necessary, by utilizing its available lines of credit. Excluding commercial paper, scheduled maturities of long-term debt and finance leases outstanding as of December 31, 2025 were as follows:


Years Ended December 31,
2026	$	1,115
2027	523
2028	615
2029	591
2030	500
Thereafter	4,495
Total	$	7,839

The Company’s debt issuances and redemptions support its capital structure strategy objectives of funding its business and growth initiatives while minimizing its risk-adjusted cost of capital. During the year ended December 31, 2024, the Company redeemed at maturity $500 of ten-year Medium-Term Notes with a fixed coupon rate of 3.25%. During the year ended December 31, 2025, the Company redeemed at maturity $130 of 30-year Medium-Term Notes with a fixed coupon rate of 7.60% and $500 of three-year Senior Notes with a fixed coupon of 3.10%. These redemptions were financed with commercial paper borrowings.

In April 2025, the Company issued $500 of five-year Senior Notes at a fixed coupon rate of 4.20%. In November 2025, the Company issued €600 of 10-year Senior Notes at a fixed coupon rate of 3.25%.

At December 31, 2025, the Company had access to unused domestic and foreign lines of credit of $3,641 (including under the facility discussed below) and could also issue long-term debt pursuant to an effective shelf registration statement. In November 2022, the Company entered into an amended and restated $3,000 five-year revolving credit facility with a syndicate of banks for a five-year term expiring November 2027, which replaced, on substantially similar terms, the Company’s $3,000 revolving credit facility that was scheduled to expire in August 2026. The term of the revolving credit facility was subsequently extended by one year in each of November 2023, November 2024 and November 2025. The expiration date of the revolving credit facility is now November 2030. The credit facility serves as a backstop for the Company's commercial paper program. Commitment fees related to the credit facility are not material.

Certain agreements with respect to the Company’s bank borrowings contain financial and other covenants as well as cross-default provisions. Noncompliance with these requirements could ultimately result in the acceleration of amounts owed. The Company is in full compliance with all such requirements.

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8A
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(c))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481544/470-10-50-6

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481544/470-10-50-6

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 405
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477092/405-40-50-1

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 470
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/470/tableOfContent

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482925/835-30-45-2

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1B
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1C
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1E
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1I
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I

+ Details

Fair Value Measurements and Financial Instruments - Schedule of Gain (Loss) on Hedges Recognized in Statements of Income (Details) - Fair Value Hedges - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative instrument	$ 100	$ (54)
Foreign currency contracts \| Selling, general and administrative expenses
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative instrument	$ 100	$ (54)

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

+ Details

Acquisitions - Narrative (Details) $ in Millions, $ in Millions	Apr. 30, 2025 USD ($)	Dec. 31, 2025 USD ($)	Apr. 30, 2025 AUD ($)	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)
Business Combination [Line Items]
Goodwill		$ 3,122		$ 3,272	$ 3,410
Care TopCo Pty Ltd
Business Combination [Line Items]
Fair value of net assets acquired	$ 301		$ 471
Goodwill	$ 207
Care TopCo Pty Ltd \| Minimum
Business Combination [Line Items]
Useful life	5 years
Care TopCo Pty Ltd \| Maximum
Business Combination [Line Items]
Useful life	20 years

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-4

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-8

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 47
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479303/805-10-55-47

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479907/805-20-50-5

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (f)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479581/805-30-50-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)(1)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479907/805-20-50-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)(1)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479907/805-20-50-1

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479581/805-30-50-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479581/805-30-50-1

Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479907/805-20-50-1

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-2

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-2

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479907/805-20-50-2

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-2

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479581/805-30-50-2

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479581/805-30-50-1

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (f)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479581/805-30-50-1

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (e)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479907/805-20-50-1

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-3

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4A
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479907/805-20-50-4A

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479907/805-20-50-4

Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479907/805-20-50-1

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479907/805-20-50-1

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479907/805-20-50-1

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4A
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479907/805-20-50-4A

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479907/805-20-50-1

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479907/805-20-50-1

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4A
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479907/805-20-50-4A

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479581/805-30-50-4

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479581/805-30-50-1

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479581/805-30-50-1

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479581/805-30-50-1

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (e)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479907/805-20-50-1

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479907/805-20-50-1

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479907/805-20-50-1

Reference 36: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479907/805-20-50-1

Reference 37: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-2

Reference 38: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (g)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-2

Reference 39: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (g)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-2

Reference 40: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (g)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-2

Reference 41: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (g)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-2

Reference 42: http://www.xbrl.org/2003/role/disclosureRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-2

+ Details

- Definition

Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 24
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482548/350-20-55-24

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479328/805-10-50-8

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 41
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479303/805-10-55-41

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 740
-Name Accounting Standards Codification
-Section 55
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478064/805-740-55-13

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 39
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479303/805-10-55-39

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 49
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-49

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 100
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482078/820-10-55-100

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Topic 852
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481372/852-10-55-10

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(15))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482598/350-20-45-1

Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 350
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482573/350-20-50-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(10)(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1

Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 805
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479581/805-30-50-4

+ Details

Fair Value Measurements and Financial Instruments

12 Months Ended

Dec. 31, 2025

Fair Value Disclosures [Abstract]

Fair Value Measurements and Financial Instruments

The Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. The Company is exposed to the risk of credit loss in the event of nonperformance by counterparties to financial instrument contracts; however, nonperformance is considered unlikely and any nonperformance is unlikely to be material, as it is the Company’s policy to contract only with diverse, credit-worthy counterparties based upon both strong credit ratings and other credit considerations.

The Company is exposed to market risk from foreign currency exchange rates, interest rates and commodity price fluctuations. Volatility relating to these exposures is managed on a global basis by utilizing a number of techniques, including working capital management, sourcing strategies, selling price increases, selective borrowings in local currencies and entering into selective derivative instrument transactions, issued with standard features, in accordance with the Company’s treasury and risk management policies, which prohibit the use of derivatives for speculative purposes and leveraged derivatives for any purpose. It is the Company’s policy to enter into derivative instrument contracts with terms that match the underlying exposure being hedged. Provided below are details of the Company’s exposures by type of risk and derivative instruments by type of hedge designation.

Valuation Considerations

The Company’s derivative instruments include foreign currency contracts and commodity contracts. The fair value of these instruments is classified as follows:

Level 1: Quoted market prices in active markets for identical assets or liabilities.

Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.

Level 3: Unobservable inputs reflecting the reporting entity’s own assumptions.

Foreign Exchange Risk

As the Company markets its products in over 200 countries and territories, it is exposed to currency fluctuations related to manufacturing and selling its products in currencies other than the U.S. dollar. The Company manages its foreign currency exposures through a combination of cost containment measures, sourcing strategies, selling price increases and the hedging of certain costs in an effort to minimize the impact on earnings of foreign currency rate movements.

The Company primarily utilizes foreign currency contracts, including forward and swap contracts, foreign and local currency deposits and local currency borrowings to hedge portions of its foreign currency purchases, assets and liabilities arising in the normal course of business and the net investment in certain foreign subsidiaries. The duration of foreign currency contracts generally does not exceed 12 months and the contracts are valued using observable market rates (Level 2 valuation).

Interest Rate Risk

The Company manages its targeted mix of fixed and floating rate debt with debt issuances and by entering into interest rate swaps in order to mitigate fluctuations in earnings and cash flows that may result from interest rate volatility. The Company utilizes forward-starting interest rate swaps to mitigate the risk of variability in interest rates for future debt issuances. The notional amount, interest payment and maturity date of the swaps generally match the principal, interest payment and maturity date of the related debt, and the swaps are valued using observable benchmark rates (Level 2 valuation).

Commodity Price Risk

The Company is exposed to price volatility related to raw materials used in production, such as resins, essential oils, tropical oils, pulp, tallow, corn, poultry and soybeans. The Company manages its raw material exposures through a combination of cost containment measures, sourcing strategies, ongoing productivity initiatives and the limited use of commodity hedging contracts. Futures contracts are used on a limited basis, primarily in the Hill’s Pet Nutrition segment, to manage volatility related to raw material inventory purchases of certain traded commodities, and these contracts are measured using quoted commodity exchange prices (Level 1 valuation). The duration of the commodity contracts generally does not exceed 12 months.

Credit Risk

The Company is exposed to the risk of credit loss in the event of nonperformance by counterparties to financial instrument contracts; however, nonperformance is considered unlikely and any nonperformance is unlikely to be material as it is the Company’s policy to contract with diverse, credit-worthy counterparties based upon both strong credit ratings and other credit considerations.

The following table summarizes the fair value of the Company’s derivative instruments and other financial instruments which are carried at fair value in the Company’s Consolidated Balance Sheets as of December 31, 2025 and 2024:


	Assets					Liabilities
	Account	Fair Value				Account	Fair Value
Designated derivative instruments		December 31, 2025		December 31, 2024			December 31, 2025		December 31, 2024




Foreign currency contracts	Other current assets	$	18	$	33	Other accruals	$	22	$	22

Commodity contracts	Other current assets	—		—		Other accruals	—		1
Total designated		$	18	$	33		$	22	$	23







Other financial instruments
Marketable securities	Other current assets	107		160
Total other financial instruments		$	107	$	160

The carrying amount of cash, cash equivalents, accounts receivable and short-term debt approximated fair value as of December 31, 2025 and 2024. The estimated fair value of the Company’s total debt as of December 31, 2025 and 2024, was $7,518 and $7,441, respectively, and the related carrying value was $7,988 and $7,949, respectively. The estimated fair value of long-term debt was derived principally from quoted prices on the Company’s outstanding fixed-term notes (Level 2 valuation).

The following tables present the notional values as of:


	December 31, 2025
	Foreign Currency Contracts		Foreign Currency Debt		Commodity Contracts		Total
Fair Value Hedges	$	2,093	$	—	$	—	$	2,093
Cash Flow Hedges	1,106		—		16		1,122
Net Investment Hedges	336		3,942		—		4,278


	December 31, 2024
	Foreign Currency Contracts		Foreign Currency Debt		Commodity Contracts		Total
Fair Value Hedges	$	1,669	$	—	$	—	$	1,669
Cash Flow Hedges	1,023		—		18		1,041
Net Investment Hedges	289		3,750		—		4,039

The following table presents the location and amount of gain (loss) on fair value hedges recognized in the Company’s Consolidated Statements of Income for the twelve months ended December 31, 2025 and 2024:


		Gain (Loss) Recognized in Income
	Location of Gain (Loss) Recognized in Income	Twelve Months Ended December 31,
		2025		2024

Hedging instruments:
Foreign currency contracts	Selling, general and administrative expenses	$	100	$	(54)
Total gain (loss) on fair value hedges		$	100	$	(54)

The amount of gain (loss) recognized in income and Accumulated Other Comprehensive Income (AOCI) associated with cash flow hedges did not have a material impact on the Company’s Consolidated Financial Statements during the twelve months ended December 31, 2025.

The following table presents the amount of gain (loss) on net investment hedges recognized in the Company’s AOCI for the twelve months ended December 31, 2025 and 2024:


	Gain (Loss) Recognized in AOCI
	Twelve Months Ended December 31,
Hedging instruments:	2025		2024
Foreign currency contracts	$	(39)	$	42
Foreign currency debt	(541)		211
Total gain (loss) on net investment hedges	$	(580)	$	253

Income Taxes - Schedule of Provision for Income Taxes (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Income Tax Disclosure [Abstract]
U.S. federal	$ 168	$ 169	$ 77
U.S. state and local	42	19	(5)
International	588	719	865
Total Provision for income taxes	$ 798	$ 907	$ 937

- Definition

Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-4

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 21
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-21

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 220
-SubTopic 40
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147476153/220-40-55-14

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 270
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482964/270-10-50-1

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (ee)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 231
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482663/740-10-55-231

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-9

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.7)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 250
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483443/250-10-50-8

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-10

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(9))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Subparagraph (a)
-SubTopic 20
-Topic 740
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482659/740-20-45-2

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h))
-SubTopic 10
-Topic 235
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

+ Details

Segment Information (Tables)

12 Months Ended

Dec. 31, 2025

Segment Reporting [Abstract]

Schedule of Net Sales and Operating Profit by Segment


	2025
	Net sales		Cost of Sales		Selling, general and administrative expenses		Other (income) expense, net (3)		Operating Profit
Reportable Segments
Oral, Personal and Home Care
North America(1)	$	4,045	$	1,589	$	1,626	$	47	$	784
Latin America	4,776		2,107		1,268		(11)		1,411
Europe	2,962		1,099		1,087		28		748
Asia Pacific	2,814		1,067		1,013		(27)		760
Africa/Eurasia	1,172		465		436		16		255
Total Oral, Personal and Home Care	15,769								3,959
Pet Nutrition(2)	4,613		1,818		1,717		14		1,064
Reconciliation with Total Company Operating Profit
Corporate									(1,717)
Total	$	20,382							$	3,306

Note: Table may not sum due to rounding.

(1) Net sales in the United States for Oral, Personal and Home Care were $3,596 in 2025.

(2) Net sales in the United States for Pet Nutrition were $3,062 in 2025.

(3) Refer to Note 17, Supplemental Income Statement for information related to Other (income) expense, net.


	2024
	Net sales		Cost of Sales		Selling, general and administrative expenses		Other (income) expense, net (3)		Operating Profit
Reportable Segments
Oral, Personal and Home Care
North America(1)	$	4,113	$	1,571	$	1,668	$	36	$	839
Latin America	4,782		1,933		1,328		(5)		1,526
Europe	2,770		1,050		1,031		31		658
Asia Pacific	2,858		1,078		997		(30)		812
Africa/Eurasia	1,095		432		395		16		253
Total Oral, Personal and Home Care	15,618								4,088
Pet Nutrition(2)	4,483		1,869		1,641		8		965
Reconciliation with Total Company Operating Profit
Corporate									(784)
Total	$	20,101							$	4,268

Note: Table may not sum due to rounding.

(1) Net sales in the United States for Oral, Personal and Home Care were $3,640 in 2024.

(2) Net sales in the United States for Pet Nutrition were $3,059 in 2024.

(3) Refer to Note 17, Supplemental Income Statement for information related to Other (income) expense, net.


	2023
	Net sales		Cost of Sales		Selling, general and administrative expenses		Other (income) expense, net (3)		Operating Profit
Reportable Segments
Oral, Personal and Home Care
North America(1)	$	4,091	$	1,588	$	1,594	$	37	$	871
Latin America	4,640		1,977		1,241		5		1,417
Europe	2,571		1,069		899		31		573
Asia Pacific	2,782		1,108		925		(18)		767
Africa/Eurasia	1,083		442		377		9		254
Total Oral, Personal and Home Care	15,167								3,882
Pet Nutrition(2)	4,290		1,964		1,493		26		806
Reconciliation with Total Company Operating Profit
Corporate									(704)
Total	$	19,457							$	3,984

Note: Table may not sum due to rounding.

(1) Net sales in the United States for Oral, Personal and Home Care were $3,625 in 2023.

(2) Net sales in the United States for Pet Nutrition were $2,918 in 2023

(3) Refer to Note 17, Supplemental Income Statement for information related to Other (income) expense, net.


	2025		2024		2023
Capital expenditures
Oral, Personal and Home Care
North America	$	65	$	52	$	46
Latin America	141		126		146
Europe	63		63		44
Asia Pacific	80		64		65
Africa/Eurasia	12		12		10
Total Oral, Personal and Home Care	361		317		311
Pet Nutrition	88		143		301
Corporate	115		101		93
Total Capital expenditures	$	564	$	561	$	705


	2025		2024		2023
Depreciation and amortization
Oral, Personal and Home Care
North America	$	123	$	124	$	116
Latin America	106		100		98
Europe	66		65		65
Asia Pacific	80		81		84
Africa/Eurasia	10		8		9
Total Oral, Personal and Home Care	385		378		372
Pet Nutrition	144		132		101
Corporate	101		95		94
Total Depreciation and amortization	$	630	$	605	$	567


	2025		2024
Long-lived assets(1)
United States	$	2,663	$	2,728
International	2,528		2,223
Total Long-lived assets	$	5,191	$	4,951

(1) Long-lived assets include Property, plant and equipment, net and lease right-of-use assets.

Capital Stock and Stock-Based Compensation Plans - Schedule of Fair Value Assumptions (Details) - $ / shares	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]
Expected term of options	6 years	6 years	6 years
Expected volatility rate	20.60%	20.50%	19.80%
Risk-free interest rate	4.00%	3.80%	4.30%
Expected dividend yield	2.10%	2.10%	2.50%
Weighted-average estimated fair value (in dollars per share)	$ 18.21	$ 22.65	$ 14.89

Supplemental Balance Sheet Information - Schedule of Other Accruals (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Other accruals
Accrued advertising and consumer and trade promotions	$ 997	$ 912
Accrued payroll and employee benefits	420	437
Accrued taxes other than income taxes	254	162
Restructuring accrual	31	15
Pension and other retiree benefits	96	93
Lease liabilities due in one year	118	107
Accrued interest	72	72
Derivatives	22	23
Dividend payable	418	408
Other	836	662
Other accruals	$ 3,264	$ 2,891

Retirement Plans and Other Retiree Benefits

12 Months Ended

Dec. 31, 2025

Retirement Benefits [Abstract]

Retirement Plans and Other Retiree Benefits

Retirement Plans

The Company and certain of its U.S. and foreign subsidiaries maintain defined benefit retirement plans. Benefits under these plans are based primarily on years of service and employees’ earnings.

In the United States, effective January 1, 2014, the Company provides virtually all future retirement benefits through the Company’s defined contribution plan. As a result, service after December 31, 2013 is not considered for participants in the Company’s principal U.S. defined benefit retirement plan. Participants in the Company’s principal U.S. defined benefit retirement plan whose retirement benefit was determined under the cash balance formula continue to earn interest credits on their vested balances as of December 31, 2013 but no longer receive pay credits. Participants whose retirement benefit was determined under the final average earnings formula or career average earnings formula continue to have their accrued benefit adjusted for pay increases until termination of employment.

During 2025, the Company recorded a charge of $65 following a decision of the United States Court of Appeals for the Second Circuit affirming the ruling of the United States District Court for the Southern District of New York (the “District Court”) on certain calculation issues related to the District Court’s earlier grant of summary judgment to the plaintiffs in a lawsuit under the Employee Retirement Income Security Act, seeking the recalculation of benefits and other relief associated with a 2005 residual annuity amendment to the Colgate-Palmolive Company Employees’ Retirement Income Plan (the “Retirement Plan”). The decision resulted in an increase in the obligations of the Retirement Plan. During 2025, the Company reclassified the plaintiffs’ attorneys’ fees and costs that will be paid by the Company from Non-service related postretirement costs to Selling, general and administrative expenses. See Note 13, Commitments and Contingencies for additional information.

In the Company’s principal U.S. plans and certain funded foreign plans, funds are contributed to trusts in accordance with regulatory limits to provide for current service and for any unfunded projected benefit obligation over a reasonable period. The target asset allocation for the Company’s defined benefit plans is as follows:


	United States		International
Asset Category
Equity securities	26	%	19	%
Fixed income securities	60	%	61	%
Other investments	14	%	20	%
Total	100	%	100	%

At December 31, 2025, the allocation of the Company’s plan assets and the level of valuation input, as applicable, for each major asset category were as follows:


	Level of Valuation Input	Pension Plans
		United States		International

Cash and cash equivalents	Level 1	$	230	$	21
U.S. common stocks	Level 1	1		2
International common stocks	Level 1	—		16
Pooled funds(1)	Level 1	33		120
Fixed income securities(2)	Level 2	600		82
Multi-asset funds(7)	Level 2	23		—
Guaranteed investment contracts(3)	Level 2	—		30
		887		271
Investments valued using NAV per share(4)
Domestic, developed and emerging markets equity funds		253		25
Fixed income funds(5)		60		237
Hedge funds(6)		—		9
Multi-asset funds(7)		131		2
Real estate funds(8)		—		33
		444		306

Other assets and liabilities, net(9)		(18)		5
Total Investments		$	1,313	$	582

At December 31, 2024, the allocation of the Company’s plan assets and the level of valuation input, as applicable, for each major asset category were as follows:


	Level of Valuation Input	Pension Plans
		United States		International

Cash and cash equivalents	Level 1	$	226	$	21
U.S. common stocks	Level 1	1		2
International common stocks	Level 1	—		15
Pooled funds(1)	Level 1	35		103
Fixed income securities(2)	Level 2	624		75
Guaranteed investment contracts(3)	Level 2	—		30
		886		246
Investments valued using NAV per share(4)
Domestic, developed and emerging markets equity funds		223		28
Fixed income funds(5)		68		222
Hedge funds(6)		—		7
Multi-asset funds(7)		157		2
Real estate funds(8)		—		27
		448		286

Other assets and liabilities, net(9)		(39)		5
Total Investments		$	1,295	$	537

(1)Pooled funds primarily invest in U.S. and foreign equity securities, debt and money market securities.

(5)Fixed income funds primarily invest in U.S. government and investment grade corporate bonds.

(7)Multi-asset funds primarily invest across a variety of asset classes, including global stocks and bonds, as well as alternative strategies.

(9)This category primarily includes unsettled trades for investments purchased and sold and interest receivables.

Equity securities in the U.S. defined benefit retirement plans did not include any investment in the Company’s common stock at either December 31, 2025 or December 31, 2024. No shares of the Company’s stock were purchased by the U.S. plans in 2025 or 2024. The plans received no dividends on the Company’s common stock in either 2025 or 2024.

Other Retiree Benefits

The Company and certain of its subsidiaries provide, to the extent not otherwise provided by government-sponsored plans, health and life insurance benefits or subsidies for retired employees who meet applicable eligibility requirements.


	Pension Plans								Other Retiree Benefit Plans
	2025		2024		2025		2024		2025		2024
	United States				International
Change in Benefit Obligations
Benefit obligations at beginning of year	$	1,831	$	1,922	$	720	$	776	$	632	$	665
Service cost	1		1		18		16		7		7
Interest cost	102		99		34		33		38		36
Participants’ contributions	—		—		5		5		—		—
Plan amendments	—		—		1		—		—		—
Actuarial loss (gain)	—		(54)		(20)		(11)		37		(14)
Foreign exchange impact	(1)		—		59		(40)		4		(8)
Termination benefits	—		5		—		—		—		—
Curtailments and settlements	—		(1)		(12)		(18)		—		—
Benefit payments	(145)		(141)		(44)		(41)		(55)		(54)
ERISA litigation matter	(34)		—		—		—		—		—
Benefit obligations at end of year	$	1,754	$	1,831	$	761	$	720	$	663	$	632
Change in Plan Assets
Fair value of plan assets at beginning of year	$	1,295	$	1,360	$	537	$	566	$	—	$	—
Actual return on plan assets	111		49		16		18		—		—
Company contributions	51		29		37		37		55		54
Participants’ contributions	—		—		5		5		—		—
Foreign exchange impact	1		—		41		(31)		—		—
Settlements and acquisitions	—		(2)		(10)		(17)		—		—
Benefit payments	(145)		(141)		(44)		(41)		(55)		(54)

Fair value of plan assets at end of year	$	1,313	$	1,295	$	582	$	537	$	—	$	—
Funded Status
Benefit obligations at end of year	$	1,754	$	1,831	$	761	$	720	$	663	$	632
Fair value of plan assets at end of year	1,313		1,295		582		537		—		—
Net amount recognized	$	(441)	$	(536)	$	(179)	$	(183)	$	(663)	$	(632)
Amounts Recognized in Balance Sheet
Noncurrent assets	$	1	$	1	$	53	$	47	$	—	$	—
Current liabilities	(28)		(27)		(16)		(15)		(52)		(51)
Noncurrent liabilities	(414)		(510)		(216)		(215)		(611)		(581)
Net amount recognized	$	(441)	$	(536)	$	(179)	$	(183)	$	(663)	$	(632)
Amounts Recognized in Accumulated Other Comprehensive Income (Loss)
Actuarial loss	$	644	$	710	$	158	$	174	$	141	$	109
Transition/prior service cost (credit)	—		—		8		8		(138)		(159)
	$	644	$	710	$	166	$	182	$	3	$	(50)
Accumulated benefit obligation	$	1,742	$	1,818	$	702	$	668	$	—	$	—


	Pension Plans								Other Retiree Benefit Plans
	2025		2024		2025		2024		2025		2024
	United States				International
Weighted-Average Assumptions Used to Determine Benefit Obligations
Discount rate	5.51	%	5.73	%	4.86	%	4.69	%	5.56	%	5.74	%

Long-term rate of compensation increase	3.50	%	3.50	%	3.27	%	3.36	%	—	%	—	%
ESOP growth rate	—	%	—	%	—	%	—	%	6.00	%	6.00	%
Medical cost trend rate of increase	—	%	—	%	—	%	—	%	7.00	%	7.00	%
Interest Crediting Rate	5.49	%	5.58	%	3.19	%	3.23	%	—	%	—	%

The actuarial gains and losses recorded during 2025 for both the U.S. pension and Other retiree benefit plans were primarily a result of changes in the discount rate, investment returns and assumption changes. The actuarial gains recorded during 2024 for both the U.S. pension and Other retiree benefit plans were primarily a result of an increase in discount rates applied against future estimated benefit payments that resulted in a decrease in the benefit obligation for both the U.S. pension and Other retiree benefit plans.

The overall investment objective of the plans is to balance risk and return so that obligations to employees are met. The Company evaluates its expected long-term rate of return on plan assets on an annual basis. In determining the expected long-term rate of return, the Company considers the nature of the plans’ investments and the historical rates of return. The assumed expected long-term rate of return on plan assets for U.S. pension plans was 6.50% as of December 31, 2025 and December 31, 2024. Average annual rates of return on plan assets for the U.S. pension plans for the most recent 1-year, 5-year, 10-year, 15-year and 25-year periods were 10%, 1%, 5%, 6% and 5%, respectively. Similar assessments were performed in determining rates of return on international pension plan assets to arrive at the Company’s 2025 weighted-average expected long-term rate of return on plan assets of 5.36%.

The medical cost trend rate of increase assumed in measuring the expected cost of benefits is projected to decrease from 7.00% in 2026 to 5.00% by 2031, remaining at 4.50% for the years thereafter.

Pension plans with projected benefit obligations in excess of plan assets and plans with accumulated benefit obligations in excess of plan assets as of December 31 consisted of the following:



	2025		2024
Benefit Obligation Exceeds Fair Value of Plan Assets
Projected benefit obligation	$	2,117	$	2,251
Fair value of plan assets	1,443		1,486

Accumulated benefit obligation	2,002		2,075
Fair value of plan assets	1,363		1,345

Other Retiree Benefit plans with accumulated postretirement benefit obligation in excess of plan assets as of December 31 consisted of the following:



	2025		2024
Benefit Obligation Exceeds Fair Value of Plan Assets
Accumulated postretirement benefit obligation	$	663	$	632
Fair value of plan assets	—		—

Summarized information regarding the net periodic benefit costs for the Company’s defined benefit and other retiree benefit plans is as follows:


	Pension Plans																		Other Retiree Benefit Plans
	2025			2024			2023			2025			2024			2023			2025			2024			2023
	United States									International
Components of Net Periodic Benefit Cost
Service cost	$	1		$	1		$	—		$	18		$	16		$	15		$	7		$	7		$	7
Interest cost	102			99			91			34			33			33			38			36			38

Expected return on plan assets	(83)			(85)			(79)			(26)			(29)			(25)			—			—			—
Amortization of transition and prior service costs (credits)	—			—			—			—			1			1			(21)			(21)			(20)
Amortization of actuarial loss	35			39			43			5			5			5			5			4			1
Net periodic benefit cost	$	55		$	54		$	55		$	31		$	26		$	29		$	29		$	26		$	26
Other postretirement charges	—			5			3			—			—			2			—			—			—

ERISA litigation matter	(34)			—			267			—			—			—			—			—			—
Total pension cost	$	21		$	59		$	325		$	31		$	26		$	31		$	29		$	26		$	26
Weighted-Average Assumptions Used to Determine Net Periodic Benefit Cost
Discount rate	5.73		%	5.40		%	5.66		%	4.69		%	4.61		%	4.75		%	5.74		%	5.37		%	5.67		%
Expected long-term rate of return on plan assets	6.50		%	6.50		%	6.25		%	5.36		%	5.69		%	4.66		%	N/A			N/A			N/A
Long-term rate of compensation increase	3.50		%	3.50		%	3.50		%	3.36		%	3.24		%	3.22		%	—		%	—		%	—		%
ESOP growth rate	—		%	—		%	—		%	—		%	—		%	—		%	6.00		%	6.00		%	6.00		%
Medical cost trend rate of increase	—		%	—		%	—		%	—		%	—		%	—		%	7.00		%	6.00		%	6.25		%
Interest Crediting Rate	5.58		%	4.99		%	5.21		%	3.23		%	0.64		%	2.28		%	—		%	—		%	—		%

The service related component of pension and other postretirement benefit costs is included in Operating profit. The non-service related components (interest cost, expected return on assets, amortization of transition and prior service costs and credits and amortization of actuarial gains and losses) are included in the line item “Non-service related postretirement costs,” which is below Operating profit.

For the twelve months ended December 31, 2025, the Company made voluntary contributions to its U.S postretirement plans of $23. The Company made no voluntary contributions in 2024 or 2023.

Expected Contributions and Benefit Payments

As of December 31, 2025, the Company expects to make contributions to its U.S. postretirement plans of $99 for the year ending December 31, 2026. Actual funding may differ from current estimates depending on the variability of the market value of the assets, changes in the benefit obligations and other market or regulatory conditions.

Total benefit payments expected to be paid to participants in both funded and unfunded plans are estimated as follows:


	Pension Plans
Years Ended December 31,	United States		International		Other Retiree Benefit Plans		Total
2026	$	335	$	47	$	53	$	435
2027	142		46		57		245
2028	143		49		58		250
2029	140		52		58		250
2030	140		52		58		250
2031-2035	633		273		288		1,194

- Definition

The entire disclosure for retirement benefits.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (o)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (p)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (q)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 60
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480266/715-60-50-3

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480126/715-20-S99-2

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 70
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480794/715-70-50-1

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 17
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480482/715-20-55-17

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)(iv)(03)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (l)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/715/tableOfContent

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)(iii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (r)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (r)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

+ Details

Leases

12 Months Ended

Dec. 31, 2025

Leases [Abstract]

Leases

The Company enters into leases for land, office space, warehouses and equipment. A number of the leases include one or more options to renew the lease terms, purchase the leased property or terminate the lease. The exercise of these options is at the Company’s discretion and is therefore recognized on the balance sheet when it is reasonably certain the Company will exercise such options. As the Company’s leases typically do not contain a readily determinable implicit rate, the Company determines the present value of the lease liability using its incremental borrowing rate at the lease commencement date.

Substantially all of the Company’s leases are considered operating leases. Finance leases were not material as of December 31, 2025 or 2024.

As of December 31, 2025 and 2024, the Company’s right-of-use assets and liabilities for operating leases were as follows:


	2025		2024
Other assets	$	531	$	529

Other accruals	118		107
Other liabilities	448		456
Total operating lease liabilities	$	566	$	563

Lease liabilities for operating leases as of December 31, 2025 were as follows:




2026	$	140
2027	125
2028	100
2029	72
2030	60
Thereafter	163
Total lease commitments	$	660
Less: Interest	(94)
Present value of lease liabilities	$	566

The components of the Company’s operating lease cost for the twelve months ended December 31, 2025 and 2024 were as follows:


	2025		2024
Operating lease cost	$	152	$	144
Short-term lease cost	1		3
Variable lease cost	17		19
Sublease Income	(1)		(2)
Total lease cost	$	169	$	164

Short-term lease cost represents the Company’s cost with respect to leases with a duration of 12 months or less and is not reflected on the Company’s Consolidated Balance Sheets. Variable lease costs are comprised of costs, such as the Company’s proportionate share of actual costs for utilities, common area maintenance, property taxes and insurance, that are not included in the lease liability and are recognized in the period in which they are incurred.

Supplemental cash flow information related to operating leases for the twelve months ended December 31, 2025 and 2024 was as follows:

▪Payments against amounts included in the measurement of lease liabilities: $151 and $132, respectively

▪Lease assets obtained in exchange for lease liabilities: $95 and $141, respectively.

As of December 31, 2025 and 2024, the weighted-average remaining lease term for operating leases was seven years for both periods, and the weighted-average discount rate for operating leases was 4.8% and 4.4%, respectively.

There were no material operating leases that the Company had entered into or that were yet to commence as of December 31, 2025.

Supplemental Income Statement Information

12 Months Ended

Dec. 31, 2025

Supplemental Income Statement Elements [Abstract]

Supplemental Income Statement Information


Other (income) expense, net	2025		2024		2023

Amortization of intangible assets	$	78	$	75	$	72
Equity income	(20)		(22)		(17)

Restructuring programs(1)	7		59		24
Product recall costs	—		—		25
Losses (gains) from marketable securities and sale of other assets	1		6		11
Indirect tax payments (refunds)	37		27		18

Acquisition-related costs	9		—		—

Other, net	11		19		58
Total Other (income) expense, net	$	123	$	164	$	191

(1) Restructuring programs consist of the Strategic Growth and Productivity Program in 2025 and 2022 Global Productivity Initiative in 2024 and 2023.

Refer to Note 4, Restructuring and Related Implementation Charges for further discussion of the Company’s Restructuring programs. Research and development and advertising costs are included in Selling, general and administrative expenses.


	2025		2024		2023
Research and development	$	366	$	355	$	343
Advertising	$	2,703	$	2,720	$	2,371

Summary of Significant Accounting Policies - Principles of Consolidation, Inventories (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Accounting Policies [Abstract]
Investments accounted for using the equity method, minimum interest	20.00%
Investments accounted for using the equity method, maximum interest	50.00%
Equity method investments included in other assets	$ 82	$ 81
Investments accounted for using the cost method, maximum interest	20.00%
Approximate percentage of inventories determined using the first-in, first-out (FIFO) method	75.00%

- Definition

This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.

+ References + Details

Long-Term Debt and Credit Facilities - Narrative (Details) € in Millions, $ in Millions	1 Months Ended		12 Months Ended
	Apr. 30, 2025 USD ($)	Nov. 30, 2022 USD ($)	Dec. 31, 2025 USD ($)	Dec. 31, 2024 USD ($)	Nov. 30, 2025 EUR (€)
Debt Instrument [Line Items]
Unused borrowing capacity			$ 3,641
Revolving Credit Facility
Debt Instrument [Line Items]
Maximum borrowing capacity		$ 3,000
Amended Foreign Revolving Credit Facility 3000 Million Capacity
Debt Instrument [Line Items]
Debt instrument term		5 years
Maximum borrowing capacity		$ 3,000
Ten Year Notes at 3.25 Percent Number
Debt Instrument [Line Items]
Debt redeemed, amount				$ 500
Debt instrument term				10 years
Fixed interest rate				3.25%
Thirty Year Notes at 7.60 Percent Number
Debt Instrument [Line Items]
Debt redeemed, amount			$ 130
Debt instrument term			30 years
Fixed interest rate			7.60%
Three Year Notes at 3.10 Percent Number
Debt Instrument [Line Items]
Debt redeemed, amount			$ 500
Debt instrument term			3 years
Fixed interest rate			3.10%
Five Year Notes at 4.200 Percent Number
Debt Instrument [Line Items]
Debt instrument term	5 years
Fixed interest rate	4.20%
Face amount	$ 500
Ten year Notes at 3.250 Percent Number
Debt Instrument [Line Items]
Debt instrument term	10 years
Fixed interest rate					3.25%
Face amount \| €					€ 600

Long-Term Debt and Credit Facilities - Schedule of Debt Payable within One Year (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Debt Disclosure [Abstract]
Notes and loans payable	$ 2	$ 8
Current portion of long-term debt	1,115	652
Debt payable within one year	$ 1,117	$ 660

Fair Value Measurements and Financial Instruments - Schedule of Gain (Loss) Included in OCI (Details) - Net Investment Hedges - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Net investment hedges [Abstract]
Total gain (loss) on investment hedges	$ (580)	$ 253
Foreign currency contracts
Net investment hedges [Abstract]
Gain (loss) on net investment hedges	(39)	42
Foreign Currency Debt
Net investment hedges [Abstract]
Gain (loss) on net investment hedges	$ (541)	$ 211

Supplemental Balance Sheet Information - Schedule of Other Current Assets (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Other current assets
Marketable securities	$ 107	$ 160
Prepaids	589	520
Derivatives	18	33
Total Other current assets	$ 714	$ 713

Restructuring and Related Implementation Charges - Schedule of Restructuring Activity and Related Accruals (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Strategic Growth and Productivity Program
Restructuring Reserve [Roll Forward]
Beginning balance	$ 0
Charges	13
Cash Payments	(3)
Ending balance	10	$ 0
Strategic Growth and Productivity Program \| Employee-Related Costs
Restructuring Reserve [Roll Forward]
Beginning balance	0
Charges	6
Cash Payments	0
Ending balance	6	0
Strategic Growth and Productivity Program \| Asset-Related Costs and Other
Restructuring Reserve [Roll Forward]
Beginning balance	0
Charges	7
Cash Payments	(3)
Ending balance	4	0
Global Productivity Initiative
Restructuring Reserve [Roll Forward]
Beginning balance	30	44
Cash Payments		(17)
Foreign exchange		3
Ending balance		30
Global Productivity Initiative \| Employee-Related Costs
Restructuring Reserve [Roll Forward]
Beginning balance	24	34
Cash Payments		(13)
Foreign exchange		3
Ending balance		24
Global Productivity Initiative \| Other
Restructuring Reserve [Roll Forward]
Beginning balance	$ 6	10
Cash Payments		(4)
Foreign exchange		0
Ending balance		$ 6

Capital Stock and Stock-Based Compensation Plans (Tables)

12 Months Ended

Dec. 31, 2025

Share-Based Payment Arrangement [Abstract]

Schedule of Common and Treasury Stock Activity

A summary of common stock and treasury stock activity for the three years ended December 31 is as follows:


	Common Stock Outstanding	Treasury Stock
Balance, January 1, 2023	830,212,606	635,493,754

Common stock acquired	(14,735,909)	14,735,909
Shares issued for stock options	5,318,430	(5,318,430)
Shares issued for restricted stock units and other	617,642	(617,642)
Balance, December 31, 2023	821,412,769	644,293,591

Common stock acquired	(18,321,422)	18,321,422
Shares issued for stock options	8,606,699	(8,606,699)
Shares issued for restricted stock units and other	876,652	(876,652)
Balance, December 31, 2024	812,574,698	653,131,662

Common stock acquired	(13,652,320)	13,652,320
Shares issued for stock options	1,339,704	(1,339,704)
Shares issued for restricted stock units and other	977,442	(977,442)
Balance, December 31, 2025	801,239,524	664,466,836

Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions

The weighted-average fair value assumptions are summarized in the following table:


	2025			2024			2023
Expected term of options	6 years			6 years			6 years
Expected volatility rate	20.6		%	20.5		%	19.8		%
Risk-free interest rate	4.0		%	3.8		%	4.3		%
Expected dividend yield	2.1		%	2.1		%	2.5		%
Weighted-average estimated fair value	$	18.21		$	22.65		$	14.89

Schedule of Share-based Compensation, Stock Options, Activity

A summary of stock option activity during 2025 is presented below:


	Shares (in thousands)	Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (in years)	Intrinsic Value of Unexercised In-the-Money Options
Options outstanding, January 1, 2025	12,774	$	78
Granted	1,284	84
Exercised	(1,340)	76
Forfeited	(87)	82
Expired	(12)	79
Options outstanding, December 31, 2025	12,619	79		4	$	32
Options exercisable, December 31, 2025	10,174	$	77	4	$	28

Schedule of Share-based Compensation, Performance Restricted Stock and Time-based Restricted Stock Units Activity

A summary of performance-based restricted stock unit activity for the year ended December 31, 2025 is presented below:


	Shares (in thousands)	Weighted Average Grant Date Fair Value Per Award
Performance-based restricted stock units as of January 1, 2025	1,037	$	74
Activity:
Granted	317	85
Vested	(458)	68
Forfeited	(217)	70
Change due to performance and/or market condition achievement	251	67
Performance-based restricted stock units as of December 31, 2025	930	$	80

A summary of restricted stock unit activity during 2025 is presented below:


	Shares (in thousands)	Weighted Average Grant Date Fair Value Per Award
Restricted stock units as of January 1, 2025	1,987	$	88
Activity:
Granted	1,197	85
Vested	(1,049)	83
Forfeited	(77)	89
Restricted stock units as of December 31, 2025	2,058	$	88

Long-Term Debt and Credit Facilities - Schedule of Long-Term Debt and Finance Lease Maturities (Details) $ in Millions	Dec. 31, 2025 USD ($)
Debt Disclosure [Abstract]
2026	$ 1,115
2027	523
2028	615
2029	591
2030	500
Thereafter	4,495
Total	$ 7,839

- Definition

Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.

+ References

+ Details

Retirement Plans and Other Retiree Benefits - Schedule of Other Retiree Benefit Plans (Details) - Other Retiree Benefit Plans - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Defined Benefit Plan Disclosure [Line Items]
Accumulated postretirement benefit obligation	$ 663	$ 632
Fair value of plan assets	$ 0	$ 0

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

+ Details

Audit Information	12 Months Ended
Audit Information	Dec. 31, 2025
Audit Information [Abstract]
Auditor Name	PricewaterhouseCoopers LLP
Auditor Location	New York, New York
Auditor Firm ID	238

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	Dec. 31, 2025
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Nature of Operations

12 Months Ended

Dec. 31, 2025

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Nature of Operations

The Company manufactures and markets a wide variety of products in 200 countries and territories around the world in two product segments: Oral, Personal and Home Care; and Pet Nutrition. Oral, Personal and Home Care products include toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners and other similar items. These products are sold primarily to a variety of retailers, wholesalers, distributors, dentists and, in some geographies, skin health professionals. Pet Nutrition products include specialty pet nutrition products for dogs and cats. The principal customers for Pet Nutrition products are authorized pet supply retailers, veterinarians and eCommerce retailers. Some of our products are also sold direct-to-consumer. Principal global and regional trademarks include Colgate, Palmolive, Darlie, elmex, hello, meridol, Sorriso, Tom’s of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline and Suavitel, as well as Hill’s Science Diet, Hill’s Prescription Diet and Prime100.

The Company’s principal classes of products accounted for the following percentages of worldwide Net sales for the past three years:


	2025		2024		2023
Oral Care	44	%	43	%	42	%
Personal Care	17	%	18	%	19	%
Home Care	16	%	17	%	17	%
Pet Nutrition	23	%	22	%	22	%
Total	100	%	100	%	100	%

Capital Stock and Stock-Based Compensation Plans - Schedule of Performance Restricted Stock Activity (Details) - Performance Shares shares in Thousands	12 Months Ended
	Dec. 31, 2025 $ / shares shares
Shares (in thousands)
Restricted stock awards - beginning balance (in shares) \| shares	1,037
Granted (in shares) \| shares	317
Vested (in shares) \| shares	(458)
Forfeited (in shares) \| shares	(217)
Change due to performance and/or market condition achievement (in shares) \| shares	251
Restricted stock awards - ending balance (in shares) \| shares	930
Weighted Average Grant Date Fair Value Per Award
Restricted stock awards - beginning of period (in dollars per share) \| $ / shares	$ 74
Restricted stock awards - shares granted (in dollars per share) \| $ / shares	85
Restricted stock awards - shares vested (in dollars per share) \| $ / shares	68
Restricted stock awards - shares forfeited (in dollars per share) \| $ / shares	70
Change due to performance and/or market condition achievement (in dollars per share \| $ / shares	67
Restricted stock awards - end of period (in dollars per share) \| $ / shares	$ 80

Earnings Per Share - Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Net income attributable to Colgate-Palmolive Company
Basic EPS	$ 2,132	$ 2,889	$ 2,300
Diluted EPS	$ 2,132	$ 2,889	$ 2,300
Shares (millions)
Basic EPS (in shares)	808.7	819.1	827.4
Stock options and restricted stock units (in shares)	2.4	4.1	1.8
Diluted EPS (in shares)	811.1	823.2	829.2
Per Share
Basic EPS (in dollars per share)	$ 2.64	$ 3.53	$ 2.78
Diluted EPS (in dollars per share)	$ 2.63	$ 3.51	$ 2.77

Income Taxes

12 Months Ended

Dec. 31, 2025

Income Tax Disclosure [Abstract]

Income Taxes

The components of Income before income taxes are as follows for the years ended December 31:


	2025		2024		2023
United States	$	1,419	$	1,084	$	692
International	1,640		2,872		2,700
Total Income before income taxes	$	3,059	$	3,956	$	3,392

The Provision for income taxes consists of the following for the years ended December 31:


	2025		2024		2023
U.S. federal	$	168	$	169	$	77
U.S. state and local	42		19		(5)
International	588		719		865
Total Provision for income taxes	$	798	$	907	$	937

Temporary differences between accounting for financial statement purposes and accounting for tax purposes result in the current provision for taxes being higher (lower) than the total provision for income taxes as follows:


	2025		2024		2023
Goodwill and intangible assets	$	129	$	3	$	1
Property, plant and equipment	23		12		(13)
Pension and other retiree benefits	(22)		(6)		68
Stock-based compensation	—		(14)		2
Right-of-use assets/lease liabilities	—		2		1
Tax credits and tax loss carryforwards, net of valuation allowance	(42)		37		29

Deferred withholding tax	(4)		(14)		7
Research and experimentation capitalization	23		21		29
Other, net	49		(8)		11
Total deferred tax benefit (provision)	$	156	$	33	$	135

The difference between the statutory U.S. federal income tax rate and the Company's global effective tax rate as reflected in the Consolidated Statements of Income is as follows:


	2025
	Amount		Percent
U.S. federal statutory tax rate	$	642	21.0	%
State and local income taxes, net of federal income tax effect(a)	42		1.4
Foreign tax effects
Brazil	38		1.2
Switzerland
Statutory income tax rate differential	(82)		(2.7)
Local income tax	35		1.1
Other	12		0.4
France
Nondeductible goodwill impairment	59		1.9
Other	(13)		(0.4)
Other foreign jurisdictions	168		5.5

Effect of cross-border tax laws
Foreign-derived intangible income benefit	(88)		(2.9)
Foreign tax credits	(83)		(2.7)
Branch U.S. tax, net of foreign tax credit	(49)		(1.6)
Other	(15)		(0.5)
Tax credits	(10)		(0.3)
Changes in valuation allowances
Branch U.S. tax	65		2.1
Other	5		0.2
Nontaxable or nondeductible items
Nondeductible goodwill impairment	37		1.2
Other	19		0.6
Changes in unrecognized tax benefits	23		0.7
Other	(7)		(0.1)
Global effective tax rate	$	798	26.1	%

(a) State taxes in Kansas, California and Illinois made up the majority (greater than 50 percent) of this category.


	2024		2023
Percentage of Income before income taxes
U.S. federal statutory rate	21.0	%	21.0	%
State and local income taxes, net of federal benefit	0.5		(0.1)
Earnings taxed at other than U.S. federal statutory rate	4.1		5.4




Non-deductible goodwill impairment charges	—		—
Foreign-derived intangible income benefit	(2.6)		(2.4)
Foreign tax matter	—		3.7
Other, net	(0.1)		—
Global effective tax rate	22.9	%	27.6	%

A summary of income taxes paid in 2025 is as follows:


	2025
U.S. federal	$	268
U.S. state and local	33
Foreign
Brazil	76
India	68
Mexico	70
Switzerland	48
Other foreign jurisdictions	350
Total	$	913

The components of deferred tax assets (liabilities) are as follows at December 31:


	2025		2024
Deferred tax liabilities:
Goodwill and intangible assets	$	(283)	$	(389)
Property, plant and equipment	(384)		(397)
Right-of-use assets	(124)		(126)
Deferred withholding tax	(114)		(110)
Other	(71)		(130)
Total deferred tax liabilities	(976)		(1,152)
Deferred tax assets:
Pension and other retiree benefits	245		272
Tax credits and tax loss carryforwards	493		430
Lease liabilities	134		137
Accrued liabilities	266		223
Stock-based compensation	61		61
Research and experimentation capitalization	132		108
Other	99		101
Total deferred tax assets	1,430		1,332
Valuation allowance	$	(430)	$	(328)
Net deferred tax assets	$	1,000	$	1,004
Net deferred income taxes	$	24	$	(148)

The changes in valuation allowance for deferred tax assets are as follows:


	2025		2024		2023
Balance, January 1	$	328	$	287	$	129
Additions
Charged to costs and expenses	102		56		158

Deductions	—		15		—
Balance, December 31	$	430	$	328	$	287

The Company has made an accounting policy election to treat Global Intangible Low-Taxed Income taxes as a current period expense rather than including these amounts in the measurement of deferred taxes.

As of December 31, 2025, the Company had net operating losses (“NOLs”) and capital loss carryforwards of $38. Of this amount, capital loss and NOL carryforwards of $4 will begin to expire in 2026 and NOLs of $6 can be carried forward indefinitely. The Company believes that it will be able to utilize these capital loss and NOL carryforwards. There is an additional NOL of $28 which has a full valuation allowance.

As of December 31, 2025, the Company has $455 of tax credits, of which $36 will begin to expire in 2031 and $17 can be carried forward indefinitely. The Company believes that it will be able to utilize these tax credits. The remaining credits of $402 have a full valuation allowance.

Applicable U.S. income and foreign withholding taxes have been provided on substantially all of the Company’s accumulated earnings of foreign subsidiaries.

Net tax benefit of $76, net tax expense of $55 and net tax benefit of $19 were recorded directly through equity in 2025, 2024 and 2023 respectively. The net tax expense or benefit in each year predominantly includes current and future tax impacts related to benefit plans and the impact of currency translation adjustments.

The Company uses a comprehensive model to recognize, measure, present and disclose in its financial statements uncertain tax positions that the Company has taken or expects to take on an income tax return.

Unrecognized tax benefits activity for the years ended December 31, 2025, 2024 and 2023 is summarized below:


	2025		2024		2023
Unrecognized tax benefits:
Balance, January 1	$	296	$	314	$	298
Increases as a result of tax positions taken during the current year	25		37		73
Decreases of tax positions taken during prior years	(22)		(53)		(61)
Increases of tax positions taken during prior years	10		10		6
Decreases as a result of settlements with taxing authorities and the expiration of statutes of limitations	(1)		(3)		(2)
Effect of foreign currency rate movements	11		(9)		—
Balance, December 31	$	319	$	296	$	314

If all of the unrecognized tax benefits for 2025 above were recognized, approximately $308 would impact the effective tax rate.

The Company recognized expenses of approximately $26, $22 and $10 for interest and penalties related to the above unrecognized tax benefits within income tax expense in 2025, 2024 and 2023, respectively. The Company had accrued interest and penalties of approximately $95, $68 and $45 as of December 31, 2025, 2024 and 2023, respectively.

The Company has ongoing federal, state and international income tax audits in various jurisdictions and evaluates uncertain tax positions that may be challenged by local tax authorities and not fully sustained. All U.S. federal income tax returns through December 31, 2013 have been audited by the IRS and there are limited matters which the Company plans to appeal for years 2010 through 2013. One such matter relates to the IRS assessment of taxes on the Company by imputing income on certain activities within one of our international operations, which is also under audit for the years 2014 through 2018. There were U.S. Tax Court rulings during 2023 in favor of the IRS against two unrelated third parties on similar matters. In October 2025, in one of those cases, the relevant U.S. Court of Appeals reversed the U.S. Tax Court’s decision and ruled in favor of the taxpayer. The case involving the other third party is still pending. The Company continues to believe that the tax assessment against the Company is without merit. While there can be no assurances, the Company believes this matter will ultimately be decided in favor of the Company.

The amount of tax plus interest for the years 2010 through 2018 is estimated to be approximately $165, which is not included in the Company’s uncertain tax positions. In May 2024, the IRS initiated an audit for the years 2019 through 2021 which is still ongoing.

On July 4, 2025, U.S. tax legislation was signed into law (known as the “One Big Beautiful Bill Act” or “OBBBA”) which makes permanent many of the tax provisions enacted in 2017 as part of the Tax Cuts and Jobs Act that were set to expire at the end of 2025. In addition, the OBBBA makes changes to certain U.S. corporate tax provisions, many of which are generally not effective until January 1, 2026. The OBBBA did not have a material effect on the Company’s Consolidated Financial Statements for the fiscal year ended December 31, 2025. The Company is currently evaluating the future impact of the OBBBA, but does not expect it will have a material impact on its Consolidated Financial Statements.

In the third quarter of 2023, the Internal Revenue Service (the “IRS”) issued a notice giving taxpayers temporary relief from the effects of certain U.S. tax regulations that were issued in December 2021 which place greater restrictions on foreign taxes that are creditable against U.S. taxes on foreign source income. This notice allowed taxpayers to defer the application of these new regulations through the end of 2023. In December 2023, the IRS issued further guidance modifying this temporary relief period to the date that a notice or other guidance withdrawing or modifying the temporary relief is issued. The Company will recognize the impact, if any, in the period in which the temporary relief is withdrawn or modified.

On August 16, 2022, the Inflation Reduction Act of 2022 (the “IRA”) was enacted, which among other things, implements a 15% minimum tax on book income of certain large corporations effective for years beginning after December 31, 2022. Subsequent to the IRA’s enactment, the U.S. Treasury Department and the IRS released proposed regulations relating principally to this 15% minimum tax. Based on the Company’s analysis, these proposed regulations have not had and, if finalized in their current form, are not expected to have an impact on its Consolidated Financial Statements. The IRS has announced its intent to partially withdraw and revise the proposed regulations. The Company will continue to evaluate any additional guidance and clarification that becomes available.

On December 15, 2022, the 27 member states of the European Union (“EU”) reached an agreement to establish a minimum level of taxation for certain large corporations by paying a minimum corporate tax rate of 15% in every jurisdiction in which they operate. This agreement, which is part of the Pillar II Model Rules initiative (“Pillar II”) agreed by all members of the Organization for Economic Cooperation and Development (“OECD”) and its Inclusive Framework (“IF”), was transposed into the laws of most EU member states by December 31, 2023. Subsequently, many other jurisdictions outside the EU have enacted similar minimum tax regimes consistent with the policy of Pillar II.

Based on current legislation and available guidance, apart from the significant additional time and resources required to comply, Pillar II did not have a material impact to the Company’s Consolidated Financial Statements for the fiscal year ended December 31, 2025 and the Company does not believe it will have a material impact going forward on its business, results of operations, cash flows and financial condition.

On January 5, 2026, IF reached an agreement known as the “Side-by-Side Package” that modifies key aspects of Pillar II and is effective from January 1, 2026. The Company is currently evaluating the potential impact of the Side-by-Side Package on its future tax liability and compliance burden. The Side-by-Side Package introduces various new safe harbors that the Company is expected to be eligible for and that, when fully enacted, should result in a reduction of compliance costs of Pillar II, among other benefits. However, as these rules and related regulations are revised and implemented, the Company will evaluate the impact, if any, on its Consolidated Financial Statements.

- Definition

The entire disclosure for income tax.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 942
-SubTopic 740
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477617/942-740-50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 944
-SubTopic 740
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478822/944-740-50-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 231
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482663/740-10-55-231

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 12B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 270
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477891/740-270-50-1

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.5.Q1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480990/946-20-50-13

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/740/tableOfContent

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-14

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-21

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 17
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-17

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 11.C)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482603/740-30-50-2

+ Details

Supplemental Other Comprehensive Income (Loss) Information - Schedule of Comprehensive Income (Loss) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other comprehensive income (loss), net of tax	$ 344	$ (292)	$ 75
Accumulated Other Comprehensive Income (Loss)
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other comprehensive income (loss), net of tax	342	(284)	117
Cumulative translation adjustments, pre-tax
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other comprehensive income (loss), pretax	258	(298)	127
Tax amounts	78	(37)	13
Other comprehensive income (loss), net of tax	336	(335)	140
Retirement Plan and other retiree benefit adjustments, pre-tax
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other comprehensive income (loss), before reclassifications, pretax	5	31	(49)
Reclassification from AOCI, pretax	24	28	30
Other comprehensive income (loss), pretax	29	59	(19)
Tax amounts	(7)	(16)	3
Other comprehensive income (loss), net of tax	22	43	(16)
Gains (losses) on cash flow hedges, pre-tax
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other comprehensive income (loss), pretax	(21)	10	(10)
Tax amounts	5	(2)	3
Other comprehensive income (loss), net of tax	$ (16)	$ 8	$ (7)

Commitments and Contingencies (Details) $ in Millions	1 Months Ended	3 Months Ended			12 Months Ended			60 Months Ended
Commitments and Contingencies (Details) $ in Millions	Feb. 23, 2026 USD ($)	Sep. 30, 2025 USD ($)	Mar. 31, 2025 USD ($)	Mar. 31, 2023 USD ($)	Dec. 31, 2025 USD ($) countryAndTerritory case	Dec. 31, 2024 USD ($) case	Dec. 31, 2023 USD ($)	Sep. 30, 2020 case	Dec. 31, 2005 USD ($)
Loss Contingencies [Line Items]
Contractual commitments, amount					$ 637
Minimum number of countries and territories serving consumers (more than) (in countries and territories) \| countryAndTerritory					200
Brazilian internal revenue authority, matter 1					$ 97
ERISA litigation matter					$ 65	$ 0	$ 267
Judicial Ruling
Loss Contingencies [Line Items]
ERISA litigation matter			$ 65	$ 267
Settled Litigation
Loss Contingencies [Line Items]
ERISA litigation matter		$ 332
Settled Litigation \| Subsequent Event
Loss Contingencies [Line Items]
ERISA litigation matter	$ 99
Brazilian Matters
Loss Contingencies [Line Items]
Loss contingency, new claims filed, number (in cases) \| case								5
Loss contingency, pending claims, number (in cases) \| case					1
Loss contingency, number of cases on appeal \| case					4
Brazilian internal revenue authority, matter 2									$ 26
Brazilian Matter Appealed by Brazilian Federal Government
Loss Contingencies [Line Items]
Loss contingency, number of cases on appeal \| case					1
Brazilian Matter Appealed by the Company
Loss Contingencies [Line Items]
Loss contingency, number of cases on appeal \| case					3
Brazilian Matter Appealed by the Company \| Judicial Ruling
Loss Contingencies [Line Items]
Loss contingency, number of cases on appeal \| case					1
Brazilian internal revenue authority, matter 2					$ 18
Talcum Powder Matters
Loss Contingencies [Line Items]
Loss contingency, new claims filed, number (in cases) \| case					253
Loss contingency, pending claims, number (in cases) \| case					454	308
Loss contingency, claims dismissed or settled, number (in cases) \| case					107
Minimum
Loss Contingencies [Line Items]
Range of reasonably possible losses					$ 0
Maximum
Loss Contingencies [Line Items]
Range of reasonably possible losses					$ 225

Leases - Narrative (Details) $ in Millions	12 Months Ended
Leases - Narrative (Details) $ in Millions	Dec. 31, 2025 USD ($) renewal_options	Dec. 31, 2024 USD ($)
Leases [Abstract]
Number of lease renewal options (one or more) \| renewal_options	1
Operating lease, payments	$ 151	$ 132
Right-of-use asset obtained in exchange for operating lease liability	$ 95	$ 141
Operating lease, weighted average remaining lease term	7 years	7 years
Operating lease, weighted average discount rate	4.80%	4.40%

Fair Value Measurements and Financial Instruments (Tables)

12 Months Ended

Dec. 31, 2025

Fair Value Disclosures [Abstract]

Schedule of Derivative Instruments


	Assets					Liabilities
	Account	Fair Value				Account	Fair Value
Designated derivative instruments		December 31, 2025		December 31, 2024			December 31, 2025		December 31, 2024




Foreign currency contracts	Other current assets	$	18	$	33	Other accruals	$	22	$	22

Commodity contracts	Other current assets	—		—		Other accruals	—		1
Total designated		$	18	$	33		$	22	$	23







Other financial instruments
Marketable securities	Other current assets	107		160
Total other financial instruments		$	107	$	160

Schedule of Notional Amounts of Outstanding Derivative Positions

The following tables present the notional values as of:


	December 31, 2025
	Foreign Currency Contracts		Foreign Currency Debt		Commodity Contracts		Total
Fair Value Hedges	$	2,093	$	—	$	—	$	2,093
Cash Flow Hedges	1,106		—		16		1,122
Net Investment Hedges	336		3,942		—		4,278


	December 31, 2024
	Foreign Currency Contracts		Foreign Currency Debt		Commodity Contracts		Total
Fair Value Hedges	$	1,669	$	—	$	—	$	1,669
Cash Flow Hedges	1,023		—		18		1,041
Net Investment Hedges	289		3,750		—		4,039

Schedule of Derivative Instruments, Gain (Loss)


		Gain (Loss) Recognized in Income
	Location of Gain (Loss) Recognized in Income	Twelve Months Ended December 31,
		2025		2024

Hedging instruments:
Foreign currency contracts	Selling, general and administrative expenses	$	100	$	(54)
Total gain (loss) on fair value hedges		$	100	$	(54)

Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss)

The following table presents the amount of gain (loss) on net investment hedges recognized in the Company’s AOCI for the twelve months ended December 31, 2025 and 2024:


	Gain (Loss) Recognized in AOCI
	Twelve Months Ended December 31,
Hedging instruments:	2025		2024
Foreign currency contracts	$	(39)	$	42
Foreign currency debt	(541)		211
Total gain (loss) on net investment hedges	$	(580)	$	253

Summary of Significant Accounting Policies - Goodwill and Other Intangibles (Details) - Local Brands, Trademarks, Customer Relationships, and Non-Compete Agreements	Dec. 31, 2025
Minimum
Finite-Lived Intangible Assets [Line Items]
Estimated useful life of finite-lived intangible assets	5 years
Maximum
Finite-Lived Intangible Assets [Line Items]
Estimated useful life of finite-lived intangible assets	40 years

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 31
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-31

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 20
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-20

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 20
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-20

Reference 4: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 38
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-38

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 31
-Subparagraph (h)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-31

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 38
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-38

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 38
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-38

Reference 8: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 38
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-38

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 38
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-38

Reference 10: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 38
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-38

Reference 11: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 31
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-31

Reference 12: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 31
-Subparagraph (g)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-31

Reference 13: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 31
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-31

Reference 14: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 31
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-31

Reference 15: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 31
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-31

Reference 16: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 31
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-31

Reference 17: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 31
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-31

Reference 18: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-31

Reference 19: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 29
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-29

Reference 20: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 29
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-29

Reference 21: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 20
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-20

Reference 22: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 20
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-20

Reference 23: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-14

Reference 24: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-14

Reference 25: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-14

Reference 26: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-14

Reference 27: http://www.xbrl.org/2003/role/exampleRef
-Topic 805
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 14
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479876/805-20-55-14

Reference 28: http://www.xbrl.org/2003/role/exampleRef
-Name Accounting Standards Codification
-Section 55
-Paragraph 40
-SubTopic 30
-Topic 350
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482640/350-30-55-40

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482665/350-30-50-2

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482665/350-30-50-2

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482686/350-30-45-1

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482665/350-30-50-2

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Topic 350
-SubTopic 30
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482665/350-30-50-3

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Topic 985
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481283/985-20-50-2

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Topic 926
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483154/926-20-50-5

+ Details

Nature of Operations (Tables)

12 Months Ended

Dec. 31, 2025

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Percentage of Worldwide Sales

The Company’s principal classes of products accounted for the following percentages of worldwide Net sales for the past three years:


	2025		2024		2023
Oral Care	44	%	43	%	42	%
Personal Care	17	%	18	%	19	%
Home Care	16	%	17	%	17	%
Pet Nutrition	23	%	22	%	22	%
Total	100	%	100	%	100	%

Supplemental Balance Sheet Information - Narrative (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Balance Sheet Related Disclosures [Abstract]
Inventories valued under LIFO	$ 476	$ 453
Excess of current cost over LIFO cost	$ 129	$ 105

Goodwill and Other Intangible Assets

12 Months Ended

Dec. 31, 2025

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Other Intangible Assets

The changes in net carrying value of Goodwill by segment for the years ended December 31, 2024 and 2025 were as follows:


	2024
	Beginning Balance		Reallocation (1)		Foreign currency translation		Ending Balance
Oral, Personal and Home Care
North America (3)	$	908	$	223	$	(23)	$	1,108
Latin America	179		—		(34)		145
Europe	1,571		(223)		(67)		1,281
Asia Pacific	179		—		(1)		178
Africa/Eurasia	88		—		(10)		78
Total Oral, Personal and Home Care	2,925		—		(135)		2,790
Pet Nutrition	485		—		(3)		482
Total Goodwill	$	3,410	$	—	$	(138)	$	3,272


	2025
	Beginning Balance		Acquisitions (2)		Impairments		Foreign currency translation		Ending Balance
Oral, Personal and Home Care
North America (3)	$	1,108	$	—	$	(582)	$	32	$	558
Latin America	145		—		—		16		161
Europe	1,281		—		—		149		1,430
Asia Pacific	178		—		—		7		185
Africa/Eurasia	78		—		—		4		82
Total Oral, Personal and Home Care	2,790		—		(582)		208		2,416
Pet Nutrition	482		207		—		17		706
Total Goodwill	$	3,272	$	207	$	(582)	$	225	$	3,122

Other intangible assets as of December 31, 2025 and 2024 were comprised of the following:


	2025						2024
	Gross Carrying Amount		Accumulated Amortization		Net		Gross Carrying Amount		Accumulated Amortization		Net
Trademarks - finite life	$	974	$	(594)	$	380	$	1,135	$	(545)	$	590
Other finite life intangible assets	574		(445)		129		603		(385)		218
Indefinite life intangible assets	1,027		—		1,027		948		—		948
Total Other intangible assets	$	2,575	$	(1,039)	$	1,536	$	2,686	$	(930)	$	1,756

The change in the net carrying amounts of Other intangible assets during 2025 was due to the impact of impairment charges related to the Filorga intangible assets as more fully described below, foreign currency translation, amortization expense of $78 and the acquisition of the Prime100 pet food business (see Note 3, Acquisitions for further information). Annual estimated amortization expense for each of the next five years is expected to be approximately $51.

Given lower than expected category growth rates and weaker than expected performance, particularly in China, in the fourth quarter of 2025 the Company lowered its outlook for the skin health reporting unit, primarily Filorga. The Company concluded that the changes in circumstances in this reporting unit triggered the need for an interim impairment review of its goodwill and long-lived assets which consists primarily of trademarks and customer relationships. As a result of the interim impairment test, the Company concluded that the carrying value of the Filorga trademark and customer relationships exceeded their estimated fair values and recorded impairment charges of $244 and $93, respectively, reducing their combined carrying values to an immaterial amount, as of December 31, 2025. After adjusting the carrying values of the Filorga trademark and customer relationship intangible assets, the Company completed a quantitative impairment test for goodwill and recorded a goodwill impairment charge of $582 in the skin health reporting unit, reducing the carrying value of goodwill to $51 as of December 31, 2025. The goodwill and intangible assets impairment charges are presented as a separate line item in the Consolidated Statements of Income.

The Company used the income approach to determine the fair value of the skin health reporting unit and the Filorga trademark and customer relationships that required significant judgments and estimates by management, including future cash flows consistent with management’s strategic plans, sales growth rates, operating margins, customer attrition rate, and the selection of royalty rate and discount rate, among others. Estimating sales growth rates requires significant judgment by management in areas such as future economic conditions, category and industry growth rates, product pricing, consumer tastes and preferences and future expansion expectations.

Goodwill and Other Intangible Assets - Schedule of Goodwill (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Goodwill [Roll Forward]
Beginning Balance	$ 3,272	$ 3,410
Reallocation		0
Acquisitions	207
Impairments	(582)
Foreign currency translation	225	(138)
Ending Balance	3,122	3,272
Goodwill accumulated impairment loss	$ 1,281	699
Goodwill, Impairment Loss, Statement of Income or Comprehensive Income [Extensible Enumeration]	Goodwill and intangible assets impairment charges
Oral, Personal and Home Care
Goodwill [Roll Forward]
Beginning Balance	$ 2,790	2,925
Reallocation		0
Acquisitions	0
Impairments	(582)
Foreign currency translation	208	(135)
Ending Balance	2,416	2,790
Pet Nutrition
Goodwill [Roll Forward]
Beginning Balance	482	485
Reallocation		0
Acquisitions	207
Impairments	0
Foreign currency translation	17	(3)
Ending Balance	706	482
North America \| Oral, Personal and Home Care
Goodwill [Roll Forward]
Beginning Balance	1,108	908
Reallocation		223
Acquisitions	0
Impairments	(582)
Foreign currency translation	32	(23)
Ending Balance	558	1,108
Latin America \| Oral, Personal and Home Care
Goodwill [Roll Forward]
Beginning Balance	145	179
Reallocation		0
Acquisitions	0
Impairments	0
Foreign currency translation	16	(34)
Ending Balance	161	145
Europe \| Oral, Personal and Home Care
Goodwill [Roll Forward]
Beginning Balance	1,281	1,571
Reallocation		(223)
Acquisitions	0
Impairments	0
Foreign currency translation	149	(67)
Ending Balance	1,430	1,281
Asia Pacific \| Oral, Personal and Home Care
Goodwill [Roll Forward]
Beginning Balance	178	179
Reallocation		0
Acquisitions	0
Impairments	0
Foreign currency translation	7	(1)
Ending Balance	185	178
Africa/Eurasia \| Oral, Personal and Home Care
Goodwill [Roll Forward]
Beginning Balance	78	88
Reallocation		0
Acquisitions	0
Impairments	0
Foreign currency translation	4	(10)
Ending Balance	$ 82	$ 78

Supplemental Income Statement Information (Tables)

12 Months Ended

Dec. 31, 2025

Supplemental Income Statement Elements [Abstract]

Schedule of Other (income) expense, net


Other (income) expense, net	2025		2024		2023

Amortization of intangible assets	$	78	$	75	$	72
Equity income	(20)		(22)		(17)

Restructuring programs(1)	7		59		24
Product recall costs	—		—		25
Losses (gains) from marketable securities and sale of other assets	1		6		11
Indirect tax payments (refunds)	37		27		18

Acquisition-related costs	9		—		—

Other, net	11		19		58
Total Other (income) expense, net	$	123	$	164	$	191

(1) Restructuring programs consist of the Strategic Growth and Productivity Program in 2025 and 2022 Global Productivity Initiative in 2024 and 2023.

Schedule of Research and development and Advertising


	2025		2024		2023
Research and development	$	366	$	355	$	343
Advertising	$	2,703	$	2,720	$	2,371

Capital Stock and Stock-Based Compensation Plans - Narrative (Details)	12 Months Ended
	Dec. 31, 2025 USD ($) plan shares	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)	Mar. 20, 2025 USD ($)
Preference Stock [Abstract]
Shares authorized (in shares) \| shares	50,262,150
Stock Repurchases [Abstract]
Repurchased stock	$ 1,214,000,000
Stock-Based Compensation [Abstract]
Number of stockholder approved plans, current \| plan	1
Total stock-based compensation expense charged against pretax income	$ 155,000,000	$ 135,000,000	$ 122,000,000
Total income tax benefit from stock compensation	$ 28,000,000	26,000,000	22,000,000
Additional disclosures pertaining to stock based compensation [Abstract]
Contractual term (in years)	8 years
Vesting period (in years)	3 years
Stock-based compensation, additional disclosures [Abstract]
Tax benefit from exercise of stock options and vesting of restricted stock unit awards	$ 3,000,000	18,000,000	4,000,000
Proceeds from exercise of stock options	$ 101,000,000	638,000,000	380,000,000
Stock Option Plans
Additional disclosures pertaining to stock based compensation [Abstract]
Number of shares available for grant (in shares) \| shares	18,063,072
Unrecognized compensation expense	$ 8,000,000
Unrecognized compensation expense, weighted-average period of recognition in years	1 year 4 months 24 days
Stock-based compensation, additional disclosures [Abstract]
Total intrinsic value of options exercised	$ 18,000,000	150,000,000	28,000,000
Performance Shares \| Incentive Stock Plans
Additional disclosures pertaining to stock based compensation [Abstract]
Vesting period (in years)	3 years
Unrecognized compensation expense	$ 32,000,000
Time-Vested Stock \| Incentive Stock Plans
Additional disclosures pertaining to stock based compensation [Abstract]
Vesting period (in years)	3 years
Number of shares available for grant (in shares) \| shares	6,091,685
Unrecognized compensation expense	$ 74,000,000
Unrecognized compensation expense, weighted-average period of recognition in years	1 year 7 months 6 days
Stock-based compensation, additional disclosures [Abstract]
Total fair value of shares vested	$ 87,000,000	$ 72,000,000	$ 45,000,000
Program 2025
Stock Repurchases [Abstract]
Stock repurchase program, authorized amount				$ 5,000,000,000

Supplemental Balance Sheet Information - Schedule of Other Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Other liabilities
Pension and other retiree benefits	$ 1,241	$ 1,306
Long-term lease liabilities	448	456
Restructuring accrual	9	29
Other	362	320
Total Other liabilities	$ 2,060	$ 2,111

Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Statement of Comprehensive Income [Abstract]
Net income including noncontrolling interests	$ 2,261	$ 3,049	$ 2,455
Other comprehensive income (loss), net of tax:
Cumulative translation adjustments	338	(343)	98
Retirement plan and other retiree benefit adjustments	22	43	(16)
Gains (losses) on cash flow hedges	(16)	8	(7)
Total Other comprehensive income (loss), net of tax	344	(292)	75
Total Comprehensive income including noncontrolling interests	2,605	2,757	2,530
Less: Net income attributable to noncontrolling interests	129	160	155
Less: Cumulative translation adjustments attributable to noncontrolling interests	2	(8)	(42)
Total Comprehensive income attributable to noncontrolling interests	131	152	113
Total Comprehensive income attributable to Colgate-Palmolive Company	$ 2,474	$ 2,605	$ 2,417

Income Taxes - Income Tax Paid (Details) $ in Millions	12 Months Ended
Income Taxes - Income Tax Paid (Details) $ in Millions	Dec. 31, 2025 USD ($)
Income Tax Contingency [Line Items]
U.S. federal	$ 268.0
U.S. state and local	33.0
Total	913.0
Brazil
Income Tax Contingency [Line Items]
Foreign	76.0
India
Income Tax Contingency [Line Items]
Foreign	68.0
Mexico
Income Tax Contingency [Line Items]
Foreign	70.0
Switzerland
Income Tax Contingency [Line Items]
Foreign	48.0
Other foreign jurisdictions
Income Tax Contingency [Line Items]
Foreign	$ 350.0

Retirement Plans and Other Retiree Benefits - Schedule of Allocation of Plan Assets and Level of Valuation Input, by Major Asset Category (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Minimum
Defined Benefit Plan Disclosure [Line Items]
Investment redemption notice period	0 months
Maximum
Defined Benefit Plan Disclosure [Line Items]
Investment redemption notice period	3 months
United States \| Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ 1,313	$ 1,295	$ 1,360
Percent of fixed income assets invested in US treasury or agency securities	30.00%	30.00%
United States \| Pension Plans \| Fair Value, Inputs, Level 1, 2 and 3
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ 887	$ 886
United States \| Pension Plans \| Fair Value Measured at Net Asset Value Per Share
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	444	448
United States \| Pension Plans \| Cash and cash equivalents \| Fair Value, Inputs, Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	230	226
United States \| Pension Plans \| U.S. common stocks \| Fair Value, Inputs, Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	1	1
United States \| Pension Plans \| International common stocks \| Fair Value, Inputs, Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
United States \| Pension Plans \| Pooled funds \| Fair Value, Inputs, Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	33	35
United States \| Pension Plans \| Fixed income securities \| Fair Value, Inputs, Level 2
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	600	624
United States \| Pension Plans \| Multi-Asset funds \| Fair Value, Inputs, Level 2
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	23
United States \| Pension Plans \| Multi-Asset funds \| Fair Value Measured at Net Asset Value Per Share
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	131	157
United States \| Pension Plans \| Guaranteed investment contracts \| Fair Value, Inputs, Level 2
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
United States \| Pension Plans \| Domestic, developed and emerging markets equity funds \| Fair Value Measured at Net Asset Value Per Share
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	253	223
United States \| Pension Plans \| Fixed income funds \| Fair Value Measured at Net Asset Value Per Share
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	60	68
United States \| Pension Plans \| Hedge funds \| Fair Value Measured at Net Asset Value Per Share
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
United States \| Pension Plans \| Real estate funds \| Fair Value Measured at Net Asset Value Per Share
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
United States \| Pension Plans \| Other assets and liabilities, net
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	(18)	(39)
International \| Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	582	537	$ 566
International \| Pension Plans \| Fair Value, Inputs, Level 1, 2 and 3
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	271	246
International \| Pension Plans \| Fair Value Measured at Net Asset Value Per Share
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	306	286
International \| Pension Plans \| Cash and cash equivalents \| Fair Value, Inputs, Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	21	21
International \| Pension Plans \| U.S. common stocks \| Fair Value, Inputs, Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	2	2
International \| Pension Plans \| International common stocks \| Fair Value, Inputs, Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	16	15
International \| Pension Plans \| Pooled funds \| Fair Value, Inputs, Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	120	103
International \| Pension Plans \| Fixed income securities \| Fair Value, Inputs, Level 2
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	82	75
International \| Pension Plans \| Multi-Asset funds \| Fair Value, Inputs, Level 2
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0
International \| Pension Plans \| Multi-Asset funds \| Fair Value Measured at Net Asset Value Per Share
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	2	2
International \| Pension Plans \| Guaranteed investment contracts \| Fair Value, Inputs, Level 2
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	30	30
International \| Pension Plans \| Domestic, developed and emerging markets equity funds \| Fair Value Measured at Net Asset Value Per Share
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	25	28
International \| Pension Plans \| Fixed income funds \| Fair Value Measured at Net Asset Value Per Share
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	237	222
International \| Pension Plans \| Hedge funds \| Fair Value Measured at Net Asset Value Per Share
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	9	7
International \| Pension Plans \| Real estate funds \| Fair Value Measured at Net Asset Value Per Share
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	33	27
International \| Pension Plans \| Other assets and liabilities, net
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ 5	$ 5

Goodwill and Other Intangible Assets - Schedule of Other Intangible Assets (Details) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Finite and indefinite-lived intangible assets [Line Items]
Finite & indefinite lived intangibles, gross	$ 2,575	$ 2,686
Finite-lived intangible assets, accumulated amortization	(1,039)	(930)
Intangible assets, net (excluding goodwill)	1,536	1,756
Indefinite life intangible assets
Finite and indefinite-lived intangible assets [Line Items]
Indefinite-lived intangible assets (excluding goodwill)	1,027	948
Intangible assets, net (excluding goodwill)	1,027	948
Trademarks
Finite and indefinite-lived intangible assets [Line Items]
Finite-lived intangible assets, gross	974	1,135
Finite-lived intangible assets, accumulated amortization	(594)	(545)
Finite-lived intangible assets, net	380	590
Other finite life intangible assets
Finite and indefinite-lived intangible assets [Line Items]
Finite-lived intangible assets, gross	574	603
Finite-lived intangible assets, accumulated amortization	(445)	(385)
Finite-lived intangible assets, net	$ 129	$ 218

Employee Stock Ownership Plan (Details) - USD ($)	12 Months Ended
Employee Stock Ownership Plan (Details) - USD ($)	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]
Shares in ESOP (in shares)	6,646,688	7,428,343
Outstanding borrowings in the ESOP	$ 0
Annual ESOP expense	0	$ 0	$ 0
Dividends paid by the Company on shares held by the ESOP	15,000,000	16,000,000	17,000,000
Company contributions to the ESOP	$ 0	$ 0	$ 0

Leases (Tables)

12 Months Ended

Dec. 31, 2025

Leases [Abstract]

Schedule of Right-of-use Assets and Liabilities for Operating Leases

As of December 31, 2025 and 2024, the Company’s right-of-use assets and liabilities for operating leases were as follows:


	2025		2024
Other assets	$	531	$	529

Other accruals	118		107
Other liabilities	448		456
Total operating lease liabilities	$	566	$	563

Schedule of Operating Lease Liabilities

Lease liabilities for operating leases as of December 31, 2025 were as follows:




2026	$	140
2027	125
2028	100
2029	72
2030	60
Thereafter	163
Total lease commitments	$	660
Less: Interest	(94)
Present value of lease liabilities	$	566

Schedule of Components of Operating Lease Expense

The components of the Company’s operating lease cost for the twelve months ended December 31, 2025 and 2024 were as follows:


	2025		2024
Operating lease cost	$	152	$	144
Short-term lease cost	1		3
Variable lease cost	17		19
Sublease Income	(1)		(2)
Total lease cost	$	169	$	164

Supplemental Income Statement Information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Other (income) expense, net
Amortization of intangible assets	$ 78	$ 75	$ 72
Equity income	(20)	(22)	(17)
Restructuring programs	7	59	24
Product recall costs	0	0	25
Losses (gains) from marketable securities and sale of other assets	1	6	11
Indirect tax payments (refunds)	37	27	18
Acquisition-related costs	9	0	0
Other, net	11	19	58
Total Other (income) expense, net	123	164	191
Research and development	366	355	343
Advertising	$ 2,703	$ 2,720	$ 2,371

Income Taxes (Tables)

12 Months Ended

Dec. 31, 2025

Income Tax Disclosure [Abstract]

Schedule of Components of Income Before Income Taxes

The components of Income before income taxes are as follows for the years ended December 31:


	2025		2024		2023
United States	$	1,419	$	1,084	$	692
International	1,640		2,872		2,700
Total Income before income taxes	$	3,059	$	3,956	$	3,392

Schedule of Provision for Income Taxes

The Provision for income taxes consists of the following for the years ended December 31:


	2025		2024		2023
U.S. federal	$	168	$	169	$	77
U.S. state and local	42		19		(5)
International	588		719		865
Total Provision for income taxes	$	798	$	907	$	937

Schedule of Components of Deferred Income Tax Benefit


	2025		2024		2023
Goodwill and intangible assets	$	129	$	3	$	1
Property, plant and equipment	23		12		(13)
Pension and other retiree benefits	(22)		(6)		68
Stock-based compensation	—		(14)		2
Right-of-use assets/lease liabilities	—		2		1
Tax credits and tax loss carryforwards, net of valuation allowance	(42)		37		29

Deferred withholding tax	(4)		(14)		7
Research and experimentation capitalization	23		21		29
Other, net	49		(8)		11
Total deferred tax benefit (provision)	$	156	$	33	$	135

Schedule of Effective Tax Rate Reconciliation

The difference between the statutory U.S. federal income tax rate and the Company's global effective tax rate as reflected in the Consolidated Statements of Income is as follows:


	2025
	Amount		Percent
U.S. federal statutory tax rate	$	642	21.0	%
State and local income taxes, net of federal income tax effect(a)	42		1.4
Foreign tax effects
Brazil	38		1.2
Switzerland
Statutory income tax rate differential	(82)		(2.7)
Local income tax	35		1.1
Other	12		0.4
France
Nondeductible goodwill impairment	59		1.9
Other	(13)		(0.4)
Other foreign jurisdictions	168		5.5

Effect of cross-border tax laws
Foreign-derived intangible income benefit	(88)		(2.9)
Foreign tax credits	(83)		(2.7)
Branch U.S. tax, net of foreign tax credit	(49)		(1.6)
Other	(15)		(0.5)
Tax credits	(10)		(0.3)
Changes in valuation allowances
Branch U.S. tax	65		2.1
Other	5		0.2
Nontaxable or nondeductible items
Nondeductible goodwill impairment	37		1.2
Other	19		0.6
Changes in unrecognized tax benefits	23		0.7
Other	(7)		(0.1)
Global effective tax rate	$	798	26.1	%

(a) State taxes in Kansas, California and Illinois made up the majority (greater than 50 percent) of this category.


	2024		2023
Percentage of Income before income taxes
U.S. federal statutory rate	21.0	%	21.0	%
State and local income taxes, net of federal benefit	0.5		(0.1)
Earnings taxed at other than U.S. federal statutory rate	4.1		5.4




Non-deductible goodwill impairment charges	—		—
Foreign-derived intangible income benefit	(2.6)		(2.4)
Foreign tax matter	—		3.7
Other, net	(0.1)		—
Global effective tax rate	22.9	%	27.6	%

Schedule of Cash Flow, Supplemental Disclosures

A summary of income taxes paid in 2025 is as follows:


	2025
U.S. federal	$	268
U.S. state and local	33
Foreign
Brazil	76
India	68
Mexico	70
Switzerland	48
Other foreign jurisdictions	350
Total	$	913

Schedule of Components of Deferred Tax Assets (Liabilities)

The components of deferred tax assets (liabilities) are as follows at December 31:


	2025		2024
Deferred tax liabilities:
Goodwill and intangible assets	$	(283)	$	(389)
Property, plant and equipment	(384)		(397)
Right-of-use assets	(124)		(126)
Deferred withholding tax	(114)		(110)
Other	(71)		(130)
Total deferred tax liabilities	(976)		(1,152)
Deferred tax assets:
Pension and other retiree benefits	245		272
Tax credits and tax loss carryforwards	493		430
Lease liabilities	134		137
Accrued liabilities	266		223
Stock-based compensation	61		61
Research and experimentation capitalization	132		108
Other	99		101
Total deferred tax assets	1,430		1,332
Valuation allowance	$	(430)	$	(328)
Net deferred tax assets	$	1,000	$	1,004
Net deferred income taxes	$	24	$	(148)

The changes in valuation allowance for deferred tax assets are as follows:


	2025		2024		2023
Balance, January 1	$	328	$	287	$	129
Additions
Charged to costs and expenses	102		56		158

Deductions	—		15		—
Balance, December 31	$	430	$	328	$	287

Schedule of Unrecognized Tax Benefits Activity

Unrecognized tax benefits activity for the years ended December 31, 2025, 2024 and 2023 is summarized below:


	2025		2024		2023
Unrecognized tax benefits:
Balance, January 1	$	296	$	314	$	298
Increases as a result of tax positions taken during the current year	25		37		73
Decreases of tax positions taken during prior years	(22)		(53)		(61)
Increases of tax positions taken during prior years	10		10		6
Decreases as a result of settlements with taxing authorities and the expiration of statutes of limitations	(1)		(3)		(2)
Effect of foreign currency rate movements	11		(9)		—
Balance, December 31	$	319	$	296	$	314

Summary of Significant Accounting Policies - Shipping and Handling Costs, Property, Plant and Equipment (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Property, Plant and Equipment [Line Items]
Selling, general and administrative expenses	$ 7,903	$ 7,729	$ 7,151
Buildings
Property, Plant and Equipment [Line Items]
Estimated useful life	40 years
Minimum \| Machinery and equipment
Property, Plant and Equipment [Line Items]
Estimated useful life	3 years
Maximum \| Machinery and equipment
Property, Plant and Equipment [Line Items]
Estimated useful life	15 years
Shipping and Handling
Property, Plant and Equipment [Line Items]
Selling, general and administrative expenses	$ 1,789	$ 1,777	$ 1,771

- Definition

The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.

+ References + Details

Long-Term Debt and Credit Facilities (Tables)

12 Months Ended

Dec. 31, 2025

Debt Disclosure [Abstract]

Schedule of Long-term Debt Instruments

Long-term debt consisted of the following at December 31:


	Weighted Average Interest Rate	Maturities			2025		2024
Notes	2.9%	2026	-	2078	$	7,767	$	6,946
Commercial paper	2.0%	2026			147		936
Finance Lease Obligations		Various			72		59
					7,986		7,941
Less: Current portion of long-term debt					(1,115)		(652)
Total					$	6,871	$	7,289

Schedule of Short-Term Debt

Debt payable within one year consisted of the following at December 31:


	2025		2024
Notes and loans payable	$	2	$	8
Current portion of long-term debt	1,115		652
Debt payable within one year	$	1,117	$	660

Schedule of Maturities of Long-term Debt

Excluding commercial paper, scheduled maturities of long-term debt and finance leases outstanding as of December 31, 2025 were as follows:


Years Ended December 31,
2026	$	1,115
2027	523
2028	615
2029	591
2030	500
Thereafter	4,495
Total	$	7,839

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22))
-SubTopic 10
-Topic 210
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 942
-SubTopic 235
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 4
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B

Reference 6: http://www.xbrl.org/2003/role/exampleRef
-Topic 470
-SubTopic 20
-Name Accounting Standards Codification
-Section 55
-Paragraph 69E
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 835
-SubTopic 30
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482925/835-30-45-2

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-3

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147477734/942-470-50-3

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-8

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 6
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-6

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-7

+ Details

Retirement Plans and Other Retiree Benefits - Schedule of Expected Contributions and Benefit Payments (Details) $ in Millions	Dec. 31, 2025 USD ($)
Total benefit payments [Abstract]
2026	$ 435
2027	245
2028	250
2029	250
2030	250
2031-2035	1,194
Other Retiree Benefit Plans
Total benefit payments [Abstract]
2026	53
2027	57
2028	58
2029	58
2030	58
2031-2035	288
United States \| Pension Plans
Total benefit payments [Abstract]
2026	335
2027	142
2028	143
2029	140
2030	140
2031-2035	633
International \| Pension Plans
Total benefit payments [Abstract]
2026	47
2027	46
2028	49
2029	52
2030	52
2031-2035	$ 273

Supplemental Other Comprehensive Income (Loss) Information

12 Months Ended

Dec. 31, 2025

Equity [Abstract]

Supplemental Other Comprehensive Income (Loss) Information

Other comprehensive income (loss) components attributable to Colgate-Palmolive Company before tax and net of tax during the years ended December 31 were as follows:


	2025		2024		2023
Cumulative translation adjustments:
Cumulative translation adjustments, pre-tax	$	258	$	(298)	$	127
Tax amounts	78		(37)		13
Cumulative translation adjustments, net of tax	336		(335)		140
Pension and other benefits:
Net actuarial gain (loss), prior service costs and settlements during the period	5		31		(49)
Amortization of net actuarial loss, transition and prior service costs(1)	24		28		30

Retirement Plan and other retiree benefit adjustments, pre-tax	29		59		(19)





Tax amounts	(7)		(16)		3
Retirement Plan and other retiree benefit adjustments, net of tax	22		43		(16)
Cash flow hedges:


Gains (losses) on cash flow hedges, pre-tax	(21)		10		(10)
Tax amounts	5		(2)		3
Gains (losses) on cash flow hedges, net of tax	(16)		8		(7)
Total Other comprehensive income (loss), net of tax	$	342	$	(284)	$	117

(1)These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 10, Retirement Plans and Other Retiree Benefits for additional details.

There were no tax impacts on Other comprehensive income (loss) attributable to Noncontrolling interests.

Accumulated Other Comprehensive Income (Loss)

Accumulated other comprehensive income (loss) is comprised of cumulative foreign currency translation gains and losses, unrecognized pension and other retiree benefit costs and unrealized gains and losses from derivative instruments designated as cash flow hedges. At December 31, 2025 and 2024, Accumulated other comprehensive income (loss) consisted primarily of aftertax unrecognized pension and other retiree benefit costs of $583 and $605, respectively, and aftertax cumulative foreign currency translation losses of $3,351 and $3,687, respectively. Foreign currency translation adjustments in 2025 primarily reflect gains from the euro, Mexican Peso and Brazilian Real. Foreign currency translation adjustments in 2024 primarily reflect losses from the euro, Brazilian Real and Mexican Peso.

Capital Stock and Stock-Based Compensation Plans - Schedule of Stock Option Activity (Details) $ / shares in Units, shares in Thousands, $ in Millions	12 Months Ended
	Dec. 31, 2025 USD ($) $ / shares shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]
Options - beginning balance (in shares) \| shares	12,774
Granted (in shares) \| shares	1,284
Exercised (in shares) \| shares	(1,340)
Forfeited (in shares) \| shares	(87)
Expired (in share) \| shares	(12)
Options - ending balance (in shares) \| shares	12,619
Options exercisable (in shares) \| shares	10,174
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Options - beginning of period (in dollars per share) \| $ / shares	$ 78
Options - shares granted (in dollars per share) \| $ / shares	84
Options - shares exercised (in dollars per share) \| $ / shares	76
Options - shares forfeited (in dollars per share) \| $ / shares	82
Options - shares expired (in dollars per share) \| $ / shares	79
Options - end of period (in dollars per share) \| $ / shares	79
Options exercisable - end of period (in dollars per share) \| $ / shares	$ 77
Weighted average remaining contractual life, options outstanding (in years)	4 years
Weighted average remaining contractual life, options exercisable (in years)	4 years
Intrinsic value of unexercised in-the-money options, options outstanding \| $	$ 32
Intrinsic value of unexercised in-the-money options, options exercisable \| $	$ 28

Retirement Plans and Other Retiree Benefits - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Defined Benefit Plan Disclosure [Line Items]
ERISA litigation matter	$ 65	$ 0	$ 267
Pension Plans \| United States
Defined Benefit Plan Disclosure [Line Items]
ERISA litigation matter	$ (34)	$ 0	267
Percentage of investments in Company's common stock	0.00%	0.00%
U.S. plans assets purchased to Company (in shares)	0	0
Defined benefit plan dividends received on employer securities	$ 0	$ 0
Expected long-term rate of return on plan assets	6.50%	6.50%
Average annual rates of return for the most recent 1-year period	10.00%
Average annual rates of return for the most recent 5-year period	1.00%
Average annual rates of return for the most recent 10-year period	5.00%
Average annual rates of return for the most recent 15-year period	6.00%
Average annual rates of return for the most recent 25-year period	5.00%
Voluntary contributions to postretirement plans	$ 23	$ 0	0
Voluntary contributions to postretirement plans for the next 12 months	99
Pension Plans \| United States \| ERISA
Defined Benefit Plan Disclosure [Line Items]
ERISA litigation matter	65
Pension Plans \| International
Defined Benefit Plan Disclosure [Line Items]
ERISA litigation matter	$ 0	0	0
Expected long-term rate of return on plan assets	5.36%
Other Retiree Benefit Plans
Defined Benefit Plan Disclosure [Line Items]
ERISA litigation matter	$ 0	$ 0	$ 0
Medical cost trend rate assumed for next fiscal year	7.00%
Defined benefit plan, health care cost trend rate assumed	5.00%
Year which ultimate medical cost trend rate is reached	2031
Ultimate medical cost trend rate	4.50%

Goodwill and Other Intangible Assets - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Goodwill [Line Items]
Amortization of intangible assets	$ 78	$ 75	$ 72
Annual estimated amortization expense, year 1	51
Annual estimated amortization expense, year 2	51
Annual estimated amortization expense, year 3	51
Annual estimated amortization expense, year 4	51
Annual estimated amortization expense, year 5	51
Impairments	582
Goodwill	3,122	$ 3,272	$ 3,410
Filorga Reporting Unit
Goodwill [Line Items]
Goodwill	51
Trademarks
Goodwill [Line Items]
Impairment, long-lived asset, held-for-use	$ 244
Impairment, Long-Lived Asset, Held-for-Use, Statement of Income or Comprehensive Income [Extensible Enumeration]	Goodwill and intangible assets impairment charges
Customer Relationships
Goodwill [Line Items]
Impairment, long-lived asset, held-for-use	$ 93

Supplier Finance Program	12 Months Ended
Supplier Finance Program	Dec. 31, 2025
Other Liabilities Disclosure [Abstract]
Supplier Finance Program	Supplier Finance Program The Company has agreements to provide supplier finance programs which facilitate participating suppliers’ ability to finance payment obligations of the Company with designated third-party financial institutions. Participating suppliers may, at their sole discretion, elect to finance one or more payment obligations of the Company prior to their scheduled due dates at a discounted price to participating financial institutions. The Company’s obligations to its suppliers, including amounts due and scheduled payment dates, are not impacted by suppliers’ decisions to finance amounts under these arrangements. The outstanding payment obligations under the Company’s supplier finance programs are included in Accounts Payable in the Consolidated Balance Sheets and were not material as of December 31, 2025 or 2024.

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Dec. 31, 2025	Dec. 31, 2024
Current Assets
Allowance for doubtful accounts receivable, current	$ 90	$ 85
Shareholders’ Equity
Common stock par value (in dollars per share)	$ 1	$ 1
Common stock authorized (in shares)	2,000,000,000	2,000,000,000
Common stock issued (in shares)	1,465,706,360	1,465,706,360

Income Taxes - Schedule of Income Tax Provision Reconciliation (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Income Tax Disclosure [Abstract]
Goodwill and intangible assets	$ 129	$ 3	$ 1
Property, plant and equipment	23	12	(13)
Pension and other retiree benefits	(22)	(6)	68
Stock-based compensation	0	(14)	2
Right-of-use assets/lease liabilities	0	2	1
Tax credits and tax loss carryforwards, net of valuation allowance	(42)	37	29
Deferred withholding tax	(4)	(14)	7
Research and experimentation capitalization	23	21	29
Other, net	49	(8)	11
Total deferred tax benefit (provision)	$ 156	$ 33	$ 135

Restructuring and Related Implementation Charges - Narrative (Details) - USD ($) $ in Millions	Jul. 31, 2025	Dec. 31, 2025
Strategic Growth and Productivity Program
Restructuring Cost and Reserve [Line Items]
Restructuring program period in force	3 years
Pretax charges related to the Restructuring Program to date		$ 13
Restructuring and related cost incurred cost to date after tax		11
Strategic Growth and Productivity Program \| Employee-Related Costs
Restructuring Cost and Reserve [Line Items]
Pretax charges related to the Restructuring Program to date		6
Strategic Growth and Productivity Program \| Asset-Related Costs and Other
Restructuring Cost and Reserve [Line Items]
Pretax charges related to the Restructuring Program to date		7
Global Productivity Initiative
Restructuring Cost and Reserve [Line Items]
Pretax charges related to the Restructuring Program to date		228
Restructuring and related cost incurred cost to date after tax		186
Minimum \| Strategic Growth and Productivity Program
Restructuring Cost and Reserve [Line Items]
Restructuring and related cost, expected cost		$ 200
Restructuring and related cost, expected cost, cash (in percent)		75.00%
Minimum \| Strategic Growth and Productivity Program \| Pet Nutrition
Restructuring Cost and Reserve [Line Items]
Restructuring and related cost, expected cost (in percent)		10.00%
Minimum \| Strategic Growth and Productivity Program \| Corporate
Restructuring Cost and Reserve [Line Items]
Restructuring and related cost, expected cost (in percent)		10.00%
Minimum \| Strategic Growth and Productivity Program \| North America
Restructuring Cost and Reserve [Line Items]
Restructuring and related cost, expected cost (in percent)		15.00%
Minimum \| Strategic Growth and Productivity Program \| Latin America
Restructuring Cost and Reserve [Line Items]
Restructuring and related cost, expected cost (in percent)		15.00%
Minimum \| Strategic Growth and Productivity Program \| Europe
Restructuring Cost and Reserve [Line Items]
Restructuring and related cost, expected cost (in percent)		10.00%
Minimum \| Strategic Growth and Productivity Program \| Asia Pacific
Restructuring Cost and Reserve [Line Items]
Restructuring and related cost, expected cost (in percent)		10.00%
Minimum \| Strategic Growth and Productivity Program \| Africa/Eurasia
Restructuring Cost and Reserve [Line Items]
Restructuring and related cost, expected cost (in percent)		5.00%
Minimum \| Strategic Growth and Productivity Program \| Employee-Related Costs
Restructuring Cost and Reserve [Line Items]
Restructuring and related cost, expected cost (in percent)		65.00%
Minimum \| Strategic Growth and Productivity Program \| Asset-Related Costs and Other
Restructuring Cost and Reserve [Line Items]
Restructuring and related cost, expected cost (in percent)		25.00%
Maximum \| Strategic Growth and Productivity Program
Restructuring Cost and Reserve [Line Items]
Restructuring and related cost, expected cost		$ 300
Restructuring and related cost, expected cost, cash (in percent)		85.00%
Maximum \| Strategic Growth and Productivity Program \| Pet Nutrition
Restructuring Cost and Reserve [Line Items]
Restructuring and related cost, expected cost (in percent)		15.00%
Maximum \| Strategic Growth and Productivity Program \| Corporate
Restructuring Cost and Reserve [Line Items]
Restructuring and related cost, expected cost (in percent)		15.00%
Maximum \| Strategic Growth and Productivity Program \| North America
Restructuring Cost and Reserve [Line Items]
Restructuring and related cost, expected cost (in percent)		20.00%
Maximum \| Strategic Growth and Productivity Program \| Latin America
Restructuring Cost and Reserve [Line Items]
Restructuring and related cost, expected cost (in percent)		20.00%
Maximum \| Strategic Growth and Productivity Program \| Europe
Restructuring Cost and Reserve [Line Items]
Restructuring and related cost, expected cost (in percent)		15.00%
Maximum \| Strategic Growth and Productivity Program \| Asia Pacific
Restructuring Cost and Reserve [Line Items]
Restructuring and related cost, expected cost (in percent)		15.00%
Maximum \| Strategic Growth and Productivity Program \| Africa/Eurasia
Restructuring Cost and Reserve [Line Items]
Restructuring and related cost, expected cost (in percent)		10.00%
Maximum \| Strategic Growth and Productivity Program \| Employee-Related Costs
Restructuring Cost and Reserve [Line Items]
Restructuring and related cost, expected cost (in percent)		75.00%
Maximum \| Strategic Growth and Productivity Program \| Asset-Related Costs and Other
Restructuring Cost and Reserve [Line Items]
Restructuring and related cost, expected cost (in percent)		35.00%

Summary of Significant Accounting Policies (Policies)	12 Months Ended
Summary of Significant Accounting Policies (Policies)	Dec. 31, 2025
Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation The Consolidated Financial Statements include the accounts of Colgate-Palmolive Company and its majority-owned or controlled subsidiaries. Intercompany transactions and balances have been eliminated. The Company’s investments in consumer products companies with interests ranging between 20% and 50%, where the Company has significant influence over the investee, are accounted for using the equity method. Net income (loss) from such investments is recorded in Other (income) expense, net in the Consolidated Statements of Income. As of December 31, 2025 and 2024, equity method investments included in Other assets in the Consolidated Balance Sheets were $82 and $81, respectively. Unrelated third parties hold the remaining ownership interests in these investments. Investments with less than a 20% interest are recorded at cost and periodically adjusted based on observable price changes or quoted market prices in active markets, if applicable.
Use of Estimates	Use of Estimates The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to use judgment and make estimates that affect the reported amounts of assets and liabilities and disclosure of contingent gains and losses at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The level of uncertainty in estimates and assumptions increases with the length of time until the underlying transactions are completed. As such, the most significant uncertainty in the Company’s assumptions and estimates involved in preparing the financial statements includes pension and other retiree benefit cost assumptions, stock-based compensation, asset impairments, uncertain tax positions, tax valuation allowances and legal and other contingency reserves. Additionally, the Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments and retirement plan assets. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. Actual results could ultimately differ from those estimates.
Revenue Recognition	Revenue Recognition The Company’s revenue contracts represent a single performance obligation to sell its products to trade customers. Sales are recorded at the time control of the products is transferred to trade customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for the products. Control is the ability of trade customers to “direct the use of” and “obtain the benefit from” our products. In evaluating the timing of the transfer of control of products to trade customers, the Company considers several control indicators, including significant risks and rewards of products, the Company’s right to payment and the legal title of the products. Based on the assessment of control indicators, sales are generally recognized when products are delivered to trade customers. Net sales reflect the transaction prices for contracts, which include units shipped at selling list prices reduced by variable consideration. Variable consideration includes expected sales returns and the cost of current and continuing promotional programs. Current promotional programs primarily include product listing allowances and co-operative advertising arrangements. Continuing promotional programs are predominantly consumer coupons and volume-based sales incentive arrangements. The cost of promotional programs is estimated using the expected value method considering all reasonably available information, including the Company’s historical experience and its current expectations, and is reflected in the transaction price when sales are recorded. Adjustments to the cost of promotional programs in subsequent periods are generally not material, as the Company’s promotional programs are typically of short duration, thereby reducing the uncertainty inherent in such estimates. Sales returns are generally accepted at the Company’s discretion and are not material to the Company’s Consolidated Financial Statements. The Company’s contracts with trade customers do not have significant financing components or non-cash consideration and the Company does not have unbilled revenue or significant amounts of prepayments from customers. The Company records Net sales excluding taxes collected on its sales to its trade customers. Shipping and handling activities are accounted for as contract fulfillment costs and classified as Selling, general and administrative expenses.
Shipping and Handling Costs	Shipping and Handling Costs Shipping and handling costs (also referred to as logistics costs) are classified as Selling, general and administrative expenses and were $1,789, $1,777 and $1,771 for the years ended December 31, 2025, 2024 and 2023, respectively.
Marketing Costs	Marketing Costs The Company markets its products through advertising and other promotional activities. Advertising costs are included in Selling, general and administrative expenses and are expensed as incurred. Certain consumer and trade promotional programs, such as consumer coupons, are recorded as a reduction of sales.
Cash and Cash equivalents	Cash and Cash Equivalents The Company considers all highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents.
Inventories	Inventories The cost of approximately 75% of inventories is determined using the FIFO method, which is stated at the lower of cost or net realizable value. The cost of the remaining inventories is determined using the LIFO method, which is stated at the lower of cost or market. Inventories in excess of one year of forecasted sales are classified in the Consolidated Balance Sheets as non-current “Other assets.”
Property, Plant and Equipment	Property, Plant and Equipment Land, buildings and machinery and equipment are stated at cost. Depreciation is provided, primarily using the straight-line method, over the estimated useful lives ranging from 3 to 15 years for machinery and equipment and up to 40 years for buildings. Depreciation attributable to manufacturing operations is included in Cost of sales. The remaining component of depreciation is included in Selling, general and administrative expenses.
Goodwill and Other Intangibles	Goodwill and Other Intangibles Goodwill and indefinite-life intangible assets, such as the Company’s global brands, are subject to impairment tests at least annually or when events or changes in circumstances indicate that an asset may be impaired. In assessing impairment, the Company performs either a quantitative or a qualitative analysis. Determining the fair value of the Company’s reporting units for goodwill and the fair value of its intangible assets requires significant judgments and estimates by management. When a quantitative analysis is performed, the Company generally uses the income approach, which requires several estimates, including future cash flows consistent with management’s strategic plans, sales growth rates, operating margins, customer attrition rate and the selection of royalty rates and discount rates. In determining the fair value of the Company’s reporting units, fair value is also generally determined using the market approach, which is generally derived from metrics of comparable publicly traded companies. As multiple valuation methodologies are used, the Company also performs a qualitative analysis comparing the fair value of a reporting unit under each method to assess its reasonableness and ensure consistency of results. The Company generally engages a third-party valuation firm to assist in determining the fair value of intangible assets acquired in business combinations. Other intangible assets with finite lives, such as local brands and trademarks, customer relationships and non-compete agreements, are amortized over their estimated useful lives, generally ranging from 5 to 40 years. Amortization expense related to intangible assets is included in Other (income) expense, net, which is included in Operating profit.
Income Taxes	Income Taxes The provision for income taxes is determined using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized based upon the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates that will be in effect at the time such differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The Company uses a comprehensive model to recognize, measure, present and disclose in its financial statements uncertain tax positions that the Company has taken or expects to take on an income tax return. The Company recognizes interest expense and penalties related to unrecognized tax benefits within Provision for income taxes.
Financial Instruments	Financial Instruments Derivative instruments are recorded as assets and liabilities at estimated fair value based on available market information. The Company’s derivative instruments that qualify for hedge accounting are designated as either fair value hedges, cash flow hedges or net investment hedges. For fair value hedges, changes in the fair value of the derivative, as well as the offsetting changes in the fair value of the hedged item, are recognized in earnings each period. For cash flow hedges, changes in the fair value of the derivative are recorded in Other comprehensive income (loss) and are recognized in earnings when the offsetting effect of the hedged item is also recognized in earnings. For hedges of the net investment in foreign subsidiaries, changes in the fair value of the derivative are recorded in Other comprehensive income (loss) to offset the change in the value of the net investment being hedged. Cash flows related to hedges are classified in the same category as the cash flows from the hedged item in the Consolidated Statements of Cash Flows. The Company may also enter into certain foreign currency and interest rate instruments that economically hedge certain of its risks but do not qualify for hedge accounting. Changes in fair value of these derivative instruments, based on quoted market prices, are recognized in earnings each period. The Company’s derivative instruments and other financial instruments are more fully described in Note 7, Fair Value Measurements and Financial Instruments along with the related fair value measurement considerations.
Stock-Based Compensation	Stock-Based Compensation The Company recognizes the cost of employee services received in exchange for awards of equity instruments, such as stock options and restricted stock units (both performance-based and time-vested), based on the fair value of those awards at the date of grant over the requisite service period. The Company uses the Black-Scholes-Merton (“Black-Scholes”) option pricing model to estimate the fair value of stock option awards. In addition to performance conditions, performance-based restricted stock units also include a total shareholder return modifier. Because the total shareholder return modifier is considered a market condition, the Company uses a Monte-Carlo simulation model to determine the fair value of performance-based restricted stock units. The fair value of time-vested restricted stock units is determined based on the closing market price of the Company’s stock at the date of grant. Stock-based compensation plans, related expenses and assumptions used in the Black-Scholes option pricing model are more fully described in Note 8, Capital Stock and Stock-Based Compensation Plans.
Currency Translation	Currency Translation The assets and liabilities of foreign subsidiaries, other than those operating in highly inflationary environments, are translated into U.S. dollars at year-end exchange rates with resulting translation gains and losses accumulated in a separate component of shareholders’ equity. Income and expense items are translated into U.S. dollars at average rates of exchange prevailing during the year. For subsidiaries operating in highly inflationary environments, local currency-denominated non-monetary assets, including inventories, goodwill and property, plant and equipment, are remeasured at their historical exchange rates, while local currency-denominated monetary assets and liabilities are remeasured at year-end exchange rates. Remeasurement adjustments for these operations are included in Net income attributable to Colgate-Palmolive Company.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In September 2025, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2025-06, “Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software.” This ASU modernizes the capitalization criteria for internal-use software by eliminating references to project stages and clarifying the threshold applied to begin capitalizing costs. This guidance is effective for the Company for fiscal years beginning after December 15, 2027. The Company is currently assessing the impact of this new guidance. In November 2024, the FASB issued ASU No. 2024-03, “Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses.” This ASU requires additional disclosures related to the disaggregation of the income statement expense categories. This guidance is effective for the Company for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. Other than the new disclosure requirements, this guidance will not have an impact on the Company’s Consolidated Financial Statements. In December 2023, the FASB issued ASU No. 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures.” This ASU improves the transparency of income tax disclosure by requiring consistent categories and greater disaggregation of information in the rate reconciliation, and income taxes paid disaggregated by jurisdiction. The Company adopted this guidance in 2025. See Note 11, Income Taxes for additional information. There have been no other accounting pronouncements issued or effective during the fiscal year that have had, or are expected to have, a material impact on the Company’s Consolidated Financial Statements.
Reclassifications	Reclassifications Certain prior year amounts have been reclassified to conform to the current year presentation.

Restructuring and Related Implementation Charges - Schedule of Restructuring Charges, Cumulative to Date (Details) - Strategic Growth and Productivity Program $ in Millions	Dec. 31, 2025 USD ($)
Restructuring Cost and Reserve [Line Items]
Pretax charges related to the Restructuring Program to date	$ 13
Employee-Related Costs
Restructuring Cost and Reserve [Line Items]
Pretax charges related to the Restructuring Program to date	6
Asset-Related Costs and Other
Restructuring Cost and Reserve [Line Items]
Pretax charges related to the Restructuring Program to date	$ 7

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References + Details

Cover - USD ($)
$ in Billions

12 Months Ended

Dec. 31, 2025

Jan. 31, 2026

Jun. 30, 2025

Entity Information [Line Items]

Document Type

10-K

Document Annual Report

true

Document Period End Date

Dec. 31, 2025

Current Fiscal Year End Date

--12-31

Document Transition Report

false

Entity File Number

1-644

Entity Registrant Name

COLGATE-PALMOLIVE COMPANY

Entity Incorporation, State or Country Code

Entity Tax Identification Number

13-1815595

Entity Address, Address Line One

300 Park Avenue

Entity Address, City or Town

New York,

Entity Address, State or Province

Entity Address, Postal Zip Code

10022

City Area Code

212

Local Phone Number

310-2000

Entity Well-known Seasoned Issuer

Yes

Entity Voluntary Filers

Entity Current Reporting Status

Yes

Entity Interactive Data Current

Yes

Entity Filer Category

Large Accelerated Filer

Entity Small Business

false

Entity Emerging Growth Company

false

ICFR Auditor Attestation Flag

true

Document Financial Statement Error Correction [Flag]

false

Entity Shell Company

false

Entity Public Float

$ 73.4

Entity Common Stock, Shares Outstanding

801,548,028

Documents Incorporated by Reference



Documents			Form 10-K Reference
Portions of Proxy Statement for the 2026 Annual Meeting of Stockholders			Part III, Items 10 through 14

Entity Central Index Key

0000021665

Document Fiscal Year Focus

2025

Document Fiscal Period Focus

Amendment Flag

false

Common Stock

Entity Information [Line Items]

Title of 12(b) Security

Common Stock, $1.00 par value

Trading Symbol

Security Exchange Name

NYSE

0.500% Notes due 2026

Entity Information [Line Items]

Title of 12(b) Security

0.500% Notes due 2026

Trading Symbol

CL26

Security Exchange Name

NYSE

0.300% Notes due 2029

Entity Information [Line Items]

Title of 12(b) Security

0.300% Notes due 2029

Trading Symbol

CL29

Security Exchange Name

NYSE

1.375% Notes due 2034

Entity Information [Line Items]

Title of 12(b) Security

1.375% Notes due 2034

Trading Symbol

CL34

Security Exchange Name

NYSE

3.250% Notes due 2035

Entity Information [Line Items]

Title of 12(b) Security

3.250% Notes due 2035

Trading Symbol

CL35

Security Exchange Name

NYSE

0.875% Notes due 2039

Entity Information [Line Items]

Title of 12(b) Security

0.875% Notes due 2039

Trading Symbol

CL39

Security Exchange Name

NYSE

Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Operating Activities
Net income including noncontrolling interests	$ 2,261	$ 3,049	$ 2,455
Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations:
Depreciation and amortization	630	605	567
ERISA litigation matter	65	0	267
Restructuring and termination benefits, net of cash	(7)	51	(23)
Stock-based compensation expense	155	135	122
Goodwill and intangible assets impairment charges	919	0	0
Deferred income taxes	(109)	(77)	(98)
Cash effects of changes in:
Receivables	(16)	(56)	(37)
Inventories	109	(100)	194
Accounts payable and other working capital	251	516	309
Other non-current assets	35	28	53
Other non-current liabilities	(95)	(44)	(64)
Net cash provided by operations	4,198	4,107	3,745
Investing Activities
Capital expenditures	(564)	(561)	(705)
Purchases of marketable securities and investments	(698)	(574)	(506)
Proceeds from sale of marketable securities and investments	752	564	502
Payment for acquisitions, net of cash acquired	(293)	0	0
Other investing activities	(14)	37	(33)
Net cash used in investing activities	(817)	(534)	(742)
Financing Activities
Short-term borrowing (repayment) less than 90 days, net	(989)	93	(906)
Principal payments on debt	(655)	(503)	(903)
Proceeds from issuance of debt	1,188	2	1,495
Dividends paid	(1,823)	(1,789)	(1,749)
Purchases of treasury shares	(1,210)	(1,739)	(1,128)
Proceeds from exercise of stock options	101	638	380
Other financing activities	132	(91)	18
Net cash used in financing activities	(3,256)	(3,389)	(2,793)
Effect of exchange rate changes on Cash and cash equivalents	67	(54)	(19)
Net increase (decrease) in Cash and cash equivalents	192	130	191
Cash and cash equivalents at beginning of year	1,096	966	775
Cash and cash equivalents at end of year	1,288	1,096	966
Supplemental Cash Flow Information
Income taxes paid	913	933	937
Interest paid	$ 270	$ 302	$ 280

Segment Information

12 Months Ended

Dec. 31, 2025

Segment Reporting [Abstract]

Segment Information

The Company operates in two product segments: Oral, Personal and Home Care; and Pet Nutrition.

The operations of the Oral, Personal and Home Care product segment are managed geographically in five reportable operating segments: North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

The Company evaluates segment performance based on several factors, including Operating profit. The Company uses Operating profit as a measure of operating segment performance because it excludes the impact of Corporate-driven decisions related to interest expense and income taxes. The Chairman of the Board, President and Chief Executive Officer has been determined to be the Company’s Chief Operating Decision Maker and he uses Operating Profit to assess performance and to allocate resources for each of the reportable operating segments in the budgeting and forecasting process. Asset information by segment is not utilized for purposes of assessing performance or allocating resources, and therefore such information has not been presented.

The accounting policies of the operating segments are generally the same as those described in Note 2, Summary of Significant Accounting Policies. Intercompany sales have been eliminated. Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs, restructuring and related implementation charges and gains and losses on sales of non-core product lines and assets. The Company reports these items within Corporate operations as they relate to Corporate-based responsibilities and decisions and are not included in the internal measures of segment operating performance used by the Company to measure the underlying performance of the operating segments.

Approximately two-thirds of the Company’s Net sales are generated from markets outside the United States, with approximately 45% of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe). Oral, Personal and Home Care sales to Walmart, Inc. and its affiliates represent approximately 11% of the Company’s Net sales in each of the years 2025, 2024 and 2023. No other customer represented more than 10% of Net sales in any period presented.

In 2025, Corporate Operating profit included goodwill and intangible assets impairment charges of $919, charges resulting from the ERISA litigation matter and the Strategic Growth and Productivity Program of $99 and $13, respectively, and acquisition-related costs of $9. In 2024, Corporate Operating profit included charges resulting from the 2022 Global Productivity Initiative of $85. In 2023, Corporate Operating profit included charges resulting from the 2022 Global Productivity Initiative of $27 and product recall costs of $25.


	2025
	Net sales		Cost of Sales		Selling, general and administrative expenses		Other (income) expense, net (3)		Operating Profit
Reportable Segments
Oral, Personal and Home Care
North America(1)	$	4,045	$	1,589	$	1,626	$	47	$	784
Latin America	4,776		2,107		1,268		(11)		1,411
Europe	2,962		1,099		1,087		28		748
Asia Pacific	2,814		1,067		1,013		(27)		760
Africa/Eurasia	1,172		465		436		16		255
Total Oral, Personal and Home Care	15,769								3,959
Pet Nutrition(2)	4,613		1,818		1,717		14		1,064
Reconciliation with Total Company Operating Profit
Corporate									(1,717)
Total	$	20,382							$	3,306

Note: Table may not sum due to rounding.

(1) Net sales in the United States for Oral, Personal and Home Care were $3,596 in 2025.

(2) Net sales in the United States for Pet Nutrition were $3,062 in 2025.

(3) Refer to Note 17, Supplemental Income Statement for information related to Other (income) expense, net.


	2024
	Net sales		Cost of Sales		Selling, general and administrative expenses		Other (income) expense, net (3)		Operating Profit
Reportable Segments
Oral, Personal and Home Care
North America(1)	$	4,113	$	1,571	$	1,668	$	36	$	839
Latin America	4,782		1,933		1,328		(5)		1,526
Europe	2,770		1,050		1,031		31		658
Asia Pacific	2,858		1,078		997		(30)		812
Africa/Eurasia	1,095		432		395		16		253
Total Oral, Personal and Home Care	15,618								4,088
Pet Nutrition(2)	4,483		1,869		1,641		8		965
Reconciliation with Total Company Operating Profit
Corporate									(784)
Total	$	20,101							$	4,268

Note: Table may not sum due to rounding.

(1) Net sales in the United States for Oral, Personal and Home Care were $3,640 in 2024.

(2) Net sales in the United States for Pet Nutrition were $3,059 in 2024.

(3) Refer to Note 17, Supplemental Income Statement for information related to Other (income) expense, net.


	2023
	Net sales		Cost of Sales		Selling, general and administrative expenses		Other (income) expense, net (3)		Operating Profit
Reportable Segments
Oral, Personal and Home Care
North America(1)	$	4,091	$	1,588	$	1,594	$	37	$	871
Latin America	4,640		1,977		1,241		5		1,417
Europe	2,571		1,069		899		31		573
Asia Pacific	2,782		1,108		925		(18)		767
Africa/Eurasia	1,083		442		377		9		254
Total Oral, Personal and Home Care	15,167								3,882
Pet Nutrition(2)	4,290		1,964		1,493		26		806
Reconciliation with Total Company Operating Profit
Corporate									(704)
Total	$	19,457							$	3,984

Note: Table may not sum due to rounding.

(1) Net sales in the United States for Oral, Personal and Home Care were $3,625 in 2023.

(2) Net sales in the United States for Pet Nutrition were $2,918 in 2023

(3) Refer to Note 17, Supplemental Income Statement for information related to Other (income) expense, net.


	2025		2024		2023
Capital expenditures
Oral, Personal and Home Care
North America	$	65	$	52	$	46
Latin America	141		126		146
Europe	63		63		44
Asia Pacific	80		64		65
Africa/Eurasia	12		12		10
Total Oral, Personal and Home Care	361		317		311
Pet Nutrition	88		143		301
Corporate	115		101		93
Total Capital expenditures	$	564	$	561	$	705


	2025		2024		2023
Depreciation and amortization
Oral, Personal and Home Care
North America	$	123	$	124	$	116
Latin America	106		100		98
Europe	66		65		65
Asia Pacific	80		81		84
Africa/Eurasia	10		8		9
Total Oral, Personal and Home Care	385		378		372
Pet Nutrition	144		132		101
Corporate	101		95		94
Total Depreciation and amortization	$	630	$	605	$	567


	2025		2024
Long-lived assets(1)
United States	$	2,663	$	2,728
International	2,528		2,223
Total Long-lived assets	$	5,191	$	4,951

(1) Long-lived assets include Property, plant and equipment, net and lease right-of-use assets.

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-21

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 21
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-21

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 31
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-31

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-15

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 42
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-42

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 48
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-48

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (f)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 270
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482964/270-10-50-1

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (ee)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 11: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 12: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 54
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-54

Reference 13: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 47
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-47

Reference 14: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 54
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-54

Reference 15: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 47
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-47

Reference 16: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 54
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-54

Reference 17: http://www.xbrl.org/2003/role/exampleRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 47
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482785/280-10-55-47

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 34
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-34

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26C
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 40
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-40

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/280/tableOfContent

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 26
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-26

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-41

+ Details

Segment Information - Narrative (Details) $ in Millions	12 Months Ended
Segment Information - Narrative (Details) $ in Millions	Dec. 31, 2025 USD ($) segment	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)
Segment Reporting Information [Line Items]
Number of operating segments (in segments) \| segment	2
Number of reportable segments (in segments) \| segment	2
Number of geographically reportable operating segments (in segments) \| segment	5
Goodwill and intangible assets impairment charges	$ 919
Restructuring costs	7	$ 59	$ 24
Corporate
Segment Reporting Information [Line Items]
Acquisition-related costs	9
Operating Profit \| Corporate
Segment Reporting Information [Line Items]
Restructuring costs			27
Acquisition-related costs			$ 25
Operating Profit \| Corporate \| ERISA
Segment Reporting Information [Line Items]
Restructuring costs	99
Operating Profit \| Global Productivity Initiative \| Corporate
Segment Reporting Information [Line Items]
Restructuring costs	$ 13	$ 85
Sales Revenue, Net
Segment Reporting Information [Line Items]
Percentage of consolidated Net sales represented by sales outside US	66.70%
Percentage of consolidated Net sales coming from emerging markets	45.00%
Sales Revenue, Net \| Customer Concentration Risk \| Walmart, Inc.
Segment Reporting Information [Line Items]
Percentage of consolidated sales represented by one customer	11.00%	11.00%	11.00%